Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SULFONAMIDE COMPOUNDS AS PROTEASE INHIBITORS
Document Type and Number:
WIPO Patent Application WO/2003/024923
Kind Code:
A1
Abstract:
The present invention relates to cysteine protease inhibitors of the general formula I, the pharmaceutically acceptable salts and N-oxides thereof; their uses as therapeutic agents and the methods of their making.

Inventors:
PALMER JAMES (US)
Application Number:
PCT/US2002/028505
Publication Date:
March 27, 2003
Filing Date:
September 09, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AXYS PHARM INC (US)
PALMER JAMES (US)
International Classes:
C07C311/46; C07D209/08; C07D213/82; C07D277/42; C07D295/155; C07D295/215; C07D417/12; (IPC1-7): C07C311/45; A61K31/18; A61K31/27; A61K31/426; A61K31/47; A61K31/496; A61K31/5375; C07D209/08; C07D213/81; C07D213/82; C07D215/48; C07D277/42; C07D295/155; C07D295/215; C07D417/12
Domestic Patent References:
WO2000055144A12000-09-21
WO1998047523A11998-10-29
WO1996030353A11996-10-03
WO2000048993A12000-08-24
Attorney, Agent or Firm:
Bansal, Rekha (CA, US)
Download PDF:
Claims:
We Claim:
1. A compound of Formula I : in which: R1 and R2 independently are R8, X2OR8, X2SR8, X2S(O)R8, X2S(O)2R8, X2C(O)R8, X2C(OR7)R7R8, X2C(O)OR8, X2NR7R8, X2NR7C(O)OR8, X2C(O)NR7R8, X2S(O)2NR7R8, X2NR7C(O)NR7R8 or X2NR7C(NR7)NR7R8, wherein X2 is (C16) alkylene, R7 is hydrogen or (Cl6) alkyl; R8 is hydrogen, (C16) alkyl, (C312)cycloalkyl(C03) alkyl, hetero (C512) cycloalkyl (Co3) alkyl, (C6l2) aryl (Co3) alkyl, hetero (C5i2) aryl (Co3) alkyl, (C912) bicycloaryl (C03) alkyl or hetero (C812) bicycloaryl (C03) alkyl; wherein within R8 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with halo, R9, X3OR9, X3SR9, X3S(O)R9, X3S(O)2R9, X3C(O)R9, X3C(OR9)R9, X3C(O)OR9, X3NR9R10, X3NR9C(O)OR9, X3C(O)NR9R10, X3S(O)2NR9R10, X3NR9C(O)NR9R10 or X3NR9C(NR9)NR9R10 ; wherein X3 is a bond or (C16)alkylene, R9 is hydrogen or (Cl 6) alkyl and Rl° is cycloalkyl ; R3 is R11, X3OR11, X3SR11, X3S(O)R11, X3S(O)2R11, X3C(O)R11, X3NR11R12, X3NR12C(O)OR11, X3C(O)NR11R12, X3S(O)2NR11R12, X3NR12C(O)NR11R12 or X3NR12C(NR12)NR11R12, wherein X3 is as described above, Rll is hydrogen, (Cl 6) alkyl, halo (Cl6) alkyl, (C312) cycloalkyl (C03) alkyl, hetero (C512) cycloalkyl (C03) alkyl, (C612) aryl (C03) alkyl, hetero (C512) aryl (C03) alkyl, (C9i2) bicycloaryl (C03) alkyl or hetero (Cgi2) bicycloaryl (C03) alkyl and Rl2 is hydrogen or (C16)alkyl, wherein any 1 to 3 annular atoms of any aromatic ring with available valences comprising R3 are optionally independently substituted with halo, nitro, cyano, (Cl 6) alkyl, halosubstituted(C16)alkyl, OR7, C(O)R7, C(O)OR7, C(O)NR7R7, S(O)2NR7R7, X2NR7R7, X2NR7C(O)OR7, X2NR7C(O)NR7R7 or X2NR7C(NR7NR7R7, wherein X2 and R7 are as defined above; R4 is hydrogen or (C16) alkyl; R5 is (Cl 6) alkyl, halo (CI6) alkyl, (C3I2) cycloalkyl (C03) alkyl, or X2S(O)R14 where X2 is as defined above and R14 is (C312) cycloalkyl (C03) alkyl, hetero (C5l2) cycloalkyl (C03) alkyl, (C612)aryl(C03) alkyl, hetero (C512) aryl (Co3) alkyl, (C912) bicycloaryl (C03) alkyl or hetero (C812) bicycloaryl (C03) alkyl; or R4 and Rs together with the carbon atom to which R4 and R5 are attached form (C37) cycloalkylene ; R is hydrogen or X4X5R13, wherein X4 isC (O), X5 is a bond,0orNR, wherein R12 is as defined above, and R13 is (C16)alkyl, R14, X3OR14, X3SR14, X3S(O)R14, X3S(O)2R14, X3C(O)R14, X3C(O)OR14, X3NR14R15, X3NR15C(O)OR14, X3C(O)NR14R15, X3S(O)2NR14R15, X3NR15C(O)NR14R15 or X3NR15C(NR15)NR14R15, wherein X3 is as defined above; R14 is (C312)cycloalkyl(C03)alkyl, hetero (C512) cycloalkyl (Co3) alkyl, (C612)aryl(C03) alkyl, hetero (C512)aryl(C03)alkyl, (C9 l2) bicycloaryl (C03) alkyl or hetero (C8 l2) bicycloaryl (C03) alkyl; R15 is hydrogen or (C1 6) alkyl; and within Rl4 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted withOCF3,CF3,OH, halo,Rl6,X3OR1, X3OR15, X3C(O)R15, X3SR16, X3S(O)R16, R15, X3S(O)2R16, X3C(O)R16, X3C(O)OR15, X3NR15R15, X3NR15C(O)OR15, X3C(O)NR15R16, X3S(O)2NR15R16, X3NR15C(O)NR15R15 or X3NR15C(NR15)NR15R16, wherein X3 and R15 are as defined above and R16 is (C3i2) cycloalkyl (Co3) alkyl, hetero (C5l2) cycloalkyl (Co3) alkyl, (C612) aryl (Co3) alkyl, hetero (C512) aryl (Co3) alkyl, (C912) bicycloaryl (C03) alkyl or hetero(C812)bicycloaryl(C03) alkyl and within Rl6 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with R15, R17, X3OR17, X3SR17, X3S(O)R17, X3S(O)2R17, X3C(O)R17, X3C(O)OR17, X3NR15R17, X3NR15R15, X3NR15C(O)OR17, X3C(O)NR15R17, X3S(O)2NR15R17, X3NR15C(O)NR15R17 or X3NR15C(NR15)NR15R17, wherein X3 and R15 are as defined above and R17 is (C312) cycloalkyl(C03)alkyl, hetero(C512)cycloalkyl(C03)alkyl, (C612)aryl(C03)alkyl, hetero (C5l2) aryl (Co3) alkyl, (C912) bicycloaryl (C03) alkyl or hetero (C812) bicycloaryl (C03) alkyl and within R17 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with R18, X3OR18, X3SR18, X3S(O)R18, X3S(O)2R18, X3C(O)R18, X3C(O)OR18, X3NR15R18, X3NR15C(O)OR18, X3C(O)NR15R18, X3S(O)2NR15R18, X3NR15C(O)NR15R18 or X3NR15C(NR15)NR15R18, wherein X3 and R15 are as defined above and R'8 is (C3 l2) cycloalkyl (C03) alkyl, hetero (C512) cycloalkyl (C03) alkyl, (C612)aryl(C03)alkyl, hetero (C512) aryl (C03) alkyl, (C912) bicycloaryl (C03) alkyl or hetero (C812) bicycloaryl (C03) alkyl; with the proviso that only one (C912) bicycloaryl (C03) alkyl or hetero (C812) bicycloaryl (C03) alkyl is present within R6, or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 in which: R2 is hydrogen; R1 is R8, X2OR8, X2C(O)R8, X2C(OR7)R7R8, X2NR7R8 or X2NR7C(O)OR8 wherein X2 is (C16) alkylene; R7 is hydrogen or (C16) alkyl; R8 is hydrogen, (C16)alkyl, (C312)cycloalkyl(C03) alkyl, hetero (C512) cycloalkyl (Co3) alkyl, (C612) aryl (C03) alkyl or hetero (C512) aryl (Co3) alkyl; wherein within R8 said cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring may be substituted with halo, R9, X3OR9, X3C(O)R9, X3C(OR9)R9, X3NR9R10 or X3NR9C(O)OR9 ; wherein X3 is a bond or (C16) alkylene, R9 is hydrogen or (Cl_ 6) alkyl and Rl° is cycloalkyl ; R3 is R11, X3NR11R12 or X3NR12C(O)OR11 where R11 is hydrogen, (C16)alkyl, halo (CI6) alkyl, (C312)cycloalkyl(C03) alkyl, hetero (C5i2) cycloalkyl (Co3) alkyl, (C612)aryl(C03) alkyl, hetero (C512)aryl(C03)alkyl, (C912) bicycloaryl (C03) alkyl or hetero (C8i2) bicycloaryl (Co3) alkyl; R4 is hydrogen or (Cl6) alkyl; R5 is (Cl 6) alkyl or (C3 l2) cycloalkyl (C03) alkyl; or R4 and Rs together with the carbon atom to which R4 and Rs are attached form (C37) cycloalkylene; is hydrogen orX4X5R, wherein X4 is C(O), X5 is a bond,0orNR, wherein Ri is as defined above, and Rl3 is (Cl6) alkyl orruz wherein R14 is (cul 2) cycloalkyl (Co3) alkyl, hetero (C512)cycloalkyl(C03) alkyl, (C612)aryl(C03)alkyl, hetero (C512) aryl (C0 3) alkyl, (C912) bicycloaryl (C03) alkyl or hetero (C812) bicycloaryl (C03)alkyl ; and within Rl4 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted withOCF3,CF3,OH, halo, R16, X3OR16, X3OR15, X3C(O)R15, R15, X3C(O)R16, X3C(O)OR15, X3NR15R15, X3NR15C(O)OR15, wherein X3 and R15 are as defined above and R16 is (C312)cycloalkyl(C03)alkyl, hetero(C512)cycloalkyl(C03)alkyl, (C612)aryl(C03)alkyl or hetero (C512) aryl (C03) alkyl, and within R16 said cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring may be substituted with R15, R17, X3NR15R17, or X3NR15R15 wherein X3 and R15 are as defined above and Rl7 is (C3 l2) cycloalkyl (C03) alkyl, hetero (C512) cycloalkyl (C03) alkyl, (C612)aryl(C03) alkyl or hetero (C512)aryl(C03)alkyl.
3. The compound of claim 1 wherein Rl is 4methoxyphenyl, 3methoxyphenyl, 2 methoxyphenyl, 4chlorophenyl, 3chlorophenyl, 2chlorophenyl, 4hydroxyphenyl, 2acetyl phenyl, 2 (1hydroxyethyl)phenyl, 2phenylaminoethyl, pyridin4ylphenyl, pyridin3yl phenyl, pyridin2ylphenyl, 1Himidazol2yl, piperidin4yl or 1methylpiperidin4yl ; and R2 is hydrogen.
4. The compound of claim 3 in which R3 is hydrogen, phenethyl, 4aminobutyl, butyl or 4benzyloxycarbonylaminobutyl.
5. The compound of claim 4 in which Rs is isobutyl, secbutyl or cyclohexylmethyl; and W is hydrogen, or R and R together with the carbon atom to which R4 and Rs are attached form cyclohexyl.
6. The compound of claim 5 in which R6 is selected from the group consisting of benzoyl, morpholin4ylcarbonyl, acetyl, furan3ylcarbonyl, 2methoxybenzoyl, 3methoxybenzoyl, naphthalen2ylcarbonyl, benzoyl, 3] dioxol5ylcarbonyl, 3pyridin3ylacryloyl, benzofuran2 ylcarbonyl, furan2ylcarbonyl, tertbutoxycarbonyl, biphenyl4carbonyl, quinolin2 ylcarbonyl, quinolin3ylcarbonyl, 3acetylbenzoyl, 4phenoxybenzoyl, 3hydroxybenzoyl, 4 hydroxybenzoyl, pyridin3ylcarbonyl, 3 (tertbutoxycarbonylaminomethyl) benzoyl, 4 carbonylpiperazin1ylcarboxylic acid tertbutyl ester, 4carbonylpiperazin1ylcarboxylic acid ethyl ester, 4 (furan2ylcarbonyl) piperazin1ylcarbonyl, pyridin4ylcarbonyl, 1oxypyridin4 ylcarbonyl, 1oxypyridin3ylcarbonyl, thiophen2ylcarbonyl, thiophen3ylcarbonyl, 4 benzoylbenzoyl, 5methylthiophen2ylcarbonyl, 3chlorothiophen2ylcarbonyl, 3 bromothiophen2ylcarbonyl, 4chlorobenzoyl, 3flouro4methoxybenzoyl, 4methoxy benzoyl, 4triflouromethoxybenzoyl, 3, 4diflourobenzoyl, 4fluorobenzoyl, 3, 4dimethoxy benzoyl, 3methylbenzoyl, 4bromobenzoyl, 4triflouromethylbenzoyl, 3benzoylbenzoyl, cyclopentanecarbonyl, benzo [b] thiophen2ylcarbonyl, 3chlorobenzo [b] thiophen2ylcarbonyl, formamylmethyl ester, 4methylpentanoyl, formamylisobutyl ester, formamylmonoallyl ester, formamylisopropyl ester, N, Ndimethylformamyl, Nisopropylformamyl, Npyridin4yl folmamyl, Npyridin3ylformamyl, 3phenylacryloyl, 1Hindol5ylcarbonyl, pyridin2 ylcarbonyl, pyrazin2ylcarbonyl, 3hydroxypyridin2ylcarbonyl, 2aminopyridin3ylcarbonyl, 2hydroxypyridin3ylcarbonyl, 6aminopyridin3ylcarbonyl, 6hydroxypyridin3ylcarbonyl, pyridazin4ylcarbonyl, 3phenoxybenzoyl, 1oxo1, 3dihydroisoindol2ylcarbonyl, 4 (4 methylpiperazinlyl) benzoyl, 4morpholin4ylbenzoyl, 4 [2 (pyridin3ylamino) thiazol4yl] benzoyl, 4 (2dimethylaminothiazol4yl) benzoyl, quinolin6ylcarbonyl, 4dimethylamino benzoyl, 3aminobenzoyl, 4methylpiperazin1ylcarbonyl and benzylacetyl.
7. The compound of Claim 1 wherein: Rl is 4methoxyphenyl, 3acetylphenyl, 3 (lhydroxyethyl)phenyl, 2 (phenylamino) ethyl or 4hydroxyphenyl; R2 is hydrogen; R3 is hydrogen, 2phenethyl, 4aminobutyl, or 4benzyloxycarbonylaminobutyl; R4 is hydrogen; R5 is isobutyl, secbutyl or cyclohexylmethyl ; or R4 and R'together with the carbon atom to which R4 and Rs are attached form cyclohexyl; and R6 is selected from the group consisting of acetyl, pyridin3ylcarbonyl, 3(tert butoxycarbonylamino) benzoyl, pyridin4ylcarbonyl, 1Hindol5ylcarbonyl, benzyloxycarbonyl, 3aminobenzoyl, 4methylpiperazin1ylcarbonyl, quinolin6ylcarbonyl, 4 [2 (pyridin3ylamino) thiazol4yl] benzoyl, 4dimethylaminobenzoyl, morpholin4yl carbonyl, 4 (2dimethylaminothiazol4yl) benzoyl, tertbutoxycarbonyl, 4 (4ethylpiperazinl yl) benzoyl, and 4 [2 (4methylpiperazin1yl) thiazol4yl] benzoyl.
8. The compound of claim 1 in which R is selected from the group consisting of benzoyl, morpholin4ylcarbonyl, acetyl, furan3ylcarbonyl, 2methoxybenzoyl, 3methoxybenzoyl, naphthalen2ylcarbonyl, benzo [1, 3] dioxol5ylcarbonyl, 3pyridin3ylacryloyl, benzofuran2 ylcarbonyl, furan2ylcarbonyl, t eitbutoxycarbonyl, biphenyl4carbonyl, quinolin2 ylcarbonyl, quinolin3ylcarbonyl, 3acetylbenzoyl, 4phenoxybenzoyl, 3hydroxybenzoyl, 4 hydroxybenzoyl, pyridin3ylcarbonyl, 3 (tertbutoxycarbonylaminomethyl) benzoyl, 4 carbonylpiperazin1ylcarboxylic acid terbutyl ester, 4carbonylpiperazin1ylcarboxylic acid <BR> <BR> <BR> <BR> etlyl ester, 4 (furan2ylcarbonyl) piperazin1ylcarbonyl, pyridin4ylcarbonyl, ?.oxypyridin4 ylcarbonyl, 1oxypyridin3ylcarbonyl, thiophen2ylcarbonyl, thiophen3ylcarbonyl, 4 benzoylbenzoyl, 5methylthiophen2ylcarbonyl, 3chlorothiophen2ylcarbonyl, 3 bromothiophen2ylcarbonyl, 4chlorobenzoyl, 3flouro4methoxybenzoyl, 4methoxy benzoyl, 4triflouromethoxybenzoyl, 3,4diflourobenzoyl, 4fluorobenzoyl, 3,4dimethoxy benzoyl, 3methylbenzoyl, 4bromobenzoyl, 4triflouromethylbenzoyl, 3benzoylbenzoyl, cyclopentanecarbonyl, benzo [b] thiophen2ylcarbonyl, 3chlorobenzo [b] thiophen2ylcarbonyl, formamylmethyl ester, 4methylpentanoyl, formamylisobutyl ester, formamylmonoallyl ester, formamylisopropyl ester, N, Ndimethylformamyl, Nisopropylformamyl, Npyridin4yl formamyl, Npyridin3ylformamyl, 3phenylacryloyl, 1Hindol5ylcarbonyl, pyridin2 ylcarbonyl, pyrazin2ylcarbonyl, 3hydroxypyridin2ylcarbonyl, 2aminopyridin3ylcarbonyl, 2hydroxypyridin3ylcarbonyl, 6aminopyridin3ylcarbonyl, 6hydroxypyridin3ylcarbonyl, pyridazin4ylcarbonyl, 3phenoxybenzoyl, 1oxo1, 3dihydroisoindol2ylcarbonyl, 4 (4 methylpiperazinlyl) benzoyl, 4morpholin4ylbenzoyl, 4 [2 (pyridin3ylamino) thiazol4yl] benzoyl, 4 (2dimethylaminothiazol4yl) benzoyl, quinolin6ylcarbonyl, 4dimethylamino benzoyl, 3aminobenzoyl, 4methylpiperazin1ylcarbonyl and benzylacetyl.
9. A compound selected from the group consisting of: benzyl (1S {1S [ (4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}3 methylbutyl) carbamate; benzyl (1S {1S [ (4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}2 methylbutyl) carbamate; tertbutyl (1 S {1 S [ (4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}3 methylbutyl) carbamate; benzyl (1S {1S [ (3acetylphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}3 methylbutyl) carbamate; N{1S[lS(4methoxyphenylSulfamoylmethyl)3phenylpropylcarbamoyl]2methylbutyl} 4methylpiperazine1carboxamide; benzyl {1S [2 (4methoxyphenylsulfamoyl)ethylcarbamoyl]2methylbutyl} carbamate; (2cyclohexyl1S{3phenyl1s[(2phenylaminoethylsulfamoyl)methyl] propylcarbamoyl} ethyl)carbamic acid tertbutyl ester; 4dimethylaminoN (1S { 1S [ (4methoxyphenylsulfamoyl) methyl]3phenyl propylcarbamoyl}3methyibutyl)benzamide ; quinoline6carboxylic acid (1S {1S [ (4methoxyphenylsulfamoyl) methyl] 3phenyl propylcarbamoyl}3methylbutyl)amide ; morpholine4carboxylic acid (2cyclohexyl1 S {3phenyl1 S [(2phenylamino ethylsulfamoyl) methyl]propylcarbamoyl} ethyl) amide; 4 (2dimethylaminothiazol4yl)N {lS [2 (4methoxyphenylsulfamoyl)ethylcarbamoyl] 3methylbutyl} benzamide ; 2Sacetylamino3cyclohexylN{1[(4methoxyphenylsulfamoyl)methyl]3phenyl propyl} propionamide ; 2Racetylamino3cyclohexylN {1 [ (4methoxyphenylsulfamoyl) methyl]3phenyl propyl} propionamide ; 2RSacetylamino3cyclohexylN {1 [ (4hydroxyphenylsulfamoyl) methyl] 3phenyl propyl}propionamide ; benzyl [6 (4methoxyphenylsulfamoyl)5S (4methyl2S {4 [2 (pyridin3ylamino) thiazol 4yl]benzoylamino} pentanoylamino) hexyl] carbamate ; N (IS1 1S [ (4methoxyphenylsulfamoyl) methyl]3phenylpropylcarbamoyl}3methyl butyl)4 [2 (pyridin3ylamino) thiazol4yl] benzamide; N(1S {1 S[(4methoxyphenylsulfamoyl) methyl]3phenylpropylcaubamoyl}3methyl butyl)nicotinamide ; N (1S{1S[(4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}3methyl butyl)isonicotinamide ; N {1 [1 (4methoxyphenylsulfamoylmethyl)3phenylpropylcarbamoyl]3methylbutyl} lHindole5carboxamide ; tertbutyl [3(1S {1 S [(4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}3 methylbutylcarbamoyl) phenyl] carbamate; 3aminoN (lS {lS [ (4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl}3 methylbutyl) benzamide; N(1S{5amino1S[(4methoxyphenylsulfamoyl) methyl] pentylcarbamoyl}3methyl butyl)4 [2 (pyridin3ylamino)thiazol4yl]benzamide ; benzyl [IS (IS1 [3 (lhydroxyethyl) phenylsulfamoyl] methyl}3phenylpropyl carbamoyl)3methylbutyl]carbamate ; morpholine 4carboxylic acid (1 S {5amino1 S [(4methoxyphenylsulfamoyl) methyl] pentylcarbamoyl}2phenylmethanesulfonylethyl) amide; (5S [2S (morpholin4ylcarbonyl) amino]3phenylmethanesulfonylpropionylamino}6 phenylsulfamoylhexyl) carbamic acid benzyl ester; morpholine 4carboxylic acid (1S{lS[(4methoxyphenylsulfamoyl) methyl] 3 phenylpropylcarbamoyl}2phenylmethanesulfonylethyl) amide ; N(1S{1S[(4methoxyhenylsulfamoyl)methyl]3phenylpropylcarbamoyl} cyclohexyl)4 [2 (4methylpiperazin1yl) thiazol4yl] benzamide; and N S {1 S[(4methoxyphenylsulfamoyl)methyl]3phenylpropylcarbamoyl} cyclohexyl)4 (4propylpiperazin1yl)benzamide ; or a pharmaceutically acceptable salt thereof.
10. A pharmaceutical composition comprising a therapeutically effective amount of a compound of Claim 1 in combination with one or more pharmaceutically acceptable excipient (s).
11. The composition of Claim 10 which further comprises one or more active ingredient (s) selected from the group consisting of (i) a therapeutically effective amount of a bisphosphonic acid or acid ester thereof or a pharmaceutically acceptable salt thereof and (ii) a therapeutically effective amount of an estrogen receptor agonist or a pharmaceutically acceptable salt thereof.
12. The composition of Claim 11 wherein the bisphosphonic acid is selected from the group consisting of 1, 1dichloromethylene1, ldiphosphonic acid, 1hydroxy 3pyrrolidin1ylpropylidene1, 1bisphosphonic acid, 1hydroxyethylidene1,1diphosphonic acid, lhydroxy3(NmethylNpentylamino) propylidenel, lbisphosphonic acid, 6amino lhydroxyhexylidenel, lbisphosphonic acid, 3 (dimethylamino)lhydroxypropylidene 1, 1bisphosphonic acid, 3amino1hydroxypropylidene1, 1bisphosphonic acid, 2pyrid2ylethylidene1, 1bisphosphonic acid, 1hydroxy2pyrid3ylethylidene1, 1 bisphosphonic acid, 4chlorophenylthiomethylenebisphosphonic acid and 1hydroxy 2 (IHimidazol1yl) ethylideneI, Ibisphosphonic acid or acid ester thereof or a pharmaceutically acceptable salt thereof.
13. The composition of Claim 11 wherein the bisphosphonic acid is 1, 1dichloromethylene 1, 1diphosphonic acid or a pharmaceutically acceptable salt thereof.
14. The composition of Claim 11 which comprises 1, 1dichloromethylene 1, 1diphosphonate monosodium trihydrate.
15. A method for treating a disease in an animal in which inhibition of a cysteine protease can prevent, inhibit or ameliorate the pathology and/or symptomatology of the disease, which method comprises administering to the animal a therapeutically effective amount of compound of Claim 1 or a pharmaceutically acceptable salt thereof.
16. The method of Claim 15 wherein the disease is osteoporosis.
17. The method of Claim 16 wherein the animal is a human.
18. The method of Claim 17 wherein the human is a postmenopausal woman.
19. The method of Claim 18 wherein the cysteine protease activity is cathepsin K activity.
20. A process for preparing a compound of Claiml comprising: (A) reacting a compound of formula 4 where Rl, R2, and R3 are as defined in Claim 1 above; with a compound of formula 5: where R6 is as defined in Claim 1 above; or (B) reacting a compound of formula 7: with an acid compound of formula R6OH or an acid derivative thereof, wherein Ru, R2, R3, R4, R5 and R6 are as defined in Claim 1 above; and (C) optionally converting a compound of Formula I into a pharmaceutically acceptable salt; (D) optionally converting a salt form of a compound of Formula I to nonsalt form ; (E) optionally converting an unoxidized form of a compound of Formula I into a pharmaceutically acceptable Noxide ; (F) optionally converting an Noxide form of a compound of Formula I its unoxidized form; (G) optionally resolving an individual isomer of a compound of Formula I from a mixture of isomers; (H) optionally converting a nonderivatized compound of Formula I into a pharmaceutically prodrug derivative; (I) optionally converting a prodrug derivative of a compound of Formula I to its non derivatized form ; and (J) optionally modifying any of the Rl, R2, R3, R4, R5 and R6 groups.
Description:
SULFONAMIDE COMPOUNDS AS PROTEASE INHIBITORS BACKGROUND OF THE INVENTION Field of the Invention This application relates to compounds and compositions for treating diseases associated with cysteine protease activity, particularly diseases associated with activity of cathepsins B, K, L or S.

State of the Art Cysteine proteases represent a class of peptidases characterized by the presence of a cysteine residue in the catalytic site of the enzyme. Cysteine proteases are associated with the normal degradation and processing of proteins. The aberrant activity of cysteine proteases, e. g. , as a result of increased expression or enhanced activation, however, may have pathological consequences. In this regard, certain cysteine proteases are associated with a number of disease states, including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, metachromatic leukodystrophy and others. For example, increased cathepsin B levels and redistribution of the enzyme are found in tumors; thus, suggesting a role for the enzyme in tumor invasion and metastasis. In addition, aberrant cathepsin B activity is implicated in such disease states as rheumatoid arthritis, osteo arthritis, pneumocystis carinii, acute pancreatitis, inflammatory airway disease and bone and joint disorders.

The prominent expression of cathepsin K in osteoclasts and osteoclast-related multinucleated cells and its high collagenolytic activity suggest that the enzyme is involved in ososteoclast-mediated bone resorption and, hence, in bone abnormalities such as occurs in osteoporosis. In addition, cathepsin K expression in the lung and its elastinolytic activity suggest that the enzyme plays a role in pulmonary disorders as well.

Cathepsin L is implicated in normal lysosomal proteolysis as well as several disease states, including, but not limited to, metastasis of melanomas. Cathepsin S is implicated in Alzheimer's disease and certain autoimmune disorders, including, but not limited to juvenile onset diabetes, multiple sclerosis, pemphigus vulgaris, Graves'disease, myasthenia gravis, systemic lupus erythemotasus, rheumatoid arthritis and Hashimoto's thyroiditis. In addition, cathepsin S is implicated in: allergic disorders, including, but not limited to asthma; and allogeneic immune reponses, including, but not limited to, rejection of organ transplants or

tissue grafts.

In view of the number of diseases wherein it is recognized that an increase in cysteine protease activity contributes to the pathology and/or symptomatology of the disease, molecules which are shown to inhibit the activity of this class of enzymes, in particular molecules which are inhibitors of cathepsins B, K, L and/or S, will be useful as therapeutic agents.

SUMMARY OF THE INVENTION In one aspect, this invention is directed to a compound of Formula I : in which: R1 and R2 independently are -R8, -X2OR8, -X2SR8, -X2S(O)R8, -X2S(O)2R8, -X2C(O)R8, -X2C(OR7)R7R8, -X2C(O)OR8, -X2NR7R8, -X2NR7C(O)OR8, -X2C(O)NR7R8, -X2S(O)2NR7R8, -X2NR7C(O)NR7R8 or -X2NR7C(NR7)NR7R8, wherein X2 is (CI 6) alkylene, R7 is hydrogen or (Cl 6) alkyl ; R8 is hydrogen, (C1-6)alkyl, (C3-12)cycloalkyl(C0-3) alkyl, hetero (C5-12)cycloalkyl(C0-3)alkyl, (C6-12)aryl(C0-3) alkyl, hetero (C5-12) aryl (Co-3) alkyl, (C9 l2) bicycloaryl (Co-3) alkyl or hetero (C8-12) bicyclo-aryl (Co-3) alkyl ; wherein within R8 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with halo,-R9,-X3OR9,-X3SR9,-X'3S (O) R9,-X3S (0) 2R9,-Xi3C (O) R9, -X3C(OR9)R9, -X3C(O)OR9, -X3NR9R10, -X3NR9C(O)OR9, -X3C(O)NR9R10, -X3S(O)2NR9R10, -X3NR9C(O)NR9R10 or -X3NR9C(NR9)NR9R10 ; wherein X3 is a bond or (C1-6)alkylene, R9 is hydrogen or (Cl 6) alkyl and Rlo is cycloalkyl ; R3 is -R11, -X3OR11, -X3SR11, -X3S(O)R11, -X3S(O)2R11, -X3C(O)R11, -X3C(O)OR11, -X3NR11R12, -X3NR12C(O)OR11, -X3C(O)NR11R12, -X3S(O)2NR11R12, -X3NR12C(O)NR11R12 or -X3NR12C(NR12)NR11R12, wherein X3 is as described above, R"is hydrogen, (Cl 6) alkyl, halo (C1-6) alkyl, (C3-12)cycloalkyl(C0-3) alkyl, hetero (C5-12) cycloalkyl- (Co-3) alkyl, (C6-l2) aryl (Co-3) alkyl, hetero (C5-12)aryl(C0-3) alkyl, (C9-12) bicycloaryl (Co-3) alkyl or hetero (C8-12) bicycloaryl (Co-3) alkyl and R12 is hydrogen or (Cl 6) alkyl, wherein any 1 to 3 annular atoms of any aromatic ring with available valences comprising R3 are optionally independently substituted with halo, nitro, cyano, (Cl 6) alkyl, halo-substituted (C1-6)alkyl, -OR7,

-C(O)R7, -C(O)OR7, -C(O)NR7R7, -S(O)2NR7R7, -X2NR7R7, -X2NR7C(O)OR7, -X2NR7C(O)NR7R7 or -X2NR7C(NR7NR7R7, wherein X2 and R7are as defined above; R4 is hydrogen or (C1-6) alkyl; R5 is (C1-6) alkyl, halo (Cl 6) alkyl, (C3-12) cycloalkyl (C0-3) alkyl, or-X2S (o) Rl4 where X2 is as defined above and R14 is (C3 i2) cycloalkyl (Co-3) alkyl, hetero (C5-12) cycloalkyl (C0-3) alkyl, (C6-i2) arYI (Co-3) alkyl, hetero (C5-12)aryl(C0-3)alkyl, (C9-12) bicycloaryl (C0-3) alkyl or hetero (C8-12) bicycloaryl (C0-3) alkyl; or R4 and R5 together with the carbon atom to which R4 and R5 are attached form (C3-7) cycloalkylene; R6 is hydrogen or -X4X5R13, wherein X4 is-C (O)-, X5 is a bond,-O-or-NR12-, wherein R12 is as defined above, and R13 is (C1-6)alkyl, -R14, -X3OR14, -X3SR14, -X3S(O)R14, -X3S(O)2R14, -X3C(O)R14, -X3C(O)OR14, -X3NR14R15, -X3NR15C(O)OR14, -X3C(O)NR14R15, -X3S(O)2NR14R15, -X3NR15C(O)NR14R15 or -X3NR15C(NR15)NR14R15, wherein X3 is as defined above; R14 is (C3-12)cycloalkyl(C0-3)alkyl, hetero (C5-12) cycloalkyl (Co-3) alkyl, (C6-12)aryl(C0-3) alkyl, hetero (C5-l2) aryl (Co-3) alkyl, (C9-12) bicycloaryl (C0-3) alkyl or hetero (C8-12) bicycloaryl (Co-3) alkyl; Rl5 is hydrogen or (C1- 6) alkyl; and within R14 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with-OCF3,-CF3,-OH, halo, -R16, -X3OR16, -X3OR15, -X3C(O)R15, -X3SR16, -X3S(O)R16, -R15, -X3S(O)2R16, -X3C(O)R16, -X3C(O)OR15, -X3NR15R15, -X3NR15C(O)OR15, -X3C(O)NR15R16, -X3S(O)2NR15R16, -X3NR15C(O)NR15R15 or-X3NRI5C (NR15) NR15R16, wherein X3 and Rl5 are as defined above and R 16 is (C3-12) cycloalkyl (Co-3) alkyl, hetero (C5-12) cycloalkyl (Co-3) alkyl, (C6-12) aryl (Co-3) alkyl, hetero (C5 l2) aryl (C0-3)alkyl, (C9-12) bicycloaryl (C0-3)alkyl or hetero(C8-12)bicycloaryl-(C0-3)alkyl and within R said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with -R15, -R17, -X3OR17, -X3SR17, - -X3S(O)2R17, -X3C(O)R17, -X3C(O)OR17, -X3NR15R17, -X3NR15R15, -X3NR15C(O)OR17, -X3C(O)NR15R17, -X3S(O)2NR15R17, -X3NR15C(O)NR15R17 or -X3NR15C(NR15)NR15R17, wherein X3 and R15 are as defined above and Rl7 is (C3-12) cycloalkyl (Co-3) alkyl, hetero (C5-l2) cycloalkyl (C0-3) alkyl, (C6-I2) aryl (Co-3) alkyl, hetero (C5-12) aryl (C0-3) alkyl, (C9-12) bicycloaryl (C0-3)alkyl or hetero(C8-12)bicycloaryl(C0-3) alkyl and within Rl7 said cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with -R18, -X3OR18, -X3SR18, -X3S(O)R18, -X3S(O)2R18, -X3C(O)R18, -X3C(O)OR18, -X3NR15R18, -X3NR15C(O)OR18, -X3C(O)NR15R18, - X3S(O)2NR15R18, -X3NR15C(O)NR15R18 or -X3NR15C(NR15)NR15R18, wherein X3 and R15 are

as defined above and Rl8 is (C3-l2) cycloalkyl (Co-3) alkyl, hetero (C5 l2) cycloalkyl (Co-3) alkyl, (C6-12) aryl (Co-3) alkyl, hetero (C5-12) aryl (Co-3) alkyl, (Cg l2) bicycloaryl (Co-3) alkyl or hetero (C8-12) bicycloaryl (Co-3) alkyl; with the proviso that only one (C9 l2) bicycloaryl (Co-3) alkyl or hetero (C8 l2) bicycloaryl (Co-3) alkyl is present within R6, or a pharmaceutically acceptable salt thereof.

A second aspect of this invention is a pharmaceutical composition that contains a compound of Formula I or a pharmaceutically acceptable salt thereof in admixture with one or more suitable excipients.

A third aspect of this invention is a method of treating a disease in an animal in which inhibition of a cysteine protease can prevent, inhibit or ameliorate the pathology and/or symptomatology of the disease. Said method comprises administering to the animal a therapeutically effective amount of compound of Formula I or a pharmaceutically acceptable salt thereof.

A fourth aspect of this invention is the processes for preparing compounds of Formula I and the pharmaceutically acceptable salts thereof as set forth in"Detailed Description of the Invention".

DETAILED DESCRIPTION OF THE INVENTION Definitions: Unless otherwise stated, the following terms used in the specification and claims are defined for the purposes of this Application and have the meanings given this Section: "Aliphatic"means a moiety characterized by straight or branched chain arrangement of the constituent carbon atoms and may be saturated or partially unsaturated with two or more double or triple bonds.

"Alkyl"represented by itself means a straight or branched, saturated or unsaturated, aliphatic radical having the number of carbon atoms indicated (e. g., (C1-6)alkyl includes methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, tert-butyl, vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 2-methylallyl, ethynyl, 1-propynyl, 2-propynyl, and the like). Alkyl represented along with another radical (e. g. , as in arylalkyl) means a straight or branched, saturated or unsaturated aliphatic divalent radical having the number of atoms indicated or when zero atoms are indicated means a bond (e. g., (C6-12) aryl (Co-3) alkyl includes phenyl, benzyl, phenethyl, 1-phenylethyl, 3-phenylpropyl, and the like).

"Alkylene", unless indicated otherwise, means a straight or branched, saturated or

unsaturated, aliphatic, divalent radical having the number of carbon atoms indicated (e. g., (C2 5) alkylene includes ethylene (-CH2CH2-or-CH (CH3)-), 1-methylethylene (-CH (CH3) CH2-), trimethylene (-CH2CH2CH2-), tetramethylene (-CH2CH2CH2CH2-), pentamethylene (- CH2CH2CH2CH2CH2-), and the like.

"Alkyloxy"means the radical-OR, wherein R is alkyl as defined above, having the number of carbon atoms indicated (e. g., (Cl 6) alkyloxy includes the radicals methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, isobutoxy, tert-butoxy, vinyloxy, allyloxy, 1- propenyloxy, isopropenyloxy, 1-butenyloxy, 2-butenyloxy, 3-butenyloxy, 2-methylallyloxy, ethynyloxy, 1-propynyloxy, 2-propynyloxy, and the like).

"Amino"means the radical-NH2. Unless indicated otherwise, the compounds of the invention containing amino moieties include protected derivatives thereof. Suitable protecting groups for amino moieties include acetyl, tert-butoxycarbonyl, benzyloxycarbonyl, and the like.

"Animal"includes humans, non-human mammals (e. g. , dogs, cats, rabbits, cattle, horses, sheep, goats, swine, deer, and the like) and non-mammals (e. g. , birds, and the like).

"Aromatic"means a moiety wherein the constituent atoms make up an unsaturated ring system, all atoms in the ring are sp2 hybridized and the total number of pi electrons is equal to 4n+2.

"Aryl"means a monocyclic or bicyclic ring assembly (fused or linked by a single bond) containing the total number of ring carbon atoms indicated, wherein each ring is aromatic or when fused with another ring forms an aromatic ring assembly. For example, (C6-l2) aryl includes phenyl, naphthalenyl, and biphenylyl.

"Bicycloaryl"means a bicyclic ring assembly containing the number of annular carbon atoms indicated, wherein the rings are linked by a single bond or fused and one, but not both, of the rings comprising the assembly is aromatic, and any carbocyclic ketone, thioketone or iminoketone derivative thereof. For example, (C9_12) bicycloaryl includes indanyl, indenyl, 1,2, 3,4-tetrahydronaphthalenyl, 1,2-dihydronaphthalenyl, cyclohexylphenyl, phenylcyclohexyl, 2, 4-dioxo-1, 2,3, 4-tetrahydro-naphthalenyl, or the like.

"Carbamoyl"means the radical-C (O) NH2. Unless indicated otherwise, the compounds of the invention containing carbamoyl moieties include protected derivatives thereof. Suitable protecting groups for carbamoyl moieties include acetyl, tert-butoxycarbonyl, benzyloxycarbonyl, and the like and both the unprotected and protected derivatives fall within the scope of the invention.

"Cycloalkyl"means a saturated or partially unsaturated, monocyclic ring, bicyclic ring assembly (directly linked by a single bond or fused) or bridged polycyclic ring assembly containing the number of annular carbon atoms indicated, and any carbocyclic ketone, thioketone or iminoketone derivative thereof. For example, (C3 l2) cycloalkyl includes cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclohexenyl, 2,5-cyclohexadienyl, bicyclohexylyl, cyclopentylcyclohexyl, bicyclo [2.2. 2] octyl, adamantan-1-yl, decahydronaphthalenyl, oxocyclohexyl, dioxocyclohexyl, thiocyclohexyl, 2-oxobicyclo- [2.2. 1] hept-1-yl, and the like.

"Cycloalkylene"means a divalent saturated or partially unsaturated, monocyclic ring, bicyclic ring assembly (directly linked by a single bond or fused) or bridged polycyclic ring assembly containing the number of annular carbon atoms indicated, and any carbocyclic ketone, thioketone or iminoketone derivative thereof. For example, (C3 l2) cycloalkylene includes cyclopropylene, cyclobutylene, cyclopentylene, cyclohexylene, cyclohexenylene, 2,5- cyclohexadienylene, bicyclohexylylene, and the like.

"Disease"specifically includes any unhealthy condition of an animal or part thereof and includes an unhealthy condition that may be caused by, or incident to, medical or veterinary therapy applied to that animal, i. e. , the"side effects"of such therapy.

"Halo"means fluoro, chloro, bromo or iodo.

"Haloalkyl"or"halo-substituted alkyl"means an alkyl group as defined above that is substituted with a halo group as defined above e. g. , trifluoromethyl, fluoroethyl, fluoropropyl, fluorobutyl, and the like.

"Heteroaryl"means aryl, as defined herein, provided that one or more, preferably one to four, of the ring carbon atoms indicated, are replaced by a heteroatom moiety selected from -N=,-N+ (O-) =,-NR-,-0-or-S-, wherein R is hydrogen, (Cl-6) alkyl or a protecting group, and each ring contained therein is comprised of 5 to 6 annular members (e. g. , hetero (C5. i4) aryl includes thienyl, furyl, pyrrolyl, pyrimidinyl, isoxazolyl, oxazolyl, indolyl, benzo [b] thienyl, isobenzofuranyl, purinyl, isoquinolyl, pterdinyl, perimidinyl, imidazolyl, 1-methylimidazolyl, 1-benzylimidazolyl, pyridyl, pyrazolyl, pyrazinyl, tetrazolyl, quinolyl, [2,4'] bipyridinylyl, 2- phenylpyridyl, 4-thiazol-4-ylphenyl, 1H-imidazol-1-ylphenyl, and the like). Suitable protecting groups include tert-butoxycarbonyl, benzyloxycarbonyl, benzyl, 4-methoxybenzyl, 2- nitrobenzyl, and the like.

"Heterobicycloaryl"means bicycloaryl, as defined herein, except one or more of the annular carbon atoms indicated are replaced by a heteroatom moiety selected from-N-,-NR-,

-O-or-S-, wherein R is hydrogen, (Cl_6) alkyl or a protecting group, and any carbocyclic ketone, thioketone or iminoketone derivative thereof. For example, hetero (C8 l2) bicycloaryl includes 3, 4-dihydro-2H-quinolinyl, 5, 6, 7, 8-tetrahydroquinolinyl, 3, 4-dihydro-2H- [1, 8] naphthyridinyl, morpholinylpyridyl, piperidinylphenyl, 1,2, 3,4, 5,6-hexahydro- [2,2'] bipyridinylyl, 2,4-dioxo-3, 4-dihydro-2H-quinazolinyl, 3-oxo-2,3-dihydrobenzo- [1, 4] oxazinyl, and the like.

"Heterocycloalkyl"means cycloalkyl, as defined herein, provided that one or more, preferably one to three, of the annular carbon atoms indicated is replaced by heteroatom moiety selected from-N-,-NR-,-O-or-S-, wherein R is hydrogen, (C1 6) alkyl or a protecting group, and any carbocyclic ketone, thioketone or iminoketone derivative thereof (e. g. , the term hetero (C3 l4) cycloalkyl includes piperidyl, pyrrolidinyl, pyrrolinyl, imidazolidinyl, quinuclidinyl, morpholinyl, [1, 4'] bipiperidinylyl, 1', 2'-dihydro-2H- [1, 4'] bipyridinylyl, 1- morpholin-4-ylpiperidinyl, and the like). Suitable protecting groups include tert- butoxycarbonyl, benzyloxycarbonyl, benzyl, 4-methoxybenzyl, 2-nitrobenzyl, and the like. For example, a compound of Formula I wherein Rl is piperidin-4-ylcarbonyl may exist as either the unprotected or a protected derivative, e. g. , wherein R'is 1-tert-butoxycarbonylpiperidin-4- ylcarbonyl, and both the unprotected and protected derivatives fall within the scope of the invention.

"Hydioxy"means the radical-OH. Unless indicated otherwise, the compounds of the invention containing hydroxy radicals include protected derivatives thereof. Suitable protecting groups for hydroxy moieties include benzyl and the like and both the unprotected and protected derivatives fall within the scope of the invention.

"Iminoketone derivative"means a derivative containing the moiety-C (NR) -, wherein R is hydrogen or (Cl-6) alkyl.

"Isomers"mean compounds of Formula I having identical molecular formulae but differ in the nature or sequence of bonding of their atoms or in the arrangement of their atoms in space. Isomers that differ in the arrangement of their atoms in space are termed"steroisomers".

Stereoisomers that are not mirror images of one another are termed"diastereomers"and stereoisomers that are nonsuperimposable mirror images are termed"enantiomers"or sometimes"optical isomers". A carbon atom bonded to four nonidentical substituents is termed a"chiral center". A compound with one chiral center has two enantiomeric forms of opposite chirality is termed a"racemic mixture". A compound that has more than one chiral center has 2'1-enantiomeric pairs, where n is the number of chiral centers. Compounds with

more than one chiral center may exist as ether an individual diasteromer or as a mixture of diastereomers, termed a"diastereomeric mixture". When one chiral center is present a stereoisomer may be characterized by the absolute configuration of that chiral center. Absolute configuration refers to the arrangement in space of the substituents attached to the chiral center.

Enantiomers are characterized by the absolute configuration of their chiral centers and described by the R-and S-sequencing rules of Cahn, Ingold and Prelog. Conventions for stereochemical nomenclature, methods for the determination of stereochemistry and the separation of stereoisomers are well known in the art (e. g. , see"Advanced Organic Chemistry", 4th edition, March, Jerry, John Wiley & Sons, New York, 1992). It is understood that the names and illustration used in this Application to describe compounds of Formula I are meant to encompass all possible stereoisomers and any mixture, racemic or otherwise, thereof.

"Ketone derivative"means a derivative containing the moiety-C (O)-.

"Leaving group"has the meaning conventionally associated with it in synthetic organic chemistry, i. e. , an atom or group displaceable under alkylating conditions, and includes, halogen, hydroxy, alkyloxy, alkylsulfonyloxy (e. g. , mesyloxy, ethanesulfonyloxy, or the like), arylsulfonyloxy (e. g. , benzenesulfonyloxy and tosyloxy, thienyloxy), dihalophosphinoyloxy, tetrahalophosphaoxy, and the like.

"Nitro"means the radical-N02.

"Optional"or"optionally"means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where the event or circumstance occurs and instances in which it does not. For example, the phrase"any 1 to 3 annular atoms of any aromatic ring with available valences comprising R optionally independently is substituted"means that the aromatic ring referred to may or may not be substituted in order to fall within the scope of the invention.

"N-oxide derivatives"means derivatives of compounds of Formula I in which nitrogen atom (s) is in an oxidized state (i. e., N-40) and which possess the desired pharmacological activity. The n-oxide derivative of a compound of Formula I is within the scope of this invention.

"Oxo"means the radical =0.

"Pathology"of a disease means the essential nature, causes and development of the disease as well as the structural and functional changes that result from the disease processes.

"Pharmaceutically acceptable"means that which is useful in preparing a pharmaceutical composition that is generally safe, non-toxic and neither biologically nor otherwise undesirable

and includes that which is acceptable for veterinary use as well as human pharmaceutical use.

"Pharmaceutically acceptable salts"means salts of compounds of Formula I which are pharmaceutically acceptable, as defined above, and which possess the desired pharmacological activity. Such salts include acid addition salts formed with inorganic acids such as hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, and the like; or with organic acids such as acetic acid, propionic acid, hexanoic acid, heptanoic acid, cyclopentanepropionic acid, glycolic acid, pyruvic acid, lactic acid, malonic acid, succinic acid, malic acid, maleic acid, fumaric acid, tartatic acid, citric acid, benzoic acid, o- (4- hydroxybenzoyl) benzoic acid, cinnamic acid, madelic acid, methanesulfonic acid, ethanesulfonic acid, 1, 2-ethanedisulfonic acid, 2-hydroxyethanesulfonic acid, benzenesulfonic acid, p-chlorobenzenesulfonic acid, 2-naphthalenesulfonic acid, p-toluenesulfonic acid, camphorsulfonic acid, 4-methylbicyclo [2.2. 2] oct-2-ene-1-carboxylic acid, glucoheptonic acid, 4,4'-methylenebis (3-hydroxy-2-ene-1-carboxylic acid), 3-phenylpropionic acid, trimethylacetic acid, tertiary butylacetic acid, lauryl sulfuric acid, gluconic acid, glutamic acid, hydroxynaphthoic acid, salicylic acid, stearic acid, muconic acid and the like.

Pharmaceutically acceptable salts also include base addition salts which may be formed when acidic protons present are capable of reacting with inorganic or organic bases.

Acceptable inorganic bases include sodium hydroxide, sodium carbonate, potassium hydroxide, aluminum hydroxide and calcium hydroxide. Acceptable organic bases include ethanolamine, diethanolamine, triethanolamine, tromethamine, N-methylglucamine and the like.

"Prodrug derivatives"means derivatives of compounds of Formula I which are converted in vivo to the corresponding non-derivatized form of a compound of Formula I. All prodrugs of a compound of Formula I are within the scope of this invention.

"Protected derivatives"means derivatives of compounds of Formula I in which a reactive site or sites are blocked with protective groups. Protected derivatives of compounds of Formula I are useful in the preparation of compounds of Formula I or in themselves may be active cysteine protease inhibitors. A comprehensive list of suitable protective groups can be found in T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Synthesis, John Wiley & Sons, Inc. (3rd Edition) 1999. All protective derivatives of a compound of Formula I are within the scope of this invention.

"Therapeutically effective amount"means that amount which, when administered to an animal for treating a disease, is sufficient to effect such treatment for the disease.

"Thioketone derivative"means a derivative containing the moiety-C (S)-.

"Treatment"or"treating"means any administration of a compound of the present invention and includes: preventing the disease from occurring in an animal which may be predisposed to the disease but does not yet experience or display the pathology or symptomatology of the disease, inhibiting the disease in an animal that is experiencing or displaying the pathology or symptomatology of the diseased (i. e. , arresting further development of the pathology and/or symptomatology), or ameliorating the disease in an animal that is experiencing or displaying the pathology or symptomatology of the diseased (i. e. , reversing the pathology and/or symptomatology).

Abbreviations used: acetonitrile (ACN); t-butyloxycarbonyl (BOC); dichloromethane (DCM); 2,3-dichloro-5, 6-dicyano-1, 4-benzoquinone (DDQ); diisopropylcarbodiimide (DIC); 4-dimethylamino-pyridine (DMAP) ; electrospray ionization (ESI) ; diethyl ether (Et20) ; High performance liquid chromatography (HPLC); Liquid Chromatography/Mass Spectroscopy (LC/MS); tetrahydrofuran (THF) ; trifluoroacetic acid (TFA); tetrapyrrolidinophosphonium hexafluorophosphate (PyBOP); N- { (dimethylamino) (lu-1, 2,3-triazole [4, 5-b] pyridin-1-yl)- methylene}-N-methylmethan-aminium hexafluorophosphate N-oxide (HATU) ; 4- dimethylamino-pyridine (DMAP) ; dicyclohexylcarbodiimide (DCC) ; dimethylformamide (DMF).

Nomenclature : The compounds of Formula I and the intermediates and starting materials used in their preparation are named in accordance with IUPAC rules of nomenclature in which the characteristic groups have decreasing priority for citation as the principle group as follows: acids, esters, amides, etc. Alternatively, the compounds are named by AutoNom 2.1 or 4.0 (Beilstein Information System, Inc.). For example, compounds of Formula I in which: Rl is 4-methoxy-benzyl; R2 is 4-phenylethyl; R3 is cyclohexylmethyl; and R4 is acetyl is named 2-acetylamino-3-cyclohexyl-N [2- (4-methoxy-phenylsulfomoyl)-ethyl]-propionamide ; or R'is 4-methoxy-benzyl; R2 is 4-phenylethyl; R3 is isobutyl; and R4 is pyridine-3-carbonyl is named N-(1- {1- [ (4-methoxy-phenylsulfamoyl)-methyl]-3-phenyl-propylcarbamoyl }-3-methyl- butyl)-nicotinamide.

Presently Preferred Embodiments:

While the broadest definition of this invention is set forth in the Summary of the Invention, certain aspects of the invention are preferred. Preferred aspects of the invention are the compounds of Formula I in which: R1 is -R8, -X2OR8, -X2C(O)R8, -X2C(OR7)R7R8, -X2NR7R8 or -X2NR7C(O)OR8 ; wherein X2 is (Cl-6) alkylene; R7 is hydrogen or (C1-6) alkyl; R8 is hydrogen, (C1-6)alkyl, (C3-12) cycloalkyl (C0-3) alkyl, hetero (C5-l2) cycloalkyl (Co-3) alkyl, (C6-12)aryl(C0-3)alkyl or hetero (C5-12) aryl (C0-3) alkyl; wherein within R8 said cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring may be substituted with halo, -R9, -X3OR9, -X3C(O)R9, -X3C(OR9)R9, -X3NR9R10 or -X3NR9C(O)OR9 ; wherein X3 is a bond or (Cl 6) alkylene, R9 is hydrogen or (C1- 6) alkyl and Rl° is cycloalkyl ; R2 is hydrogen ; R3 is -R11, -X3NR11R12 or -X3NR12C(O)OR11; wherein X3 is a bond or (Calkylene, R"is hydrogen, (C1-6)alkyl, halo (Cl 6) alkyl, (C3-12)cycloalkyl(C0-3)alkyl, hetero (C5-12) cycloalkyl (C0-3) alkyl, (C6-12) aryl (C0-3) alkyl, hetero (C5-12)aryl(C0-3) alkyl, (C9-12) bicycloaryl (C0-3) alkyl or hetero (Cg-i2) bicycloaryl (C0-3) alkyl and R12 is hydrogen or (C1- 6) alkyl, wherein any 1 to 3 annular atoms of any aromatic ring with available valences comprising R3 are optionally independently substituted with halo, nitro, cyano, (C1-6) alkyl, halo-substituted (C1-6)alkyl, -OR7, -C(O)R7, -C(O)OR7, -C(O)NR7R7, -S(O)2NR7R7, -X2NR7R7, -X2NR7C(O)OR7, -X2NR7C(O)NR7R7 or -X2NR7C(NR7NR7R7, wherein X2 and Ware as defined above; R is hydrogen or (Cl 6) alkyl; R5 is (Cl 6) alkyl, halo (Cl 6) alkyl, (C3 l2) cycloalkyl (C0-3)alkyl, or -X2S(O)R14 where X2 is as defined above and R14 is (C3-l2) cycloalkyl (Co-3) alkyl, hetero (C5-12) cycloalkyl (C0-3) alkyl, (C6-12)aryl(C0-3) alkyl, hetero (C5-12)aryl(C0-3) alkyl, (C9-12) bicycloaryl (C0-3) alkyl or hetero (C8-12) bicycloaryl (C0-3) alkyl; preferably, Rs is (C1-6) alkyl or (C3-12)cycloalkyl(C0-3) alkyl; or R4 and R5 together with the carbon atom to which R4 and R5 are attached form (C3- 7) cycloalkylene ; R6 is hydrogen or -X4X5R13, wherein X4 is -C(O)-, X5 is a bond,-O-or-NR12-, wherein Rl2 is as defined above, and R13 is (C1-6) alkyl or-Rl4 wherein R' is (C3-12) cycloalkyl (C0-3)- alkyl, hetero (C5-12) cycloalkyl (C0-3) alkyl, (C6-12) aryl (C0-3) alkyl, hetero (C5-12)arylo(C0-3) alkyl, (C9-12) bicycloaryl (C0-3) alkyl or hetero (C8-12) bicycloaryl (C0-3) alkyl; and within R14 said

cycloalkyl, heterocycloalkyl, aryl, heteroaryl, bicycloaryl or heterobicycloaryl ring may be substituted with-OCF3,-CF3,-OH, halo, -R16, -X3OR16, -X3OR15, -X3C(O)R15, -R15 -X3C(O)R16, -X3C(O)OR15, -X3NR15R15, -X3NR15C(O)OR15, wherein X3 is as defined above, RIS is hydrogen or (Cl 6) alkyl ; and Rl6 is (C3-i2) cycloalkyl (Co-3) alkyl, hetero (C5-l2) cycloalkyl- (Co-3) alkyl, (C6-i2) aryl (Co-3) alkyl or hetero (C5-12)aryl(C0-3)alkyl, and within Rl6 said cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring may be substituted with-Rl5,-Rl7,-X3NRl5Rl7, -X3NR15R15 wherein X3 and R' are as defined above and Rl7 is (C3-i2) cycloalkyl (Co-3) alkyl, hetero (Cs l2) cycloalkyl (Co 3) alkyl, (C6-12) aryl (Co-3) alkyl or hetero (C5-i2) aryl (C0-3) alkyl; with the proviso that only one (C9-12) bicycloaryl (Co-3) alkyl or hetero (C8-12) bicycloaryl (Co-3) alkyl is present within R6 ; and the pharmaceutically acceptable salts thereof.

More preferably, Rl is 4-methoxyphenyl, 3-methoxyphenyl, 2-methoxyphenyl, 4- chlorophenyl, 3-chloro-phenyl, 2-chlorophenyl, 4-hydroxyphenyl, 2-acetylphenyl, 2- (1- hydroxyethyl) phenyl, 2-phenylaminoethyl, pyridin-4-ylphenyl, pyridin-3-ylphenyl, pyridin-2- phenyl, lH-imidazol-2-yl, piperidin-4-yl or 1-methylpiperidin-4-yl ; R2 is hydrogen; R3 is hydrogen, phenethyl, 4-aminobutyl, butyl or 4-benzyloxycarbonylaminobutyl; R4 is hydrogen; R5 is isobutyl, sec-butyl or cyclohexylmethyl; or R4 and R5 together with the carbon atom to which R4 and R5 are attached form cyclohexyl; and R6 is selected from the group consisting of benzoyl, morpholin-4-ylcarbonyl, acetyl, furan-3-ylcarbonyl, 2-methoxybenzoyl, 3-methoxybenzoyl, naphthalen-2-ylcarbonyl, benzo [1, 3] dioxol-5-ylcarbonyl, 3-pyridin-3-ylacryloyl, benzofuran-2-ylcarbonyl, furan-2- ylcarbonyl, tert-butoxycarbonyl, biphenyl-4-carbonyl, quinolin-2-ylcarbonyl, quinolin-3- ylcarbonyl, 3-acetylbenzoyl, 4-phenoxybenzoyl, 3-hydroxybenzoyl, 4-hydroxybenzoyl, pyridin- 3-ylcarbonyl, 3- (tert-butoxycarbonylaminomethyl) benzoyl, 4-carbonylpiperazin-1-ylcarboxylic acid tert-butyl ester, 4-carbonylpiperazin-1-ylcarboxylic acid ethyl ester, 4- (furan-2- ylcarbonyl) piperazin-1-ylcarbonyl, pyridin-4-ylcarbonyl, 1-oxypyridin-4-ylcarbonyl, 1- oxypyridin-3-ylcarbonyl, thiophen-2-ylcarbonyl, thiophen-3-ylcarbonyl, 4-benzoylbenzoyl, 5- methylthiophen-2-ylcarbonyl, 3-chlorothiophen-2-ylcarbonyl, 3-bromothiophen-2-ylcarbonyl, 4-chlorobenzoyl, 3-flouro-4-methoxybenzoyl, 4-methoxy-benzoyl, 4-triflouromethoxybenzoyl, 3, 4-diflourobenzoyl, 4-fluorobenzoyl, 3,4-dimethoxy-benzoyl, 3-methylbenzoyl, 4- bromobenzoyl, 4-triflouromethylbenzoyl, 3-benzoylbenzoyl, cyclopentanecarbonyl, benzo [b] thiophen-2-ylcarbonyl, 3-chlorobenzo[b] thiophen-2-ylcarbonyl, formamylmethyl

ester, 4-methylpentanoyl, formamylisobutyl ester, formamylmonoallyl ester, formamylisopropyl ester, N, N-dimethylformamyl, N-isopropylformamyl, N-pyridin-4-yl- formamyl, N-pyridin-3-ylformamyl, 3-phenylacryloyl, 1H-indol-5-ylcarbonyl, pyridin-2- ylcarbonyl, pyrazin-2-ylcarbonyl, 3-hydroxypyridin-2-ylcarbonyl, 2-aminopyridin-3-ylcarbonyl, 2-hydroxypyridin-3-ylcarbonyl, 6-aminopyridin-3-ylcarbonyl, 6-hydroxypyridin-3-ylcarbonyl, pyridazin-4-ylcarbonyl, 3-phenoxybenzoyl, 1-oxo-1, 3-dihydroisoindol-2-ylcarbonyl, 4- (4- metliylpiperazin-1-yl) benzoyl, 4-morpholin-4-ylbenzoyl, 4- [2- (pyridin-3-ylamino) thiazol-4-yl] - benzoyl, 4- (2-dimethylaminothiazol-4-yl) benzoyl, quinolin-6-ylcarbonyl, 4-dimethylamino- benzoyl, 3-aminobenzoyl, 4-methylpiperazin-1-ylcarbonyl and benzylacetyl.

More preferably, R1 is 4-methoxyphenyl, 3-methoxyphenyl, 2-methoxyphenyl, 4- chlorophenyl, 3-chloro-phenyl, 2-chlorophenyl, 4-hydroxyphenyl, 2-acetylphenyl, 2- (1- hydroxyethyl) phenyl, 2-phenylaminoethyl, pyridin-4-ylphenyl, pyridin-3-ylphenyl, pyridin-2- phenyl, lH-imidazol-2-yl, piperidin-4-yl or 1-methylpiperidin-4-yl ; R2 is hydrogen; R3 is benzylsulfonylmethyl; R4 is hydrogen; Rs is isobutyl, sec-butyl or cyclohexylmethyl; or R4 and R5 together with the carbon atom to which R and R5 are attached form cyclohexyl; and R6 is selected from the group consisting of R6 is selected from the group consisting of benzoyl, morpholin-4-ylcarbonyl, acetyl, furan-3-ylcarbonyl, 2-methoxybenzoyl, 3- methoxybenzoyl, naphthalen-2-ylcarbonyl, benzo [1, 3] dioxol-5-ylcarbonyl, 3-pyridin-3- ylacryloyl, benzofuran-2-ylcarbonyl, furan-2-ylcarbonyl, tert-butoxycarbonyl, biphenyl-4- carbonyl, quinolin-2-ylcarbonyl, quinolin-3-ylcarbonyl, 3-acetylbenzoyl, 4-phenoxybenzoyl, 3- hydroxybenzoyl, 4-hydroxybenzoyl, pyridin-3-ylcarbonyl, 3-(tert- butoxycarbonylaminomethyl) benzoyl, 4-carbonylpiperazin-1-ylcarboxylic acid tert-butyl ester, 4-carbonylpiperazin-1-ylcarboxylic acid ethyl ester, 4- (furan-2-ylcarbonyl) piperazin-1- ylcarbonyl, pyridin-4-ylcarbonyl, 1-oxypyridin-4-ylcarbonyl, 1-oxypyridin-3-ylcarbonyl, tliiophen-2-ylcarbonyl, thiophen-3-ylcarbonyl, 4-benzoylbenzoyl, 5-methylthiophen-2- ylcarbonyl, 3-chlorothiophen-2-ylcarbonyl, 3-bromothiophen-2-ylcarbonyl, 4-chlorobenzoyl, 3- flouro-4-methoxybenzoyl, 4-methoxy-benzoyl, 4-triflouromethoxybenzoyl, 3,4- diflourobenzoyl, 4-fluorobenzoyl, 3,4-dimethoxy-benzoyl, 3-methylbenzoyl, 4-bromobenzoyl, 4-triflouromethylbenzoyl, 3-benzoylbenzoyl, cyclopentanecarbonyl, benzo [b] thiophen-2- ylcarbonyl, 3-chlorobenzo [b] thiophen-2-ylcarbonyl, formamylmethyl ester, 4-methylpentanoyl,

formamylisobutyl ester, formamylmonoallyl ester, formamylisopropyl ester, N,N- <BR> <BR> <BR> <BR> <BR> dimethylfolanamyl, N-isopropylformamyl, N-pyridin-4-yl-formamyl, N-pyridin-3-ylformamyl, 3-phenylacryloyl, lH-indol-5-ylcarbonyl, pyridin-2-ylcarbonyl, pyrazin-2-ylcarbonyl, 3- hydroxypyridin-2-ylcarbonyl, 2-aminopyridin-3-ylcarbonyl, 2-hydroxypyridin-3-ylcarbonyl, 6- aminopyridin-3-ylcarbonyl, 6-hydroxypyridin-3-ylcarbonyl, pyridazin-4-ylcarbonyl, 3- phenoxybenzoyl, 1-oxo-1, 3-dihydroisoindol-2-ylcarbonyl, 4- (4-methylpiperazin-1-yl) benzoyl, 4-morpholin-4-ylbenzoyl, 4- [2- (pyridin-3-ylamino) thiazol-4-yl]-benzoyl, 4- (2- dimethylaminothiazol-4-yl) benzoyl, quinolin-6-ylcarbonyl, 4-dimethylamino-benzoyl, 3- aminobenzoyl, 4-methylpiperazin-1-ylcarbonyl and benzylacetyl.

Even more preferably, Rl is 4-methoxyphenyl, 3-acetylphenyl, 3-(1-hydroxyethyl)- phenyl, 2- (phenylamino) ethyl or 4-hydroxyphenyl; R2 is hydrogen; R3 is hydrogen, 2-phenethyl, 4-aminobutyl, or 4-benzyloxycarbonylaminobutyl ; R4 is hydrogen; R 5 is isobutyl, sec-butyl or cyclohexylmethyl; or R4 and Rs together with the carbon atom to which R4 and R are attached form cyclohexyl; and R6 is selected from the group consisting of acetyl, pyridin-3-ylcarbonyl, 3-(tert- butoxycarbonylamino) benzoyl, pyridin-4-ylcarbonyl, lH-indol-5-ylcarbonyl, benzyloxycarbonyl, 3-aminobenzoyl, 4-methylpiperazin-1-ylcarbonyl, quinolin-6-ylcarbonyl, 4- [2- (pyridin-3-ylamino) thiazol-4-yl] benzoyl, 4-dimethylaminobenzoyl, morpholin-4-yl- carbonyl, 4- (2-dimethylaminothiazol-4-yl) benzoyl, tert-butoxycarbonyl, 4-(4-ethylpiperazin-1- yl) -benzoyl, and 4- [2- (4-methylpiperazin-1-yl) tliiazol-4-yl] benzoyl.

A number of different preferences have been given above, and following any one of these preferences results in a compound of this invention that is more presently preferred than a compound in which that particular preference is not followed. However, these preferences are generally independent [although some (alternative) preferences are mutually exclusive], and additive; and following more than one of these preferences may result in a more presently preferred compound than one in which fewer of the preferences are followed.

Particular compounds of the invention are selected from the compounds formed by joining C* of one of the fragments (A1 to A77) shown in Table 1 to the nitrogen atom (*N) of one of the fragments (B1 to B4) shown in Table 2, and joining the methine carbon atom (CH*) of one of the fragments (B1 to B4) shown in Table 2 to the acyl carbon atom (C*) of one of the fragments (C1 to C31) depicted in Table 3.

TABLE 1 s1 R A2 R A3 R Al 0 SNC 0 A3 0 A4 R A5 R A6 R c* c* c* "Z N H3C I o I' 01 A7 A8 A9 R 11 11 11 . OMe Orme II* g 9 II* \ \ o C* \ \ i i ou AIO 0 All 0 A12 0 Xc* HC* CC* o c* c* o c* / i C N C t C 3 \ \ c* 14 \ \ c . e15 * tuo i 16 R i17 R R A18 R R 11 11 C* c C* Buo N H3C s A19A20jA21 11 11 11 N 0 ho O A22A23A24 ="C 11 c* NC* C* C* Et0 <J/NJ/ EtOyN N 0 0 A25 0 A26 A27 in 11 11 11 I i 0 O A28A29A30 s c* c* * OYID 0 A31 A32 0 A33 0 s c* s c* s c* Mye C1 ber A34 0 A35 0 36 0 /c* s c* s c* s C ci A37 R A38 R A39 R N 11 11 I/\N ßN Ns Mv "\ ° N N N N 01 c* F I c I c* CF a A43JJA44JJA45 11 11 11 Br/Me0/CF30 A46A47A48 C* me C* Me C* 0 A49A50A51 c* c* c* A49 R A50 R A51 R C* (CH3) 2CHCH2CH2/ (CH3) 2CHCH2° F 2 c* c* c* c* c* c* CH30 CH2 =CHCH20 (CH3) 2CHO ASS 0 A56 0 A57 c* c* j i h (CH3) 2CHNH (CH3) 2N iC* H H A58 n ° A59 A60 1°l 11 11 N I/N I/ H H 61 ° I I 6 I I 63 I I C* C* (N C* N nu N A64A65A66 11 11 11 i i i N OH HO N H, N N A67A68OHA69 11 11 11 N C 0 C 70 ° II 1 II H \ i i N r zizi N 73 i 74 I i 75 I i w c* w c c* 0 C* X 0C* A76 ¢ W C* A77 C N Nia IN I S_ A76A770 / nu2 dz NH, TABLE 2 c * zCH* *HN *HN *HN/CH *HO

4 CH* CH* /cl* TABLE 3 8 H ci 1 0 H C2 H C3 IN 0 *C N N O O % O O % \O O _ O XH2, C4 H C5 0 H C6 0 *C *C N N,'N' s c OH O/o v OH ii o H Cg H H 9 H i 'o H N 0 0- *c 0 _ II TI II I C _ ( cio"y,, ? Icuyci2"Vg CIO H Cil H C12 H u S n _ S n- C C13 H o H C14 ii a H C15 13"14 5l5" S ii S N ii 9 C13 7 C14 C15 N 0,, Hq-N N *c-'s *c-"--'s-, *c--'s- 11 s 11 S''DN 11 C16 7 C17 7 0 H cis H, 11 d'C u u S u/ 0--ONH 0 C19 o H C20 H C21 H , N 0 H 0,, H, _ 0 1 0 O/ o, H c I c -X -T -T u S u-S n- O/ v _C1 C25 H C26 H C27 H *. Nv N N\ *. Nyt N *. Nit N 9 ii _ S N -9 0'Z. N ft, Ne C2S,, C,, Tc, 1 < C28 0 H C29 H C30 0 H H C31' ? Y Or NH O'I1 O N :/ C31 N x *e'N w o I r p 0 x wiz

Particularly preferred compounds of "A", "B", and"C"combinations are illustrated in table 4, infra: Table 4 A1-B1-C1 A18-B1-C1 A35-B1-C1 A52-B1-C1 B2-B1-C1 A19-B1-C1 A36-B1-C1 A53-B1-C1 A3-B1-C1 A20-B1-C1 A37-B1-C1 A54-B1-C1 A4-B1-C1 A21-B1-C1 A38-B1-C1 A55-B1-C1 A5-B1-C1 A22-B1-C1 A39-B1-C1 A56-B1-C1 A6-B1-C1 A23-B1-C1 A40-B1-C1 A57-B1-C1 A7-B1-C1 A24-B1-C1 A41-Bl-Cl A58-B1-C1 A8-B1-C1 A25-B1-C1 A42-B1-C1 A59-B1-C1 A9-B1-C1 A26-B1-C1 A43-B1-C1 A60-B1-C1 A10-B1-C1 A27-B1-C1 A44-B1-C1 A61-B1-C1 A11-B1-C1 A28-B1-C1 A45-B1-C1 A62-B1-C1 A12-B1-C1 A29-B1-C1 A46-B1-C1 A63-B1-C1 A13-B1-C1 A30-B1-C1 A47-B1-C1 A64-B1-C1 A14-B1-C1 A31-B1-C1 A48-B1-C1 A65-B1-C1 A15-B1-C1 A32-B1-C1 A49-B1-C1 A66-B1-C1 A16-B1-C1 A33-B1-C1 A50-B1-C1 A67-B1-C1 A17-B1-C1 A34-B1-C1 A51-B1-C1 A68-B1-C1 A69-B1-C1 A58-B2-C1 A47-B3-C1 A36-B4-C1 A70-B1-C1 A59-B2-C1 A48-B3-C1 A37-B4-C1 A71-B1-C1 A60-B2-C1 A49-B3-C1 A38-B4-C1 A72-B1-C1 A61-B2-C1 A50-B3-C1 A39-B4-C1 A73-B1-C1 A62-B2-C1 A51-B3-C1 A40-B4-C1 A74-B1-C1 A63-B2-C1 A52-B3-C1 A41-B4-C1 A75-B1-C1 A64-B2-C1 A53-B3-C1 A42-B4-C1 A76-B1-C1 A65-B2-C1 A54-B3-C1 A43-B4-C1 A77-B1-C1 A66-B2-C1 A55-B3-C1 A44-B4-C1 A1-B2-C1 A67-B2-C1 A56-B3-C1 A45-B4-C1 A2-B2-C1 A68-B2-C1 A57-B3-C1 A46-B4-C1 A3-B2-C1 A69-B2-C1 A58-B3-C1 A47-B4-C1 A4-B2-C1 A70-B2-C1 A59-B3-C1 A48-B4-C1 A5-B2-C1 A71-B2-C1 A60-B3-C1 A49-B4-C1 A6-B2-C1 A72-B2-C1 A61-B3-C1 A50-B4-C1 A7-B2-C1 A73-B2-C1 A62-B3-C1 A51-B4-C1 A8-B2-C1 A74-B2-C1 A63-B3-C1 A52-B4-C1 A9-B2-C1 A75-B2-C1 A64-B3-C1 A53-B4-C1 A10-B2-C1 A76-B2-C1 A65-B3-C1 A54-B4-C1 A11-B2-C1 A77-B2-C1 A66-B3-C1 A55-B4-C1 A12-B2-C1 A1-B3-C1 A67-B3-C1 A56-B4-C1 A13-B2-C1 A2-B3-C1 A68-B3-C1 A57-B4-C1 A14-B2-C1 A3-B3-C1 A69-B3-C1 A58-B4-C1 A15-B2-C1 A4-B3-C1 A70-B3-C1 A59-B4-C1 A16-B2-C1 A5-B3-C1 A71-B3-C1 A60-B4-C1 A17-B2-C1 A6-B3-C1 A72-B3-C1 A61-B4-C1 A18-B2-C1 A7-B3-C1. A73-B3-C1 A62-B4-C1 A19-B2-C1 A8-B3-C1 A74-B3-C1 A63-B4-C1 A20-B2-C1 A9-B3-C1 A75-B3-C1 A64-B4-C1 A21-B2-C1 A10-B3-C1 A76-B3-C1 A65-B4-C1 A22-B2-C1 Al1-B3-C1 A77-B3-C1 A66-B4-C1 A23-B2-C1 A12-B3-C1 A1-B4-C1 A67-B4-C1 A24-B2-C1 A13-B3-C1 A2-B4-C1 A68-B4-C1 A25-B2-C1 A14-B3-C1 A3-B4-C1 A69-B4-C1 A26-B2-C1 A15-B3-C1 A4-B4-C1 A70-B4-C1 A27-B2-C1 A16-B3-C1 A5-B4-C1 A71-B4-C1 A28-B2-C1 A17-B3-C1 A6-B4-C1 A72-B4-C1 A29-B2-C1 A18-B3-C1 A7-B4-C1 A73-B4-C1 A30-B2-C1 A19-B3-C1 A8-B4-C1 A74-B4-C1 A31-B2-C1 A20-B3-C1 A9-B4-C1 A75-B4-C1 A32-B2-C1 A21-B3-C1 A10-B4-C1 A76-B4-C1 A33-B2-C1 A22-B3-C1 A11-B4-C1 A77-B4-C1 A34-B2-C1 A23-B3-C1 A12-B4-C1 A1-B1-C2 A35-B2-C1 A24-B3-C1 A13-B4-C1 A2-B1-C2 A36-B2-C1 A25-B3-C1 A14-B4-C1 A3-B1-C2 A37-B2-C1 A26-B3-C1 A15-B4-C1 A4-B1-C2 A38-B2-C1 A27-B3-C1 A16-B4-C1 A5-B1-C2 A39-B2-C1 A28-B3-C1 A17-B4-C1 A6-B1-C2 A40-B2-C1 A29-B3-C1 A18-B4-C1 A7-B1-C2 A41-B2-C1 A30-B3-C1 A19-B4-C1 A8-B1-C2 A42-B2-C1 A31-B3-C1 A20-B4-C1 A9-B1-C2 A43-B2-C1 A32-B3-C1 A21-B4-C1 A10-B1-C2 A44-B2-C1 A33-B3-C1 A22-B4-C1 A11-B1-C2 A45-B2-C1 A34-B3-C1 A23-B4-C1 A12-B1-C2 A46-B2-C1 A35-B3-C1 A24-B4-C1 A13-B1-C2 A47-B2-C1 A36-B3-C1 A25-B4-C1 A14-B1-C2 A48-B2-C1 A37-B3-C1 A26-B4-C1 A15-B1-C2 A49-B2-C1 A38-B3-C1 A27-B4-C1 A16-B1-C2 A50-B2-C1 A39-B3-C1 A28-B4-C1 A17-B1-C2 A51-B2-C1 A40-B3-C1 A29-B4-C1 A18-B1-C2 A52-B2-C1 A41-B3-C1 A30-B4-C1 A19-B1-C2 A53-B2-C1 A42-B3-C1 A31-B4-C1 A20-B1-C2 A54-B2-C1 A43-B3-C1 A32-B4-C1 A21-B1-C2 A55-B2-C1 A44-B3-C1 A33-B4-C1 A22-B1-C2 A56-B2-C1 A45-B3-C1 A34-B4-C1 A23-B1-C2 A57-B2-C1 A46-B3-C1 A35-B4-C1 A24-B1-C2 A25-B1-C2 A14-B2-C2 A3-B3-C2 A69-B3-C2 A26-B1-C2 A15-B2-C2 A4-B3-C2 A70-B3-C2 A27-B1-C2 A16-B2-C2 A5-B3-C2 A71-B3-C2 A28-B1-C2 A17-B2-C2 A6-B3-C2 A72-B3-C2 A29-B1-C2 A18-B2-C2 A7-B3-C2 A73-B3-C2 A30-B1-C2 A19-B2-C2 A8-B3-C2 A74-B3-C2 A31-B1-C2 A20-B2-C2 A9-B3-C2 A75-B3-C2 A32-B1-C2 A21-B2-C2 A10-B3-C2 A76-B3-C2 A33-B1-C2 A22-B2-C2 A11-B3-C2 A77-B3-C2 A34-B1-C2 A23-B2-C2 A12-B3-C2 A1-B4-C2 A35-B1-C2 A24-B2-C2 A13-B3-C2 A2-B4-C2 A36-B1-C2 A25-B2-C2 A14-B3-C2 A3-B4-C2 A37-B1-C2 A26-B2-C2 A15-B3-C2 A4-B4-C2 A38-B1-C2 A27-B2-C2 A16-B3-C2 A5-B4-C2 A39-B1-C2 A28-B2-C2 A17-B3-C2 A6-B4-C2 A40-B1-C2 A29-B2-C2 A18-B3-C2 A7-B4-C2 A41-B1-C2 A30-B2-C2 A19-B3-C2 A8-B4-C2 A42-B1-C2 A31-B2-C2 A20-B3-C2 A9-B4-C2 A43-B1-C2 A32-B2-C2 A21-B3-C2 A10-B4-C2 A44-B1-C2 A33-B2-C2 A22-B3-C2 Al1-B4-C2 A45-B1-C2 A34-B2-C2 A23-B3-C2 A12-B4-C2 A46-B1-C2 A35-B2-C2 A24-B3-C2 A13-B4-C2 A47-B1-C2 A36-B2-C2 A25-B3-C2 A14-B4-C2 A48-B1-C2 A37-B2-C2 A26-B3-C2 A15-B4-C2 A49-B1-C2 A38-B2-C2 A27-B3-C2 A16-B4-C2 A50-B1-C2 A39-B2-C2 A28-B3-C2 A17-B4-C2 A51-B1-C2 A40-B2-C2 A29-B3-C2 A18-B4-C2 A52-B1-C2 A41-B2-C2 A30-B3-C2 A19-B4-C2 A53-B1-C2 A42-B2-C2 A31-B3-C2 A20-B4-C2 A54-B1-C2 A43-B2-C2 A32-B3-C2 A21-B4-C2 A55-B1-C2 A44-B2-C2 A33-B3-C2 A22-B4-C2 A56-B1-C2 A45-B2-C2 A34-B3-C2 A23-B4-C2 A57-B1-C2 A46-B2-C2 A35-B3-C2 A24-B4-C2 A58-B1-C2 A47-B2-C2 A36-B3-C2 A25-B4-C2 A59-B1-C2 A48-B2-C2 A37-B3-C2 A26-B4-C2 A60-B1-C2 A49-B2-C2 A38-B3-C2 A27-B4-C2 A61-B1-C2 A50-B2-C2 A39-B3-C2 A28-B4-C2 A62-B1-C2 A51-B2-C2 A40-B3-C2 A29-B4-C2 A63-B1-C2 A52-B2-C2 A41-B3-C2 A30-B4-C2 A64-B1-C2 A53-B2-C2 A42-B3-C2 A31-B4-C2 A65-B1-C2 A54-B2-C2 A43-B3-C2 A32-B4-C2 A66-B1-C2 A55-B2-C2 A44-B3-C2 A33-B4-C2 A67-B1-C2 A56-B2-C2 A45-B3-C2 A34-B4-C2 A68-B1-C2 A57-B2-C2 A46-B3-C2 A35-B4-C2 A69-B1-C2 A58-B2-C2 A47-B3-C2 A36-B4-C2 A70-B1-C2 A59-B2-C2 A48-B3-C2 A37-B4-C2 A71-B1-C2 A60-B2-C2 A49-B3-C2 A38-B4-C2 A72-B1-C2 A61-B2-C2 A50-B3-C2 A39-B4-C2 A73-B1-C2 A62-B2-C2 A51-B3-C2 A40-B4-C2 A74-B1-C2 A63-B2-C2 A52-B3-C2 A41-B4-C2 A75-B1-C2 A64-B2-C2 A53-B3-C2 A42-B4-C2 A76-B1-C2 A65-B2-C2 A54-B3-C2 A43-B4-C2 A77-B1-C2 A66-B2-C2 A55-B3-C2 A44-B4-C2 A1-B2-C2 A67-B2-C2 A56-B3-C2 A45-B4-C2 A2-B2-C2 A68-B2-C2 A57-B3-C2 A46-B4-C2 A3-B2-C2 A69-B2-C2 A58-B3-C2 A47-B4-C2 A4-B2-C2 A70-B2-C2 A59-B3-C2 A48-B4-C2 A5-B2-C2 A71-B2-C2 A60-B3-C2 A49-B4-C2 A6-B2-C2 A72-B2-C2 A61-B3-C2 A50-B4-C2 A7-B2-C2 A73-B2-C2 A62-B3-C2 A51-B4-C2 A8-B2-C2 A74-B2-C2 A63-B3-C2 A52-B4-C2 A9-B2-C2 A75-B2-C2 A64-B3-C2 A53-B4-C2 A10-B2-C2 A76-B2-C2 A65-B3-C2 A54-B4-C2 A11-B2-C2 A77-B2-C2 A66-B3-C2 A55-B4-C2 A12-B2-C2 A1-B3-C2 A67-B3-C2 A56-B4-C2 A13-B2-C2 A2-B3-C2 A68-B3-C2 A57-B4-C2 A58-B4-C2 A47-B1-C3 A36-B2-C3 A25-B3-C3 A59-B4-C2 A48-B1-C3 A37-B2-C3 A26-B3-C3 A60-B4-C2 A49-B1-C3 A38-B2-C3 A27-B3-C3 A61-B4-C2 A50-B1-C3 A39-B2-C3 A28-B3-C3 A62-B4-C2 A51-B1-C3 A40-B2-C3 A29-B3-C3 A63-B4-C2 A52-B1-C3 A41-B2-C3 A30-B3-C3 A64-B4-C2 A53-B1-C3 A42-B2-C3 A31-B3-C3 A65-B4-C2 A54-B1-C3 A43-B2-C3 A32-B3-C3 A66-B4-C2 A55-B1-C3 A44-B2-C3 A33-B3-C3 A67-B4-C2 A56-B1-C3 A45-B2-C3 A34-B3-C3 A68-B4-C2 A57-B1-C3 A46-B2-C3 A35-B3-C3 A69-B4-C2 A58-B1-C3 A47-B2-C3 A36-B3-C3 A70-B4-C2 A59-B1-C3 A48-B2-C3 A37-B3-C3 A71-B4-C2 A60-B1-C3 A49-B2-C3 A38-B3-C3 A72-B4-C2 A61-B1-C3 A50-B2-C3 A39-B3-C3 A73-B4-C2 A62-B1-C3 A51-B2-C3 A40-B3-C3 A74-B4-C2 A63-B1-C3 A52-B2-C3 A41-B3-C3 A75-B4-C2 A64-B1-C3 A53-B2-C3 A42-B3-C3 A76-B4-C2 A65-B1-C3 A54-B2-C3 A43-B3-C3 A77-B4-C2 A66-B1-C3 A55-B2-C3 A44-B3-C3 A1-B1-C3 A67-B1-C3 A56-B2-C3 A45-B3-C3 A2-B1-C3 A68-B1-C3 A57-B2-C3 A46-B3-C3 A3-B1-C3 A69-B1-C3 A58-B2-C3 A47-B3-C3 A4-B1-C3 A70-B1-C3 A59-B2-C3 A48-B3-C3 A5-B1-C3 A71-B1-C3 A60-B2-C3 A49-B3-C3 A6-B1-C3 A72-B1-C3 A61-B2-C3 A50-B3-C3 A7-B1-C3 A73-B1-C3 A62-B2-C3 A51-B3-C3 A8-B1-C3 A74-B1-C3 A63-B2-C3 A52-B3-C3 A9-B1-C3 A75-B1-C3 A64-B2-C3 A53-B3-C3 A10-B1-C3 A76-B1-C3 A65-B2-C3 A54-B3-C3 A11-B1-C3 A77-B1-C3 A66-B2-C3 A55-B3-C3 A12-B1-C3 A1-B2-C3 A67-B2-C3 A56-B3-C3 A13-B1-C3 A2-B2-C3 A68-B2-C3 A57-B3-C3 A14-B1-C3 A3-B2-C3 A69-B2-C3 A58-B3-C3 A15-B1-C3 A4-B2-C3 A70-B2-C3 A59-B3-C3 A16-B1-C3 A5-B2-C3 A71-B2-C3 A60-B3-C3 A17-B1-C3 A6-B2-C3 A72-B2-C3 A61-B3-C3 A18-B1-C3 A7-B2-C3 A73-B2-C3 A62-B3-C3 A19-B1-C3 A8-B2-C3 A74-B2-C3 A63-B3-C3 A20-B1-C3 A9-B2-C3 A75-B2-C3 A64-B3-C3 A21-B1-C3 A10-B2-C3 A76-B2-C3 A65-B3-C3 A22-B1-C3 A11-B2-C3 A77-B2-C3 A66-B3-C3 A23-B1-C3 A12-B2-C3 A1-B3-C3 A67-B3-C3 A24-B1-C3 A13-B2-C3 A2-B3-C3 A68-B3-C3 A25-B1-C3 A14-B2-C3 A3-B3-C3 A69-B3-C3 A26-B1-C3 A15-B2-C3 A4-B3-C3 A70-B3-C3 A27-B1-C3 A16-B2-C3 A5-B3-C3 A71-B3-C3 A28-B1-C3 A17-B2-C3 A6-B3-C3 A72-B3-C3 A29-B1-C3 A18-B2-C3 A7-B3-C3 A73-B3-C3 A30-B1-C3 A19-B2-C3 A8-B3-C3 A74-B3-C3 A31-B1-C3 A20-B2-C3 A9-B3-C3 A75-B3-C3 A32-B1-C3 A21-B2-C3 A10-B3-C3 A76-B3-C3 A33-B1-C3 A22-B2-C3 A11-B3-C3 A77-B3-C3 A34-B1-C3 A23-B2-C3 A12-B3-C3 A1-B4-C3 A35-B1-C3 A24-B2-C3 A13-B3-C3 A2-B4-C3 A36-B1-C3 A25-B2-C3 A14-B3-C3 A3-B4-C3 A37-B1-C3 A26-B2-C3 A15-B3-C3 A4-B4-C3 A38-B1-C3 A27-B2-C3 A16-B3-C3 A5-B4-C3 A39-B1-C3 A28-B2-C3 A17-B3-C3 A6-B4-C3 A40-B1-C3 A29-B2-C3 A18-B3-C3 A7-B4-C3 A41-B1-C3 A30-B2-C3 A19-B3-C3 A8-B4-C3 A42-B1-C3 A31-B2-C3 A20-B3-C3 A9-B4-C3 A43-B1-C3 A32-B2-C3 A21-B3-C3 A10-B4-C3 A44-B1-C3 A33-B2-C3 A22-B3-C3 A11-B4-C3 A45-B1-C3 A34-B2-C3 A23-B3-C3 A12-B4-C3 A46-B1-C3 A35-B2-C3 A24-B3-C3 A13-B4-C3 A14-B4-C3 A3-B1-C4 A69-B1-C4 A58-B2-C4 A15-B4-C3 A4-B1-C4 A70-B1-C4 A59-B2-C4 A16-B4-C3 A5-B1-C4 A71-B1-C4 A60-B2-C4 A17-B4-C3 A6-B1-C4 A72-B1-C4 A61-B2-C4 A18-B4-C3 A7-B1-C4 A73-B1-C4 A62-B2-C4 A19-B4-C3 A8-B1-C4 A74-B1-C4 A63-B2-C4 A20-B4-C3 A9-B1-C4 A75-B1-C4 A64-B2-C4 A21-B4-C3 A10-B1-C4 A76-B1-C4 A65-B2-C4 A22-B4-C3 A11-B1-C4 A77-B1-C4 A66-B2-C4 A23-B4-C3 A12-B1-C4 A1-B2-C4 A67-B2-C4 A24-B4-C3 A13-B1-C4 A2-B2-C4 A68-B2-C4 A25-B4-C3 A14-B1-C4 A3-B2-C4 A69-B2-C4 A26-B4-C3 A15-B1-C4 A4-B2-C4 A70-B2-C4 A27-B4-C3 A16-B1-C4 A5-B2-C4 A71-B2-C4 A28-B4-C3 A17-B1-C4 A6-B2-C4 A72-B2-C4 A29-B4-C3 A18-B1-C4 A7-B2-C4 A73-B2-C4 A30-B4-C3 A19-B1-C4 A8-B2-C4 A74-B2-C4 A31-B4-C3 A20-B1-C4 A9-B2-C4 A75-B2-C4 A32-B4-C3 A21-B1-C4 A10-B2-C4 A76-B2-C4 A33-B4-C3 A22-B1-C4 A11-B2-C4 A77-B2-C4 A34-B4-C3 A23-B1-C4 A12-B2-C4 A1-B3-C4 A35-B4-C3 A24-B1-C4 A13-B2-C4 A2-B3-C4 A36-B4-C3 A25-B1-C4 A14-B2-C4 A3-B3-C4 A37-B4-C3 A26-B1-C4 A15-B2-C4 A4-B3-C4 A38-B4-C3 A27-B1-C4 A16-B2-C4 A5-B3-C4 A39-B4-C3 A28-B1-C4 A17-B2-C4 A6-B3-C4 A40-B4-C3 A29-B1-C4 A18-B2-C4 A7-B3-C4 A41-B4-C3 A30-B1-C4 A19-B2-C4 A8-B3-C4 A42-B4-C3 A31-B1-C4 A20-B2-C4 A9-B3-C4 A43-B4-C3 A32-B1-C4 A21-B2-C4 A10-B3-C4 A44-B4-C3 A33-B1-C4 A22-B2-C4 A11-B3-C4 A45-B4-C3 A34-B1-C4 A23-B2-C4 A12-B3-C4 A46-B4-C3 A35-B1-C4 A24-B2-C4 A13-B3-C4 A47-B4-C3 A36-B1-C4 A25-B2-C4 A14-B3-C4 A48-B4-C3 A37-B1-C4 A26-B2-C4 A15-B3-C4 A49-B4-C3 A38-B1-C4 A27-B2-C4 A16-B3-C4 A50-B4-C3 A39-B1-C4 A28-B2-C4 A17-B3-C4 A51-B4-C3 A40-B1-C4 A29-B2-C4 A18-B3-C4 A52-B4-C3 A41-B1-C4 A30-B2-C4 A19-B3-C4 A53-B4-C3 A42-B1-C4 A31-B2-C4 A20-B3-C4 A54-B4-C3 A43-B1-C4 A32-B2-C4 A21-B3-C4 A55-B4-C3 A44-B1-C4 A33-B2-C4 A22-B3-C4 A56-B4-C3 A45-B1-C4 A34-B2-C4 A23-B3-C4 A57-B4-C3 A46-B1-C4 A35-B2-C4 A24-B3-C4 A58-B4-C3 A47-B1-C4 A36-B2-C4 A25-B3-C4 A59-B4-C3 A48-B1-C4 A37-B2-C4 A26-B3-C4 A60-B4-C3 A49-B1-C4 A38-B2-C4 A27-B3-C4 A61-B4-C3 A50-B1-C4 A39-B2-C4 A28-B3-C4 A62-B4-C3 A51-B1-C4 A40-B2-C4 A29-B3-C4 A63-B4-C3 A52-B1-C4 A41-B2-C4 A30-B3-C4 A64-B4-C3 A53-B1-C4 A42-B2-C4 A31-B3-C4 A65-B4-C3 A54-B1-C4 A43-B2-C4 A32-B3-C4 A66-B4-C3 A55-B1-C4 A44-B2-C4 A33-B3-C4 A67-B4-C3 A56-B1-C4 A45-B2-C4 A34-B3-C4 A68-B4-C3 A57-B1-C4 A46-B2-C4 A35-B3-C4 A69-B4-C3 A58-B1-C4 A47-B2-C4 A36-B3-C4 A70-B4-C3 A59-B1-C4 A48-B2-C4 A37-B3-C4 A71-B4-C3 A60-B1-C4 A49-B2-C4 A38-B3-C4 A72-B4-C3 A61-B1-C4 A50-B2-C4 A39-B3-C4 A73-B4-C3 A62-B1-C4 A51-B2-C4 A40-B3-C4 A74-B4-C3 A63-B1-C4 A52-B2-C4 A41-B3-C4 A75-B4-C3 A64-B1-C4 A53-B2-C4 A42-B3-C4 A76-B4-C3 A65-B1-C4 A54-B2-C4 A43-B3-C4 A77-B4-C3 A66-B1-C4 A55-B2-C4 A44-B3-C4 A1-B1-C4 A67-B1-C4 A56-B2-C4 A45-B3-C4 A2-B1-C4 A68-B1-C4 A57-B2-C4 A46-B3-C4 A47-B3-C4 A36-B4-C4 A25-B1-C5 A14-B2-C5 A48-B3-C4 A37-B4-C4 A26-B1-C5 A15-B2-C5 A49-B3-C4 A38-B4-C4 A27-B1-C5 A16-B2-C5 A50-B3-C4 A39-B4-C4 A28-B1-C5 A17-B2-C5 A51-B3-C4 A40-B4-C4 A29-B1-C5 A18-B2-C5 A52-B3-C4 A41-B4-C4 A30-B1-C5 A19-B2-C5 A53-B3-C4 A42-B4-C4 A31-B1-C5 A20-B2-C5 A54-B3-C4 A43-B4-C4 A32-B1-C5 A21-B2-C5 A55-B3-C4 A44-B4-C4 A33-B1-C5 A22-B2-C5 A56-B3-C4 A45-B4-C4 A34-B1-C5 A23-B2-C5 A57-B3-C4 A46-B4-C4 A35-B1-C5 A24-B2-C5 A58-B3-C4 A47-B4-C4 A36-B1-C5 A25-B2-C5 A59-B3-C4 A48-B4-C4 A37-B1-C5 A26-B2-C5 A60-B3-C4 A49-B4-C4 A38-B1-C5 A27-B2-C5 A61-B3-C4 A50-B4-C4 A39-B1-C5 A28-B2-C5 A62-B3-C4 A51-B4-C4 A40-B1-C5 A29-B2-C5 A63-B3-C4 A52-B4-C4 A41-B1-C5 A30-B2-C5 A64-B3-C4 A53-B4-C4 A42-B1-C5 A31-B2-C5 A65-B3-C4 A54-B4-C4 A43-B1-C5 A32-B2-C5 A66-B3-C4 A55-B4-C4 A44-B1-C5 A33-B2-C5 A67-B3-C4 A56-B4-C4 A45-B1-C5 A34-B2-C5 A68-B3-C4 A57-B4-C4 A46-B1-C5 A35-B2-C5 A69-B3-C4 A58-B4-C4 A47-B1-C5 A36-B2-C5 A70-B3-C4 A59-B4-C4 A48-B1-C5 A37-B2-C5 A71-B3-C4 A60-B4-C4 A49-B1-C5 A38-B2-C5 A72-B3-C4 A61-B4-C4 A50-B1-C5 A39-B2-C5 A73-B3-C4 A62-B4-C4 A51-B1-C5 A40-B2-C5 A74-B3-C4 A63-B4-C4 A52-B1-C5 A41-B2-C5 A75-B3-C4 A64-B4-C4 A53-B1-C5 A42-B2-C5 A76-B3-C4 A65-B4-C4 A54-B1-C5 A43-B2-C5 A77-B3-C4 A66-B4-C4 A55-B1-C5 A44-B2-C5 A1-B4-C4 A67-B4-C4 A56-B1-C5 A45-B2-C5 A2-B4-C4 A68-B4-C4 A57-B1-C5 A46-B2-C5 A3-B4-C4 A69-B4-C4 A58-B1-C5 A47-B2-C5 A4-B4-C4 A70-B4-C4 A59-B1-C5 A48-B2-C5 A5-B4-C4 A71-B4-C4 A60-B1-C5 A49-B2-C5 A6-B4-C4 A72-B4-C4 A61-B1-C5 A50-B2-C5 A7-B4-C4 A73-B4-C4 A62-B1-C5 A51-B2-C5 A8-B4-C4 A74-B4-C4 A63-B1-C5 A52-B2-C5 A9-B4-C4 A75-B4-C4 A64-B1-C5 A53-B2-C5 A10-B4-C4 A76-B4-C4 A65-B1-C5 A54-B2-C5 A11-B4-C4 A77-B4-C4 A66-B1-C5 A55-B2-C5 A12-B4-C4 Al-Bl-C5 A67-B1-C5 A56-B2-C5 A13-B4-C4 A2-B1-C5 A68-B1-C5 A57-B2-C5 A14-B4-C4 A3-B1-C5 A69-B1-G5 A58-B2-C5 A15-B4-C4 A4-B1-C5 A70-B1-C5 A59-B2-C5 A16-B4-C4 A5-B1-C5 A71-B1-C5 A60-B2-C5 A17-B4-C4 A6-B1-C5 A72-B1-C5 A61-B2-C5 A18-B4-C4 A7-B1-C5 A73-B1-C5 A62-B2-C5 A19-B4-C4 A8-B1-C5 A74-B1-C5 A63-B2-C5 A20-B4-C4 A9-B1-C5 A75-B1-C5 A64-B2-C5 A21-B4-C4 A10-B1-C5 A76-B1-C5 A65-B2-C5 A22-B4-C4 All-Bl-C5 A77-B1-C5 A66-B2-C5 A23-B4-C4 A12-B1-C5 A1-B2-C5 A67-B2-C5 A24-B4-C4 A13-B1-C5 A2-B2-C5 A68-B2-C5 A25-B4-C4 A14-B1-C5 A3-B2-C5 A69-B2-C5 A26-B4-C4 A15-B1-C5 A4-B2-C5 A70-B2-C5 A27-B4-C4 A16-B1-C5 A5-B2-C5 A71-B2-C5 A28-B4-C4 A17-B1-C5 A6-B2-C5 A72-B2-C5 A29-B4-C4 A18-B1-C5 A7-B2-C5 A73-B2-C5 A30-B4-C4 A19-B1-C5 A8-B2-C5 A74-B2-C5 A31-B4-C4 A20-B1-C5 A9-B2-C5 A75-B2-C5 A32-B4-C4 A21-B1-C5 A10-B2-C5 A76-B2-C5 A33-B4-C4 A22-B1-C5 All-B2-C5 A77-B2-C5 A34-B4-C4 A23-B1-C5 A12-B2-C5 A1-B3-C5 A35-B4-C4 A24-B1-C5 A13-B2-C5 A2-B3-C5 A3-B3-C5 A69-B3-C5 A58-B4-C5 A47-B1-C6 A4-B3-C5 A70-B3-C5 A59-B4-C5 A48-B1-C6 A5-B3-C5 A71-B3-C5 A60-B4-C5 A49-B1-C6 A6-B3-C5 A72-B3-C5 A61-B4-C5 A50-B1-C6 A7-B3-C5 A73-B3-C5 A62-B4-C5 A51-B1-C6 A8-B3-C5 A74-B3-C5 A63-B4-C5 A52-B1-C6 A9-B3-C5 A75-B3-C5 A64-B4-C5 A53-B1-C6 A10-B3-C5 A76-B3-C5 A65-B4-C5 A54-B1-C6 All-B3-C5 A77-B3-C5 A66-B4-C5 A55-B1-C6 A12-B3-C5 A1-B4-C5 A67-B4-C5 A56-B1-C6 A13-B3-C5 A2-B4-C5 A68-B4-C5 A57-B1-C6 A14-B3-C5 A3-B4-C5 A69-B4-C5 A58-B1-C6 A15-B3-C5 A4-B4-C5 A70-B4-C5 A59-B1-C6 A16-B3-C5 A5-B4-C5 A71-B4-C5 A60-B1-C6 A17-B3-C5 A6-B4-C5 A72-B4-C5 A61-B1-C6 A18-B3-C5 A7-B4-C5 A73-B4-C5 A62-B1-C6 A19-B3-C5 A8-B4-C5 A74-B4-C5 A63-B1-C6 A20-B3-C5 A9-B4-C5 A75-B4-C5 A64-B1-C6 A21-B3-C5 A10-B4-C5 A76-B4-C5 A65-B1-C6 A22-B3-C5 A11-B4-C5 A77-B4-C5 A66-B1-C6 A23-B3-C5 A12-B4-C5 A1-B1-C6 A67-B1-C6 A24-B3-C5 A13-B4-C5 A2-B1-C6 A68-B1-C6 A25-B3-C5 A14-B4-C5 A3-B1-C6 A69-B1-C6 A26-B3-C5 A15-B4-C5 A4-B1-C6 A70-B1-C6 A27-B3-C5 A16-B4-C5 A5-B1-C6 A71-B1-C6 A28-B3-C5 A17-B4-C5 A6-B1-C6 A72-B1-C6 A29-B3-C5 A18-B4-C5 A7-B1-C6 A73-B1-C6 A30-B3-C5 A19-B4-C5 A8-B1-C6 A74-B1-C6 A31-B3-C5 A20-B4-C5 A9-B1-C6 A75-B1-C6 A32-B3-C5 A21-B4-C5 A10-B1-C6 A76-B1-C6 A33-B3-C5 A22-B4-C5 A11-B1-C6 A77-B1-C6 A34-B3-C5 A23-B4-C5 A12-B1-C6 A1-B2-C6 A35-B3-C5 A24-B4-C5 A13-B1-C6 A2-B2-C6 A36-B3-C5 A25-B4-C5 A14-B1-C6 A3-B2-C6 A37-B3-C5 A26-B4-C5 A15-B1-C6 A4-B2-C6 A38-B3-C5 A27-B4-C5 A16-B1-C6 A5-B2-C6 A39-B3-C5 A28-B4-C5 A17-B1-C6 A6-B2-C6 A40-B3-C5 A29-B4-C5 A18-B1-C6 A7-B2-C6 A41-B3-C5 A30-B4-C5 A19-B1-C6 A8-B2-C6 A42-B3-C5 A31-B4-C5 A20-B1-C6 A9-B2-C6 A43-B3-C5 A32-B4-C5 A21-B1-C6 A10-B2-C6 A44-B3-C5 A33-B4-C5 A22-B1-C6 A11-B2-C6 A45-B3-C5 A34-B4-C5 A23-B1-C6 A12-B2-C6 A46-B3-C5 A35-B4-C5 A24-B1-C6 A13-B2-C6 A47-B3-C5 A36-B4-C5 A25-B1-C6 A14-B2-C6 A48-B3-C5 A37-B4-C5 A26-B1-C6 A15-B2-C6 A49-B3-C5 A38-B4-C5 A27-B1-C6 A16-B2-C6 A50-B3-C5 A39-B4-C5 A28-B1-C6 A17-B2-C6 A51-B3-C5 A40-B4-C5 A29-B1-C6 A18-B2-C6 A52-B3-C5 A41-B4-C5 A30-B1-C6 A19-B2-C6 A53-B3-C5 A42-B4-C5 A31-B1-C6 A20-B2-C6 A54-B3-C5 A43-B4-C5 A32-B1-C6 A21-B2-C6 A55-B3-C5 A44-B4-C5 A33-B1-C6 A22-B2-C6 A56-B3-C5 A45-B4-C5 A34-B1-C6 A23-B2-C6 A57-B3-C5 A46-B4-C5 A35-B1-C6 A24-B2-C6 A58-B3-C5 A47-B4-C5 A36-B1-C6 A25-B2-C6 A59-B3-C5 A48-B4-C5 A37-B1-C6 A26-B2-C6 A60-B3-C5 A49-B4-C5 A38-B1-C6 A27-B2-C6 A61-B3-C5 A50-B4-C5 A39-B1-C6 A28-B2-C6 A62-B3-C5 A51-B4-C5 A40-B1-C6 A29-B2-C6 A63-B3-C5 A52-B4-C5 A41-B1-C6 A30-B2-C6 A64-B3-C5 A53-B4-C5 A42-Bl-C6 A31-B2-C6 A65-B3-C5 A54-B4-C5 A43-B1-C6 A32-B2-C6 A66-B3-C5 A55-B4-C5 A44-B1-C6 A33-B2-C6 A67-B3-C5 A56-B4-C5 A45-B1-C6 A34-B2-C6 A68-B3-C5 A57-B4-C5 A46-B1-C6 A35-B2-C6 A36-B2-C6 A25-B3-C6 A14-B4-C6 A3-B1-C7 A37-B2-C6 A26-B3-C6 A15-B4-C6 A4-B1-C7 A38-B2-C6 A27-B3-C6 A16-B4-C6 A5-B1-C7 A39-B2-C6 A28-B3-C6 A17-B4-C6 A6-B1-C7 A40-B2-C6 A29-B3-C6 A18-B4-C6 A7-B1-C7 A41-B2-C6 A30-B3-C6 A19-B4-C6 A8-B1-C7 A42-B2-C6 A31-B3-C6 A20-B4-C6 A9-B1-C7 A43-B2-C6 A32-B3-C6 A21-B4-C6 A10-B1-C7 A44-B2-C6 A33-B3-C6 A22-B4-C6 A11-B1-C7 A45-B2-C6 A34-B3-C6 A23-B4-C6 A12-B1-C7 A46-B2-C6 A35-B3-C6 A24-B4-C6 A13-B1-C7 A47-B2-C6 A36-B3-C6 A25-B4-C6 A14-B1-C7 A48-B2-C6 A37-B3-C6 A26-B4-C6 A15-B1-C7 A49-B2-C6 A38-B3-C6 A27-B4-C6 A16-B1-C7 A50-B2-C6 A39-B3-C6 A28-B4-C6 A17-B1-C7 A51-B2-C6 A40-B3-C6 A29-B4-C6 A18-B1-C7 A52-B2-C6 A41-B3-C6 A30-B4-C6 A19-B1-C7 A53-B2-C6 A42-B3-C6 A31-B4-C6 A20-B1-C7 A54-B2-C6 A43-B3-C6 A32-B4-C6 A21-B1-C7 A55-B2-C6 A44-B3-C6 A33-B4-C6 A22-B1-C7 A56-B2-C6 A45-B3-C6 A34-B4-C6 A23-B1-C7 A57-B2-C6 A46-B3-C6 A35-B4-C6 A24-B1-C7 A58-B2-C6 A47-B3-C6 A36-B4-C6 A25-B1-C7 A59-B2-C6 A48-B3-C6 A37-B4-C6 A26-B1-C7 A60-B2-C6 A49-B3-C6 A38-B4-C6 A27-B1-C7 A61-B2-C6 A50-B3-C6 A39-B4-C6 A28-B1-C7 A62-B2-C6 A51-B3-C6 A40-B4-C6 A29-B1-C7 A63-B2-C6 A52-B3-C6 A41-B4-C6 A30-B1-C7 A64-B2-C6 A53-B3-C6 A42-B4-C6 A31-B1-C7 A65-B2-C6 A54-B3-C6 A43-B4-C6 A32-B1-C7 A66-B2-C6 A55-B3-C6 A44-B4-C6 A33-B1-C7 A67-B2-C6 A56-B3-C6 A45-B4-C6 A34-B1-C7 A68-B2-C6 A57-B3-C6 A46-B4-C6 A35-B1-C7 A69-B2-C6 A58-B3-C6 A47-B4-C6 A36-B1-C7 A70-B2-C6 A59-B3-C6 A48-B4-C6 A37-B1-C7 A71-B2-C6 A60-B3-C6 A49-B4-C6 A38-B1-C7 A72-B2-C6 A61-B3-C6 A50-B4-C6 A39-B1-C7 A73-B2-C6 A62-B3-C6 A51-B4-C6 A40-B1-C7 A74-B2-C6 A63-B3-C6 A52-B4-C6 A41-B1-C7 A75-B2-C6 A64-B3-C6 A53-B4-C6 A42-B1-C7 A76-B2-C6 A65-B3-C6 A54-B4-C6 A43-B1-C7 A77-B2-C6 A66-B3-C6 A55-B4-C6 A44-B1-C7 A1-B3-C6 A67-B3-C6 A56-B4-C6 A45-B1-C7 A2-B3-C6 A68-B3-C6 A57-B4-C6 A46-B1-C7 A3-B3-C6 A69-B3-C6 A58-B4-C6 A47-B1-C7 A4-B3-C6 A70-B3-C6 A59-B4-C6 A48-B1-C7 A5-B3-C6 A71-B3-C6 A60-B4-C6 A49-B1-C7 A6-B3-C6 A72-B3-C6 A61-B4-C6 A50-B1-C7 A7-B3-C6 A73-B3-C6 A62-B4-C6 A51-B1-C7 A8-B3-C6 A74-B3-C6 A63-B4-C6 A52-B1-C7 A9-B3-C6 A75-B3-C6 A64-B4-C6 A53-B1-C7 A10-B3-C6 A76-B3-C6 A65-B4-C6 A54-B1-C7 A11-B3-C6 A77-B3-C6 A66-B4-C6 A55-B1-C7 A12-B3-C6 A1-B4-C6 A67-B4-C6 A56-B1-C7 A13-B3-C6 A2-B4-C6 A68-B4-C6 A57-B1-C7 A14-B3-C6 A3-B4-C6 A69-B4-C6 A58-B1-C7 A15-B3-C6 A4-B4-C6 A70-B4-C6 A59-B1-C7 A16-B3-C6 A5-B4-C6 A71-B4-C6 A60-B1-C7 A17-B3-C6 A6-B4-C6 A72-B4-C6 A61-B1-C7 A18-B3-C6 A7-B4-C6 A73-B4-C6 A62-B1-C7 A19-B3-C6 A8-B4-C6 A74-B4-C6 A63-B1-C7 A20-B3-C6 A9-B4-C6 A75-B4-C6 A64-B1-C7 A21-B3-C6 A10-B4-C6 A76-B4-C6 A65-B1-C7 A22-B3-C6 A11-B4-C6 A77-B4-C6 A66-B1-C7 A23-B3-C6 A12-B4-C6 A1-B1-C7 A67-B1-C7 A24-B3-C6 A13-B4-C6 A2-B1-C7 A68-B1-C7 A69-B1-C7 A58-B2-C7 A47-B3-C7 A36-B4-C7 A70-B1-C7 A59-B2-C7 A48-B3-C7 A37-B4-C7 A71-B1-C7 A60-B2-C7 A49-B3-C7 A38-B4-C7 A72-B1-C7 A61-B2-C7 A50-B3-C7 A39-B4-C7 A73-B1-C7 A62-B2-C7 A51-B3-C7. A40-B4-C7 A74-B1-C7 A63-B2-C7 A52-B3-C7 A41-B4-C7 A75-B1-C7 A64-B2-C7 A53-B3-C7 A42-B4-C7 A76-B1-C7 A65-B2-C7 A54-B3-C7 A43-B4-C7 A77-B1-C7 A66-B2-C7 A55-B3-C7 A44-B4-C7 A1-B2-C7 A67-B2-C7 A56-B3-C7 A45-B4-C7 A2-B2-C7 A68-B2-C7 A57-B3-C7 A46-B4-C7 A3-B2-C7 A69-B2-C7 A58-B3-C7 A47-B4-C7 A4-B2-C7 A70-B2-C7 A59-B3-C7 A48-B4-C7 A5-B2-C7 A71-B2-C7 A60-B3-C7 A49-B4-C7 A6-B2-C7 A72-B2-C7 A61-B3-C7 A50-B4-C7 A7-B2-C7 A73-B2-C7 A62-B3-C7 A51-B4-C7 A8-B2-C7 A74-B2-C7 A63-B3-C7 A52-B4-C7 A9-B2-C7 A75-B2-C7 A64-B3-C7 A53-B4-C7 A10-B2-C7 A76-B2-C7 A65-B3-C7 A54-B4-C7 A11-B2-C7 A77-B2-C7 A66-B3-C7 A55-B4-C7 A12-B2-C7 A1-B3-C7 A67-B3-C7 A56-B4-C7 A13-B2-C7 A2-B3-C7 A68-B3-C7 A57-B4-C7 A14-B2-C7 A3-B3-C7 A69-B3-C7 A58-B4-C7 A15-B2-C7 A4-B3-C7 A70-B3-C7 A59-B4-C7 A16-B2-C7 A5-B3-C7 A71-B3-C7 A60-B4-C7 A17-B2-C7 A6-B3-C7 A72-B3-C7 A61-B4-C7 A18-B2-C7 A7-B3-C7 A73-B3-C7 A62-B4-C7 A19-B2-C7 A8-B3-C7 A74-B3-C7 A63-B4-C7 A20-B2-C7 A9-B3-C7 A75-B3-C7 A64-B4-C7 A21-B2-C7 A10-B3-C7 A76-B3-C7 A65-B4-C7 A22-B2-C7 A11-B3-C7 A77-B3-C7 A66-B4-C7 A23-B2-C7 A12-B3-C7 A1-B4-C7 A67-B4-C7 A24-B2-C7 A13-B3-C7 A2-B4-C7 A68-B4-C7 A25-B2-C7 A14-B3-C7 A3-B4-C7 A69-B4-C7 A26-B2-C7 A15-B3-C7 A4-B4-C7 A70-B4-C7 A27-B2-C7 A16-B3-C7 A5-B4-C7 A71-B4-C7 A28-B2-C7 A17-B3-C7 A6-B4-C7 A72-B4-C7 A29-B2-C7 A18-B3-C7 A7-B4-C7 A73-B4-C7 A30-B2-C7 A19-B3-C7 A8-B4-C7 A74-B4-C7 A31-B2-C7 A20-B3-C7 A9-B4-C7 A75-B4-C7 A32-B2-C7 A21-B3-C7 A10-B4-C7 A76-B4-C7 A33-B2-C7 A22-B3-C7 A11-B4-C7 A77-B4-C7 A34-B2-C7 A23-B3-C7 A12-B4-C7 A1-B1-C8 A35-B2-C7 A24-B3-C7 A13-B4-C7 A2-B1-C8 A36-B2-C7 A25-B3-C7 A14-B4-C7 A3-B1-C8 A37-B2-C7 A26-B3-C7 A15-B4-C7 A4-B1-C8 A38-B2-C7 A27-B3-C7 A16-B4-C7 A5-B1-C8 A39-B2-C7 A28-B3-C7 A17-B4-C7 A6-B1-C8 A40-B2-C7 A29-B3-C7 A18-B4-C7 A7-B1-C8 A41-B2-C7 A30-B3-C7 A19-B4-C7 A8-B1-C8 A42-B2-C7 A31-B3-C7 A20-B4-C7 A9-B1-C8 A43-B2-C7 A32-B3-C7 A21-B4-C7 A10-B1-C8 A44-B2-C7 A33-B3-C7 A22-B4-C7 A11-B1-C8 A45-B2-C7 A34-B3-C7 A23-B4-C7 A12-B1-C8 A46-B2-C7 A35-B3-C7 A24-B4-C7 A13-B1-C8 A47-B2-C7 A36-B3-C7 A25-B4-C7 A14-B1-C8 A48-B2-C7 A37-B3-C7 A26-B4-C7 A15-B1-C8 A49-B2-C7 A38-B3-C7 A27-B4-C7 A16-B1-C8 A50-B2-C7 A39-B3-C7 A28-B4-C7 A17-B1-C8 A51-B2-C7 A40-B3-C7 A29-B4-C7 A18-B1-C8 A52-B2-C7 A41-B3-C7 A30-B4-C7 A19-B1-C8 A53-B2-C7 A42-B3-C7 A31-B4-C7 A20-B1-C8 A54-B2-C7 A43-B3-C7 A32-B4-C7 A21-B1-C8 A55-B2-C7 A44-B3-C7 A33-B4-C7 A22-B1-C8 A56-B2-C7 A45-B3-C7 A34-B4-C7 A23-B1-C8 A57-B2-C7 A46-B3-C7 A35-B4-C7 A24-B1-C8 A25-B1-C8 A14-B2-C8 A3-B3-C8 A69-B3-C8 A26-B1-C8 A15-B2-C8 A4-B3-C8 A70-B3-C8 A27-B1-C8 A16-B2-C8 A5-B3-C8 A71-B3-C8 A28-B1-C8 A17-B2-C8 A6-B3-C8 A72-B3-C8 A29-B1-C8 A18-B2-C8 A7-B3-C8 A73-B3-C8 A30-B1-C8 A19-B2-C8 A8-B3-C8 A74-B3-C8 A31-B1-C8 A20-B2-C8 A9-B3-C8 A75-B3-C8 A32-B1-C8 A21-B2-C8 A10-B3-C8 A76-B3-C8 A33-B1-C8 A22-B2-C8 A11-B3-C8 A77-B3-C8 A34-B1-C8 A23-B2-C8 A12-B3-C8 A1-B4-C8 A35-B1-C8 A24-B2-C8 A13-B3-C8 A2-B4-C8 A36-B1-C8 A25-B2-C8 A14-B3-C8 A3-B4-C8 A37-B1-C8 A26-B2-C8 A15-B3-C8 A4-B4-C8 A38-B1-C8 A27-B2-C8 A16-B3-C8 A5-B4-C8 A39-B1-C8 A28-B2-C8 A17-B3-C8 A6-B4-C8 A40-B1-C8 A29-B2-C8 A18-B3-C8 A7-B4-C8 A41-B1-C8 A30-B2-C8 A19-B3-C8 A8-B4-C8 A42-B1-C8 A31-B2-C8 A20-B3-C8 A9-B4-C8 A43-B1-C8 A32-B2-C8 A21-B3-C8 A10-B4-C8 A44-B1-C8 A33-B2-C8 A22-B3-C8 A11-B4-C8 A45-B1-C8 A34-B2-C8 A23-B3-C8 A12-B4-C8 A46-B1-C8 A35-B2-C8 A24-B3-C8 A13-B4-C8 A47-B1-C8 A36-B2-C8 A25-B3-C8 A14-B4-C8 A48-B1-C8 A37-B2-C8 A26-B3-C8 A15-B4-C8 A49-B1-C8 A38-B2-C8 A27-B3-C8 A16-B4-C8 A50-B1-C8 A39-B2-C8 A28-B3-C8 A17-B4-C8 A51-B1-C8 A40-B2-C8 A29-B3-C8 A18-B4-C8 A52-B1-C8 A41-B2-C8 A30-B3-C8 A19-B4-C8 A53-B1-C8 A42-B2-C8 A31-B3-C8 A20-B4-C8 A54-B1-C8 A43-B2-C8 A32-B3-C8 A21-B4-C8 A55-B1-C8 A44-B2-C8 A33-B3-C8 A22-B4-C8 A56-B1-C8 A45-B2-C8 A34-B3-C8 A23-B4-C8 A57-B1-C8 A46-B2-C8 A35-B3-C8 A24-B4-C8 A58-B1-C8 A47-B2-C8 A36-B3-C8 A25-B4-C8 A59-B1-C8 A48-B2-C8 A37-B3-C8 A26-B4-C8 A60-B1-C8 A49-B2-C8 A38-B3-C8 A27-B4-C8 A61-B1-C8 A50-B2-C8 A39-B3-C8 A28-B4-C8 A. 62-B1-C8 A51-B2-C8 A40-B3-C8 A29-B4-C8 A63-B1-C8 A52-B2-C8 A41-B3-C8 A30-B4-C8 A64-B1-C8 A53-B2-C8 A42-B3-C8 A31-B4-C8 A65-B1-C8 A54-B2-C8 A43-B3-C8 A32-B4-C8 A66-B1-C8 A55-B2-C8 A44-B3-C8 A33-B4-C8 A67-B1-C8 A56-B2-C8 A45-B3-C8 A34-B4-C8 A68-B1-C8 A57-B2-C8 A46-B3-C8 A35-B4-C8 A69-B1-C8 A58-B2-C8 A47-B3-C8 A36-B4-C8 A70-B1-C8 A59-B2-C8 A48-B3-C8 A37-B4-C8 A71-B1-C8 A60-B2-C8 A49-B3-C8 A38-B4-C8 A72-B1-C8 A61-B2-C8 A50-B3-C8 A39-B4-C8 A73-B1-C8 A62-B2-C8 A51-B3-C8 A40-B4-C8 A74-B1-C8 A63-B2-C8 A52-B3-C8 A41-B4-C8 A75-B1-C8 A64-B2-C8 A53-B3-C8 A42-B4-C8 A76-B1-C8 A65-B2-C8 A54-B3-C8 A43-B4-C8 A77-B1-C8 A66-B2-C8 A55-B3-C8 A44-B4-C8 A1-B2-C8 A67-B2-C8 A56-B3-C8 A45-B4-C8 A2-B2-C8 A68-B2-C8 A57-B3-C8 A46-B4-C8 A3-B2-C8 A69-B2-C8 A58-B3-C8 A47-B4-C8 A4-B2-C8 A70-B2-C8 A59-B3-C8 A48-B4-C8 A5-B2-C8 A71-B2-C8 A60-B3-C8 A49-B4-C8 A6-B2-C8 A72-B2-C8 A61-B3-C8 A50-B4-C8 A7-B2-C8 A73-B2-C8 A62-B3-C8 A51-B4-C8 A8-B2-C8 A74-B2-C8 A63-B3-C8 A52-B4-C8 A9-B2-C8 A75-B2-C8 A64-B3-C8 A53-B4-C8 A10-B2-C8 A76-B2-C8 A65-B3-C8 A54-B4-C8 A1l-B2-C8 A77-B2-C8 A66-B3-C8 A55-B4-C8 A12-B2-C8 A1-B3-C8 A67-B3-C8 A56-B4-C8 A13-B2-C8 A2-B3-C8 A68-B3-C8 A57-B4-C8 A58-B4-C8 A47-B1-C9 A36-B2-C9 A25-B3-C9 A59-B4-C8 A48-B1-C9 A37-B2-C9 A26-B3-C9 A60-B4-C8 A49-B1-C9 A38-B2-C9 A27-B3-C9 A61-B4-C8 A50-B1-C9 A39-B2-C9 A28-B3-C9 A62-B4-C8 A51-B1-C9 A40-B2-C9 A29-B3-C9 A63-B4-C8 A52-B1-C9 A41-B2-C9 A30-B3-C9 A64-B4-C8 A53-B1-C9 A42-B2-C9 A31-B3-C9 A65-B4-C8 A54-B1-C9 A43-B2-C9 A32-B3-C9 A66-B4-C8 A55-B1-C9 A44-B2-C9 A33-B3-C9 A67-B4-C8 A56-B1-C9 A45-B2-C9 A34-B3-C9 A68-B4-C8 A57-B1-C9 A46-B2-C9 A35-B3-C9 A69-B4-C8 A58-B1-C9 A47-B2-C9 A36-B3-C9 A70-B4-C8 A59-B1-C9 A48-B2-C9 A37-B3-C9 A71-B4-C8 A60-B1-C9 A49-B2-C9 A38-B3-C9 A72-B4-C8 A61-B1-C9 A50-B2-C9 A39-B3-C9 A73-B4-C8 A62-B1-C9 A51-B2-C9 A40-B3-C9 A74-B4-C8 A63-B1-C9 A52-B2-C9 A41-B3-C9 A75-B4-C8 A64-B1-C9 A53-B2-C9 A42-B3-C9 A76-B4-C8 A65-B1-C9 A54-B2-C9 A43-B3-C9 A77-B4-C8 A66-B1-C9 A55-B2-C9 A44-B3-C9 Al-Bl-C9 A67-B1-C9 A56-B2-C9 A45-B3-C9 A2-B1-C9 A68-B1-C9 A57-B2-C9 A46-B3-C9 A3-Bl-C9 A69-B1-C9 A58-B2-C9 A47-B3-C9 A4-B1-C9 A70-B1-C9 A59-B2-C9 A48-B3-C9 A5-B1-C9 A71-B1-C9 A60-B2-C9 A49-B3-C9 A6-Bl-C9 A72-B1-C9 A61-B2-C9 A50-B3-C9 A7-Bl-C9 A73-B1-C9 A62-B2-C9 A51-B3-C9 A8-B1-C9 A74-B1-C9 A63-B2-C9 A52-B3-C9 A9-B1-C9 A75-B1-C9 A64-B2-C9 A53-B3-C9 A10-B1-C9 A76-B1-C9 A65-B2-C9 A54-B3-C9 A11-B1-C9 A77-B1-C9 A66-B2-C9 A55-B3-C9 A12-B1-C9 A1-B2-C9 A67-B2-C9 A56-B3-C9 A13-Bl-C9 A2-B2-C9 A68-B2-C9 A57-B3-C9 A14-B1-C9 A3-B2-C9 A69-B2-C9 A58-B3-C9 A15-Bl-C9 A4-B2-C9 A70-B2-C9 A59-B3-C9 A16-B1-C9 A5-B2-C9 A71-B2-C9 A60-B3-C9 A17-B1-C9 A6-B2-C9 A72-B2-C9 A61-B3-C9 A18-B1-C9 A7-B2-C9 A73-B2-C9 A62-B3-C9 A19-Bl-C9 A8-B2-C9 A74-B2-C9 A63-B3-C9 A20-B1-C9 A9-B2-C9 A75-B2-C9 A64-B3-C9 A21-B1-C9 A10-B2-C9 A76-B2-C9 A65-B3-C9 A22-B1-C9 All-B2-C9 A77-B2-C9 A66-B3-C9 A23-B1-C9 A12-B2-C9 Al-B3-C9 A67-B3-C9 A24-B1-C9 A13-B2-C9 A2-B3-C9 A68-B3-C9 A25-B1-C9 A14-B2-C9 A3-B3-C9 A69-B3-C9 A26-B1-C9 A15-B2-C9 A4-B3-C9 A70-B3-C9 A27-B1-C9 A16-B2-C9 A5-B3-C9 A71-B3-C9 A28-B1-C9 A17-B2-C9 A6-B3-C9 A72-B3-C9 A29-B1-C9 A18-B2-C9 A7-B3-C9 A73-B3-C9 A30-B1-C9 A19-B2-C9 A8-B3-C9 A74-B3-C9 A31-B1-C9 A20-B2-C9 A9-B3-C9 A75-B3-C9 A32-B1-C9 A21-B2-C9 A10-B3-C9 A76-B3-C9 A33-B1-C9 A22-B2-C9 A11-B3-C9 A77-B3-C9 A34-B1-C9 A23-B2-C9 A12-B3-C9 A1-B4-C9 A35-B1-C9 A24-B2-C9 A13-B3-C9 A2-B4-C9 A36-B1-C9 A25-B2-C9 A14-B3-C9 A3-B4-C9 A37-B1-C9 A26-B2-C9 A15-B3-C9 A4-B4-C9 A38-B1-C9 A27-B2-C9 A16-B3-C9 A5-B4-C9 A39-B1-C9 A28-B2-C9 A17-B3-C9 A6-B4-C9 A40-B1-C9 A29-B2-C9 A18-B3-C9 A7-B4-C9 A41-B1-C9 A30-B2-C9 A19-B3-C9 A8-B4-C9 A42-B1-C9 A31-B2-C9 A20-B3-C9 A9-B4-C9 A43-B1-C9 A32-B2-C9 A21-B3-C9 A10-B4-C9 A44-B1-C9 A33-B2-C9 A22-B3-C9 A11-B4-C9 A45-B1-C9 A34-B2-C9 A23-B3-C9 A12-B4-C9 A46-B1-C9 A35-B2-C9 A24-B3-C9 A13-B4-C9 A14-B4-C9 A3-B1-C10 A69-B1-C10 A58-B2-C10 A15-B4-C9 A4-B1-C10 A70-B1-C10 A59-B2-C10 A16-B4-C9 A5-B1-C10 A71-B1-C10 A60-B2-C10 A17-B4-C9 A6-B1-C10 A72-B1-C10 A61-B2-C10 A18-B4-C9 A7-B1-C10 A73-B1-C10 A62-B2-C10 A19-B4-C9 A8-B1-C10 A74-B1-C10 A63-B2-C10 A20-B4-C9 A9-B1-C10 A75-B1-C10 A64-B2-C10 A21-B4-C9 A10-B1-C10 A76-B1-C10 A65-B2-C10 A22-B4-C9 A11-B1-C10 A77-B1-C10 A66-B2-C10 A23-B4-C9 A12-B1-C10 A1-B2-C10 A67-B2-C10 A24-B4-C9 A13-B1-C10 A2-B2-C10 A68-B2-C10 A25-B4-C9 A14-B1-C10 A3-B2-C10 A69-B2-C10 A26-B4-C9 A15-B1-C10 A4-B2-C10 A70-B2-C10 A27-B4-C9 A16-B1-C10 A5-B2-C10 A71-B2-Cl0 A28-B4-C9 A17-B1-C10 A6-B2-C10 A72-B2-C10 A29-B4-C9 A18-B1-C10 A7-B2-C10 A73-B2-C10 A30-B4-C9 A19-B1-C10 A8-B2-C10 A74-B2-C10 A31-B4-C9 A20-B1-C10 A9-B2-C10 A75-B2-C10 A32-B4-C9 A21-B1-C10 A10-B2-C10 A76-B2-C10 A33-B4-C9 A22-B1-C10 A11-B2-C10 A77-B2-C10 A34-B4-C9 A23-B1-C10 A12-B2-C10 A1-B3-C10 A35-B4-C9 A24-B1-C10 A13-B2-C10 A2-B3-C10 A36-B4-C9 A25-B1-C10 A14-B2-C10 A3-B3-C10 A37-B4-C9 A26-B1-C10 A15-B2-C10 A4-B3-C10 A38-B4-C9 A27-B1-C10 A16-B2-C10 A5-B3-C10 A39-B4-C9 A28-B1-C10 A17-B2-C10 A6-B3-C10 A40-B4-C9 A29-B1-C10 A18-B2-C10 A7-B3-C10 A41-B4-C9 A30-B1-C10 A19-B2-C10 A8-B3-C10 A42-B4-C9 A31-B1-C10 A20-B2-C10 A9-B3-C10 A43-B4-C9 A32-B1-C10 A21-B2-C10 A10-B3-C10 A44-B4-C9 A33-B1-C10 A22-B2-C10 A11-B3-C10 A45-B4-C9 A34-B1-C10 A23-B2-C10 A12-B3-C10 A46-B4-C9 A35-B1-C10 A24-B2-C10 A13-B3-C10 A47-B4-C9 A36-B1-C10 A25-B2-C10 A14-B3-C10 A48-B4-C9 A37-B1-C10 A26-B2-C10 A15-B3-C10 A49-B4-C9 A38-B1-C10 A27-B2-C10 A16-B3-C10 A50-B4-C9 A39-B1-C10 A28-B2-C10 A17-B3-C10 A51-B4-C9 A40-B1-C10 A29-B2-C10 A18-B3-C10 A52-B4-C9 A41-B1-C10 A30-B2-C10 A19-B3-C10 A53-B4-C9 A42-B1-C10 A31-B2-C10 A20-B3-C10 A54-B4-C9 A43-B1-C10 A32-B2-C10 A21-B3-C10 A55-B4-C9 A44-B1-C10 A33-B2-C10 A22-B3-C10 A56-B4-C9 A45-B1-C10 A34-B2-C10 A23-B3-C10 A57-B4-C9 A46-B1-C10 A35-B2-C10 A24-B3-C10 A58-B4-C9 A47-B1-C10 A36-B2-C10 A25-B3-C10 A59-B4-C9 A48-B1-C10 A37-B2-C10 A26-B3-C10 A60-B4-C9 A49-B1-C10 A38-B2-C10 A27-B3-C10 A61-B4-C9 A50-B1-C10 A39-B2-C10 A28-B3-C10 A62-B4-C9 A51-B1-C10 A40-B2-C10 A29-B3-C10 A63-B4-C9 A52-B1-C10 A41-B2-C10 A30-B3-C10 A64-B4-C9 A53-B1-C10 A42-B2-C10 A31-B3-C10 A65-B4-C9 A54-B1-C10 A43-B2-C10 A32-B3-C10 A66-B4-C9 A55-B1-C10 A44-B2-C10 A33-B3-C10 A67-B4-C9 A56-B1-C10 A45-B2-C10 A34-B3-C10 A68-B4-C9 A57-B1-C10 A46-B2-C10 A35-B3-C10 A69-B4-C9 A58-B1-C10 A47-B2-C10 A36-B3-C10 A70-B4-C9 A59-B1-C10 A48-B2-C10 A37-B3-C10 A71-B4-C9 A60-B1-C10 A49-B2-C10 A38-B3-C10 A72-B4-C9 A61-B1-C10 A50-B2-C10 A39-B3-C10 A73-B4-C9 A62-B1-C10 A51-B2-C10 A40-B3-C10 A74-B4-C9 A63-B1-C10 A52-B2-C10 A41-B3-C10 A75-B4-C9 A64-B1-C10 A53-B2-C10 A42-B3-C10 A76-B4-C9 A65-B1-C10 A54-B2-C10 A43-B3-C10 A77-B4-C9 A66-B1-C10 A55-B2-C10 A44-B3-C10 A1-B1-C10 A67-B1-C10 A56-B2-C10 A45-B3-C10 A2-B1-C10 A68-B1-C10 A57-B2-C10 A46-B3-C10 A47-B3-C10 A36-B4-C10 A25-B1-C11 A14-B2-C11 A48-B3-C10 A37-B4-C10 A26-B1-C11 A15-B2-C11 A49-B3-C10 A38-B4-C10 A27-B1-C11 A16-B2-C11 A50-B3-C10 A39-B4-C10 A28-B1-C11 A17-B2-C11 A51-B3-C10 A40-B4-C10 A29-B1-C11 A18-B2-C11 A52-B3-C10 A41-B4-C10 A30-B1-C11 A19-B2-C11 A53-B3-C10 A42-B4-C10 A31-B1-C11 A20-B2-C11 A54-B3-C10 A43-B4-C10 A32-B1-C11 A21-B2-C11 A55-B3-C10 A44-B4-C10 A33-B1-C11 A22-B2-C11 A56-B3-C10 A45-B4-C10 A34-B1-C11 A23-B2-C11 A57-B3-C10 A46-B4-C10 A35-B1-C11 A24-B2-C11 A58-B3-C10 A47-B4-C10 A36-B1-C11 A25-B2-C11 A59-B3-C10 A48-B4-C10 A37-B1-C11 A26-B2-C11 A60-B3-C10 A49-B4-C10 A38-B1-C11 A27-B2-Cll A61-B3-C10 A50-B4-C10 A39-B1-C11 A28-B2-C11 A62-B3-C10 A51-B4-C10 A40-B1-C11 A29-B2-C11 A63-B3-C10 A52-B4-C10 A41-B1-C11 A30-B2-C11 A64-B3-C10 A53-B4-C10 A42-B1-C11 A31-B2-C11 A65-B3-C10 A54-B4-C10 A43-B1-C11 A32-B2-C11 A66-B3-C10 A55-B4-C10 A44-B1-C11 A33-B2-C11 A67-B3-C10 A56-B4-C10 A45-B1-C11 A34-B2-C11 A68-B3-C10 A57-B4-C10 A46-B1-C11 A35-B2-C11 A69-B3-C10 A58-B4-C10 A47-B1-C11 A36-B2-C11 A70-B3-C10 A59-B4-C10 A48-B1-C11 A37-B2-C11 A71-B3-C10 A60-B4-C10 A49-B1-C11 A38-B2-C11 A72-B3-C10 A61-B4-C10 A50-B1-C11 A39-B2-C11 A73-B3-C10 A62-B4-C10 A51-B1-C11 A40-B2-C11 A74-B3-C10 A63-B4-C10 A52-B1-C11 A41-B2-C11 A75-B3-C10 A64-B4-C10 A53-B1-C11 A42-B2-Cll A76-B3-C10 A65-B4-C10 A54-B1-C11 A43-B2-C11 A77-B3-C10 A66-B4-C10 A55-B1-C11 A44-B2-Cll A1-B4-C10 A67-B4-C10 A56-B1-C11 A45-B2-C11 A2-B4-C10 A68-B4-C10 A57-B1-C11 A46-B2-C11 A3-B4-C10 A69-B4-C10 A58-B1-C11 A47-B2-C11 A4-B4-C10 A70-B4-C10 A59-Bl-Cll A48-B2-C11 A5-B4-C10 A71-B4-C10 A60-B1-C11 A49-B2-C11 A6-B4-C10 A72-B4-C10 A61-B1-C11 A50-B2-C11 A7-B4-C10 A73-B4-C10 A62-B1-C11 A51-B2-C11 A8-B4-C10 A74-B4-C10 A63-B1-C11 A52-B2-C11 A9-B4-C10 A75-B4-C10 A64-B1-C11 A53-B2-C11 A10-B4-C10 A76-B4-C10 A65-B1-C11 A54-B2-Cll A11-B4-C10 A77-B4-C10 A66-B1-C11 A55-B2-C11 A12-B4-C10 A1-B1-C11 A67-B1-C11 A56-B2-C11 A13-B4-C10 A2-B1-C11 A68-Bl-Cll A57-B2-C11 A14-B4-C10 A3-B1-C11 A69-B1-C11 A58-B2-C11 A15-B4-C10 A4-B1-C11 A70-B1-C11 A59-B2-C11 A16-B4-C10 A5-B1-C11 A71-B1-C11 A60-B2-C11 A17-B4-C10 A6-B1-C11 A72-B1-C11 A61-B2-C11 A18-B4-C10 A7-B1-C11 A73-B1-C11 A62-B2-C11 A19-B4-C10 A8-B1-C11 A74-B1-C11 A63-B2-C11 A20-B4-C10 A9-B1-C11 A75-B1-C11 A64-B2-C11 A21-B4-C10 A10-B1-C11 A76-B1-C11 A65-B2-C11 A22-B4-C10 A11-B1-C11 A77-B1-C11 A66-B2-C11 A23-B4-C10 A12-B1-C11 A1-B2-C11 A67-B2-C11 A24-B4-C10 A13-B1-C11 A2-B2-C11 A68-B2-C11 A25-B4-C10 A14-B1-C11 A3-B2-C11 A69-B2-C11 A26-B4-C10 A15-B1-C11 A4-B2-C11 A70-B2-C11 A27-B4-C10 A16-B1-C11 A5-B2-C11'A71-B2-C11 A28-B4-C10 A17-B1-C11 A6-B2-C11 A72-B2-C11 A29-B4-C10 A18-B1-C11 A7-B2-C11 A73-B2-C11 A30-B4-C10 A19-B1-C11 A8-B2-C11 A74-B2-C11 A31-B4-C10 A20-B1-C11 A9-B2-C11 A75-B2-C11 A32-B4-C10 A21-B1-C11 A10-B2-C11 A76-B2-C11 A33-B4-C10 A22-B1-C11 A11-B2-C11 A77-B2-C11 A34-B4-C10 A23-B1-C11 A12-B2-C11 A1-B3-C11 A35-B4-C10 A24-B1-C11 A13-B2-C11 A2-B3-C11 A3-B3-C11 A69-B3-C11 A58-B4-C11 A47-B1-C12<BR> <BR> <BR> A4-B3-C11 A70-B3-C11 A59-B4-C11 A48-B1-C12<BR> A5-B3-C11 A71-B3-C11 A60-B4-C11 A49-B1-C12<BR> A6-B3-C11 A72-B3-C11 A61-B4-C11 A50-B1-C12<BR> A7-B3-Cll A73-B3-C11 A62-B4-C11 A51-B1-C12<BR> A8-B3-C11 A74-B3-Cll A63-B4-C11 A52-B1-C12<BR> A9-B3-C11 A75-B3-C11 A64-B4-C11 A53-B1-C12<BR> A10-B3-C11 A76-B3-C11 A65-B4-C11 A54-B1-C12<BR> A11-B3-C11 A77-B3-Cll A66-B4-C11 A55-B1-C12<BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> A12-B3-C11 A1-B4-C11 A67-B4-C11 A56-B1-C12<BR> <BR> <BR> A13-B3-C11 A2-B4-C11 A68-B4-C11 A57-B1-C12<BR> <BR> A14-B3-C11 A3-B4-C11 A69-B4-C11 A58-B1-C12<BR> A15-B3-C11 A4-B4-C11 A70-B4-C11 A59-B1-C12<BR> A16-B3-C11 A5-B4-C11 A71-B4-C11 A60-B1-C12<BR> A17-B3-C11 A6-B4-C11 A72-B4-C11 A61-B1-C12<BR> A18-B3-C11 A7-B4-C11 A73-B4-Cll A62-B1-C12<BR> A19-B3-C11 A8-B4-C11 A74-B4-C11 A63-B1-C12<BR> A20-B3-C11 A9-B4-C11 A75-B4-C11 A64-B1-C12<BR> A21-B3-C11 A10-B4-C11 A76-B4-C11 A65-B1-C12<BR> A22-B3-C11 A11-B4-C11 A77-B4-C11 A66-B1-C12<BR> A23-B3-C11 A12-B4-C11 A78-B4-C11 A67-B1-C12<BR> A24-B3-C11 A13-B4-C11 A2-Bl-C12 A68-B1-C12<BR> A25-B3-C11 A14-B4-Cll A3-B1-C12 A69-B1-C12<BR> A26-B3-Cll A15-B4-C11 A4-B1-C12 A70-B1-C12<BR> A23-B3-C11 A12-B4-C11 A1-B1-C12 A67-B1-C12<BR> <BR> A24-B3-C11 A13-B4-C11 A2-B1-C12 A68-B1-C12<BR> <BR> <BR> A25-B3-C11 A14-B4-C11 A3-B1-C12 A69-B1-C12<BR> <BR> A26-B3-C11 A15-B4-C11 A4-B1-C12 A70-B1-C12<BR> <BR> <BR> <BR> A27-B3-C11 A16-B4-C11 A5-B1-C12 A71-B1-C12<BR> A28-B3-C11 A17-B4-C11 A6-B1-C12 A72-B1-C12<BR> <BR> <BR> <BR> <BR> A29-B3-C11 A18-B4-C11 A7-B1-C12 A73-B1-C12<BR> A30-B3-C11 A19-B4-C11 A8-B1-C12 A74-B1-C12<BR> A31-B3-C11 A20-B4-C11 A9-B1-C12 A75-B1-C12<BR> <BR> <BR> A32-B3-C11 A21-B4-C11 A10-B1-C12 A76-B1-C12<BR> A33-B3-C11 A22-B4-C11 A11-B1-C12 A77-B1-C12<BR> <BR> <BR> <BR> A31-B3-C11 A20-B4-C11 A9-B1-C12 A75-B1-C12<BR> A32-B3-C11 A21-B4-C11 A10-B1-C12 A76-B1-C12<BR> A33-B3-C11 A22-B4-C11 A11-B1-C12 A77-B1-C12<BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> A34-B3-C11 A23-B4-C11 A12-B1-C12 A1-B2-C12<BR> A35-B3-C11 A24-B4-C11 A13-B4-C11 A2-B2-C12<BR> A36-B3-C11 A25-B4-C11 A14-B1-C12 A3-B2-C12<BR> A37-B3-C11 A26-B4-C11 A15-B4-C11 A4-B2-C12<BR> A38-B3-C11 A27-B4-C11 A16-B1-C12 A5-B2-C12<BR> A39-B3-C11 A28-B4-C11 A17-B1-C12 A6-B2-C12<BR> A40-B3-C11 A29-B4-C11 A18-B1-C12 A7-B2-C12<BR> A41-B3-C11 A30-B4-C11 A19-B1-C12 A8-B2-C12<BR> A42-B3-C11 A31-B4-C11 A20-B1-C12 A9-B2-C12<BR> A43-B3-C11 A32-B4-C11 A21-B1-C12 A10-B2-C12<BR> A44-B3-C11 A33-B4-C11 A22-B1-C12 A11-B2-C12<BR> A45-B3-C11 A34-B4-C11 A23-B1-C12 A12-B2-C12<BR> A46-B3-C11 A35-B4-C11 A24-B1-C12 A13-B2-C12<BR> <BR> <BR> A47-B3-C11 A36-B4-C11 A25-B1-C12 A14-B2-C12<BR> <BR> <BR> <BR> <BR> A48-B3-C11 A37-B4-C11 A26-B1-C12 A15-B2-C12<BR> A49-B3-C11 A38-B4-C11 A27-B1-C12 A16-B2-C12<BR> A50-B3-C11 A39-B4-C11 A28-B1-C12 A17-B2-C12<BR> <BR> <BR> A51-B3-C11 A40-B4-C11 A29-B1-C12 A18-B2-C12<BR> <BR> A52-B3-C11 A41-B4-C11 A30-B1-C12 A19-B2-C12<BR> <BR> <BR> A53-B3-Cll A42-B4-Cll A31-B1-C12 A20-B2-C12<BR> <BR> A54-B3-Cll A43-B4-C11 A32-B1-C12 A21-B2-C12<BR> <BR> <BR> <BR> <BR> A55-B3-C11 A44-B4-C11 A33-B1-C12 A22-B2-C12<BR> A56-B3-C11 A45-B4-C11 A34-B1-C12 A23-B2-C12<BR> A57-B3-C11 A46-B4-C11 A35-B1-C12 A24-B2-C12<BR> <BR> <BR> A58-B3-C11 A47-B4-C11 A36-B1-C12 A25-B2-C12<BR> <BR> A59-B3-C11 A48-B4-C11 A37-B1-C12 A26-B2-C12<BR> <BR> <BR> <BR> A60-B3-C11 A49-B4-C11 A38-B1-C12 A27-B2-C12<BR> A61-B3-C11 A50-B4-C11 A39-B1-C12 A28-B2-C12<BR> <BR> A62-B3-C11 A51-B4-Cll A40-B1-C12 A29-B2-C12<BR> <BR> <BR> A63-B3-C11 A52-B4-C11 A41-B1-C12 A30-B2-C12<BR> <BR> A64-B3-C11 A53-B4-C11 A42-B1-C12 A31-B2-C12<BR> <BR> <BR> A65-B3-C11 A54-B4-C11 A43-B1-C12 A32-B2-C12<BR> <BR> A66-B3-C11 A55-B4-C11 A44-B1-C12 A33-B2-C12<BR> <BR> <BR> A67-B3-C11 A56-B4-C11 A45-B1-C12 A34-B2-C12<BR> <BR> A68-B3-C11 A57-B4-C11 A46-B1-C12 A35-B2-C12 A36-B2-C12 A25-B3-C12 A14-B4-C12 A3-B1-C13<BR> <BR> <BR> <BR> <BR> A37-B2-C12 A26-B3-C12 A15-B4-C12 A4-B1-C13<BR> <BR> <BR> <BR> A38-B2-C12 A27-B3-C12 A16-B4-C12 A5-Bl-C13<BR> <BR> <BR> <BR> <BR> A39-B2-C12 A28-B3-C12 A17-B4-C12 A6-B1-C13<BR> <BR> <BR> <BR> A40-B2-C12 A29-B3-C12 A18-B4-C12 A7-B1-C13<BR> <BR> <BR> <BR> <BR> A41-B2-C12 A30-B3-C12 A19-B4-C12 A8-Bl-C13<BR> <BR> <BR> <BR> <BR> A42-B2-C12 A31-B3-C12 A20-B4-C12 A9-B1-C13<BR> <BR> <BR> <BR> A43-B2-C12 A32-B3-C12 A21-B4-C12 A10-Bl-C13<BR> <BR> <BR> <BR> <BR> A44-B2-C12 A33-B3-C12 A22-B4-C12 A11-B1-C13<BR> <BR> <BR> <BR> <BR> A45-B2-C12 A34-B3-C12 A23-B4-C12 A12-Bl-C13<BR> <BR> <BR> <BR> A46-B2-C12 A35-B3-C12 A24-B4-C12 A13-Bl-C13<BR> <BR> <BR> <BR> <BR> A47-B2-C12 A36-B3-C12 A25-B4-C12 A14-B1-C13<BR> <BR> <BR> <BR> A48-B2-C12 A37-B3-C12 A26-B4-C12 A15-B1-C13<BR> <BR> <BR> <BR> <BR> A49-B2-C12 A38-B3-C12 A27-B4-C12 A16-Bl-C13<BR> <BR> <BR> <BR> <BR> A50-B2-C12 A39-B3-C12 A28-B4-C12 A17-B1-C13<BR> <BR> <BR> <BR> A51-B2-C12 A40-B3-C12 A29-B4-C12 A18-Bl-C13<BR> <BR> <BR> <BR> <BR> A52-B2-C12 A41-B3-C12 A30-B4-C12 A19-B1-C13<BR> <BR> <BR> <BR> <BR> A53-B2-C12 A42-B3-C12 A31-B4-C12 A20-Bl-C13<BR> <BR> <BR> <BR> A54-B2-C12 A43-B3-C12 A32-B4-C12 A21-B1-C13<BR> <BR> <BR> <BR> <BR> A55-B2-C12 A44-B3-C12 A33-B4-C12 A22-B1-C13<BR> <BR> <BR> <BR> A56-B2-C12 A45-B3-C12 A34-B4-C12 A23-B1-C13<BR> <BR> <BR> <BR> <BR> A57-B2-C12 A46-B3-C12 A35-B4-C12 A24-Bl-C13<BR> <BR> <BR> <BR> <BR> A58-B2-C12 A47-B3-C12 A36-B4-C12 A25-B1-C13<BR> <BR> <BR> <BR> A59-B2-C12 A48-B3-C12 A37-B4-C12 A26-B1-C13<BR> <BR> <BR> <BR> <BR> A60-B2-C12 A49-B3-C12 A38-B4-C12 A27-B1-C13<BR> <BR> <BR> <BR> A61-B2-C12 A50-B3-C12 A39-B4-C12 A28-Bl-C13<BR> <BR> <BR> <BR> <BR> A62-B2-C12 A51-B3-C12 A40-B4-C12 A29-B1-C13<BR> <BR> <BR> <BR> <BR> A63-B2-C12 A52-B3-C12 A41-B4-C12 A30-B1-C13<BR> <BR> <BR> <BR> A64-B2-C12 A53-B3-C12 A42-B4-C12 A31-B1-C13<BR> <BR> <BR> <BR> <BR> A65-B2-C12 A54-B3-C12 A43-B4-C12 A32-Bl-C13<BR> <BR> <BR> <BR> A66-B2-C12 A55-B3-C12 A44-B4-C12 A33-B1-C13<BR> <BR> <BR> <BR> <BR> A67-B2-C12 A56-B3-C12 A45-B4-C12 A34-B1-C13<BR> <BR> <BR> <BR> <BR> A68-B2-C12 A57-B3-C12 A46-B4-C12 A35-B1-C13<BR> <BR> <BR> <BR> A69-B2-C12 A58-B3-C12 A47-B4-C12 A36-B1-C13<BR> <BR> <BR> <BR> <BR> A70-B2-C12 A59-B3-C12 A48-B4-C12 A37-B1-C13<BR> <BR> <BR> <BR> <BR> A71-B2-C12 A60-B3-C12 A49-B4-C12 A38-Bl-C13<BR> <BR> <BR> <BR> A72-B2-C12 A61-B3-C12 A50-B4-C12 A39-B1-C13<BR> <BR> <BR> <BR> <BR> A73-B2-C12 A62-B3-C12 A51-B4-C12 A40-B1-C13<BR> <BR> <BR> <BR> A74-B2-C12 A63-B3-C12 A52-B4-C12 A41-B1-C13<BR> <BR> <BR> <BR> <BR> A75-B2-C12 A64-B3-C12 A53-B4-C12 A42-B1-C13<BR> <BR> <BR> <BR> <BR> A76-B2-C12 A65-B3-C12 A54-B4-C12 A43-Bl-C13<BR> <BR> <BR> <BR> A77-B2-C12 A66-B3-C12 A55-B4-C12 A44-Bl-C13<BR> <BR> <BR> <BR> <BR> A1-B3-C12 A67-B3-C12 A56-B4-C12 A45-B1-C13<BR> <BR> <BR> <BR> A2-B3-C12 A68-B3-C12 A57-B4-C12 A46-B1-C13<BR> <BR> <BR> <BR> <BR> A3-B3-C12 A69-B3-C12 A58-B4-C12 A47-B1-C13<BR> <BR> <BR> <BR> <BR> A4-B3-C12 A70-B3-C12 A59-B4-C12 A48-Bl-C13<BR> <BR> <BR> <BR> A5-B3-C12 A71-B3-C12 A60-B4-C12 A49-B1-C13<BR> <BR> <BR> <BR> <BR> A6-B3-C12 A72-B3-C12 A61-B4-C12 A50-B1-C13<BR> <BR> <BR> <BR> A7-B3-C12 A73-B3-C12 A62-B4-C12 A51-B1-C13<BR> <BR> <BR> <BR> <BR> A8-B3-C12 A74-B3-C12 A63-B4-C12 A52-Bl-C13<BR> <BR> <BR> <BR> <BR> A9-B3-C12 A75-B3-C12 A64-B4-C12 A53-B1-C13<BR> <BR> <BR> <BR> A10-B3-C12 A76-B3-C12 A65-B4-C12 A54-B1-C13<BR> <BR> <BR> <BR> <BR> A11-B3-C12 A77-B3-C12 A66-B4-C12 A55-B1-C13<BR> <BR> <BR> <BR> A12-B3-C12 A1-B4-C12 A67-B4-C12 A56-B1-C13<BR> <BR> <BR> <BR> <BR> A13-B3-C12 A2-B4-C12 A68-B4-C12 A57-Bl-C13<BR> <BR> <BR> <BR> <BR> A14-B3-C12 A3-B4-C12 A69-B4-C12 A58-B1-C13<BR> <BR> <BR> <BR> A15-B3-C12 A4-B4-C12 A70-B4-C12 A59-Bl-C13<BR> <BR> <BR> <BR> <BR> A16-B3-C12 A5-B4-C12 A71-B4-C12 A60-Bl-C13<BR> <BR> <BR> <BR> <BR> A17-B3-C12 A6-B4-C12 A72-B4-C12 A61-B1-C13<BR> <BR> <BR> <BR> A18-B3-C12 A7-B4-C12 A73-B4-C12 A62-B1-C13<BR> <BR> <BR> <BR> <BR> A19-B3-C12 A8-B4-C12 A74-B4-C12 A63-Bl-C13<BR> <BR> <BR> <BR> A20-B3-C12 A9-B4-C12 A75-B4-C12 A64-B1-C13<BR> <BR> <BR> <BR> <BR> A21-B3-C12 A10-B4-C12 A76-B4-C12 A65-Bl-C13<BR> <BR> <BR> <BR> <BR> A22-B3-C12 A11-B4-C12 A77-B4-C12 A66-B1-C13<BR> <BR> <BR> <BR> A23-B3-C12 A12-B4-C12 A1-B1-C13 A67-Bl-C13<BR> <BR> <BR> <BR> <BR> A24-B3-C12 A13-B4-C12 A2-B1-C13 A68-B1-C13 A69-B1-C13 A58-B2-C13 A47-B3-C13 A36-B4-C13 A70-Bl-C13 A59-B2-C13 A48-B3-C13 A37-B4-C13 A71-B1-C13 A60-B2-C13 A49-B3-C13 A38-B4-C13 A72-Bl-C13 A61-B2-C13 A50-B3-C13 A39-B4-C13 A73-B1-C13 A62-B2-C13 A51-B3-C13 A40-B4-C13 A74-Bl-C13 A63-B2-C13 A52-B3-C13 A41-B4-C13 A75-B1-C13 A64-B2-C13 A53-B3-C13 A42-B4-C13 A76-B1-C13 A65-B2-C13 A54-B3-C13 A43-B4-C13 A77-B1-C13 A66-B2-C13 A55-B3-C13 A44-B4-C13 A1-B2-C13 A67-B2-C13 A56-B3-C13 A45-B4-C13 A2-B2-C13 A68-B2-C13 A57-B3-C13 A46-B4-C13 A3-B2-C13 A69-B2-C13 A58-B3-C13 A47-B4-C13 A4-B2-C13 A70-B2-C13 A59-B3-C13 A48-B4-C13 A5-B2-C13 A71-B2-C13 A60-B3-C13 A49-B4-C13 A6-B2-C13 A72-B2-C13 A61-B3-C13 A50-B4-C13 A7-B2-C13 A73-B2-C13 A62-B3-C13 A51-B4-C13 A8-B2-C13 A74-B2-C13 A63-B3-C13 A52-B4-C13 A9-B2-C13 A75-B2-C13 A64-B3-C13 A53-B4-C13 A10-B2-C13 A76-B2-C13 A65-B3-C13 A54-B4-C13 A11-B2-C13 A77-B2-C13 A66-B3-C13 A55-B4-C13 A12-B2-C13 A1-B3-C13 A67-B3-C13 A56-B4-C13 A13-B2-C13 A2-B3-C13 A68-B3-C13 A57-B4-C13 A14-B2-C13 A3-B3-C13 A69-B3-C13 A58-B4-C13 A15-B2-C13 A4-B3-C13 A70-B3-C13 A59-B4-C13 A16-B2-C13 A5-B3-C13 A71-B3-C13 A60-B4-C13 A17-B2-C13 A6-B3-C13 A72-B3-C13 A61-B4-C13 A18-B2-C13 A7-B3-C13 A73-B3-C13 A62-B4-C13 A19-B2-C13 A8-B3-C13 A74-B3-C13 A63-B4-C13 A20-B2-C13 A9-B3-C13 A75-B3-C13 A64-B4-C13 A21-B2-C13 A10-B3-C13 A76-B3-C13 A65-B4-C13 A22-B2-C13 A11-B3-C13 A77-B3-C13 A66-B4-C13 A23-B2-C13 A12-B3-C13 A1-B4-C13 A67-B4-C13 A24-B2-C13 A13-B3-C13 A2-B4-C13 A68-B4-C13 A25-B2-C13 A14-B3-C13 A3-B4-C13 A69-B4-C13 A26-B2-C13 A15-B3-C13 A4-B4-C13 A70-B4-C13 A27-B2-C13 A16-B3-C13 A5-B4-C13 A71-B4-C13 A28-B2-C13 A17-B3-C13 A6-B4-C13 A72-B4-C13 A29-B2-C13 A18-B3-C13 A7-B4-C13 A73-B4-C13 A30-B2-C13 A19-B3-C13 A8-B4-C13 A74-B4-C13 A31-B2-C13 A20-B3-C13 A9-B4-C13 A75-B4-C13 A32-B2-C13 A21-B3-C13 A10-B4-C13 A76-B4-C13 A33-B2-C13 A22-B3-C13 A11-B4-C13 A77-B4-C13 A34-B2-C13 A23-B3-C13 A12-B4-C13 A1-B1-C14 A35-B2-C13 A24-B3-C13 A13-B4-C13 A2-Bl-C14 A36-B2-C13 A25-B3-C13 A14-B4-C13 A3-Bl-C14 A37-B2-C13 A26-B3-C13 A15-B4-C13 A4-Bl-C14 A38-B2-C13 A27-B3-C13 A16-B4-C13 A5-B1-C14 A39-B2-C13 A28-B3-C13 A17-B4-C13 A6-Bl-C14 A40-B2-C13 A29-B3-C13 A18-B4-C13 A7-B1-C14 A41-B2-C13 A30-B3-C13 A19-B4-C13 A8-Bl-C14 A42-B2-C13 A31-B3-C13 A20-B4-C13 A9-Bl-C14 A43-B2-C13 A32-B3-C13 A21-B4-C13 A10-B1-C14 A44-B2-C13 A33-B3-C13 A22-B4-C13 A11-B1-C14 A45-B2-C13 A34-B3-C13 A23-B4-C13 A12-Bl-C14 A46-B2-C13 A35-B3-C13 A24-B4-C13 A13-Bl-C14 A47-B2-C13 A36-B3-C13 A25-B4-C13 A14-Bl-C14 A48-B2-C13 A37-B3-C13 A26-B4-C13 A15-Bl-C14 A49-B2-C13 A38-B3-C13 A27-B4-C13 A16-B1-C14 A50-B2-C13 A39-B3-C13 A28-B4-C13 A17-Bl-C14 A51-B2-C13 A40-B3-C13 A29-B4-C13 A18-Bl-C14 A52-B2-C13 A41-B3-C13 A30-B4-C13 A19-B1-C14 A53-B2-C13 A42-B3-C13 A31-B4-C13 A20-Bl-C14 A54-B2-C13 A43-B3-C13 A32-B4-C13 A21-B1-C14 A55-B2-C13 A44-B3-C13 A33-B4-C13 A22-Bl-C14 A56-B2-C13 A45-B3-C13 A34-B4-C13 A23-Bl-C14 A57-B2-C13 A46-B3-C13 A35-B4-C13 A24-Bl-C14 A25-B1-C14 A14-B2-C14 A3-B3-C14 A69-B3-C14<BR> <BR> <BR> <BR> <BR> A26-B1-C14 A15-B2-C14 A4-B3-C14 A70-B3-C14<BR> <BR> <BR> <BR> <BR> <BR> A27-B1-C14 A16-B2-C14 A5-B3-C14 A71-B3-C14<BR> <BR> <BR> <BR> <BR> A28-B1-C14 A17-B2-C14 A6-B3-C14 A72-B3-C14<BR> <BR> <BR> <BR> <BR> A29-Bl-C14 A18-B2-C14 A7-B3-C14 A73-B3-C14<BR> <BR> <BR> <BR> <BR> A30-B1-C14 A19-B2-C14 A8-B3-C14 A74-B3-C14<BR> <BR> <BR> <BR> <BR> A31-B1-C14 A20-B2-C14 A9-B3-C14 A75-B3-C14<BR> <BR> <BR> <BR> <BR> <BR> A32-B1-C14 A21-B2-C14 A10-B3-C14 A76-B3-C14<BR> <BR> <BR> <BR> <BR> A33-B1-C14 A22-B2-C14 A11-B3-C14 A77-B3-C14<BR> <BR> <BR> <BR> <BR> A34-B1-C14 A23-B2-C14 A12-B3-C14 A1-B4-C14<BR> <BR> <BR> <BR> <BR> A35-B1-C14 A24-B2-C14 A13-B3-C14 A2-B4-C14<BR> <BR> <BR> <BR> <BR> A36-B1-C14 A25-B2-C14 A14-B3-C14 A3-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A37-Bl-C14 A26-B2-C14 A15-B3-C14 A4-B4-C14<BR> <BR> <BR> <BR> <BR> A38-B1-C14 A27-B2-C14 A16-B3-C14 A5-B4-C14<BR> <BR> <BR> <BR> <BR> A39-Bl-C14 A28-B2-C14 A17-B3-C14 A6-B4-C14<BR> <BR> <BR> <BR> <BR> A40-B1-C14 A29-B2-C14 A18-B3-C14 A7-B4-C14<BR> <BR> <BR> <BR> <BR> A41-B1-C14 A30-B2-C14 A19-B3-C14 A8-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A42-B1-C14 A31-B2-C14 A20-B3-C14 A9-B4-C14<BR> <BR> <BR> <BR> <BR> A43-B1-C14 A32-B2-C14 A21-B3-C14 A10-B4-C14<BR> <BR> <BR> <BR> <BR> A44-Bl-C14 A33-B2-C14 A22-B3-C14 Al1-B4-C14<BR> <BR> <BR> <BR> <BR> A45-B1-C14 A34-B2-C14 A23-B3-C14 A12-B4-C14<BR> <BR> <BR> <BR> <BR> A46-B1-C14 A35-B2-C14 A24-B3-C14 A13-B4-C14<BR> <BR> <BR> <BR> <BR> A47-B1-C14 A36-B2-C14 A25-B3-C14 A14-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A48-Bl-C14 A37-B2-C14 A26-B3-C14 A15-B4-C14<BR> <BR> <BR> <BR> <BR> A49-Bl-C14 A38-B2-C14 A27-B3-C14 A16-B4-C14<BR> <BR> <BR> <BR> <BR> A50-B1-C14 A39-B2-C14 A28-B3-C14 A17-B4-C14<BR> <BR> <BR> <BR> <BR> A51-B1-C14 A40-B2-C14 A29-B3-C14 A18-B4-C14<BR> <BR> <BR> <BR> <BR> A52-B1-C14 A41-B2-C14 A30-B3-C14 A19-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A53-B1-C14 A42-B2-C14 A31-B3-C14 A20-B4-C14<BR> <BR> <BR> <BR> <BR> A54-Bl-C14 A43-B2-C14 A32-B3-C14 A21-B4-C14<BR> <BR> <BR> <BR> <BR> A55-B1-C14 A44-B2-C14 A33-B3-C14 A22-B4-C14<BR> <BR> <BR> <BR> <BR> A56-Bl-C14 A45-B2-C14 A34-B3-C14 A23-B4-C14<BR> <BR> <BR> <BR> <BR> A57-B1-C14 A46-B2-C14 A35-B3-C14 A24-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A58-B1-C14 A47-B2-C14 A36-B3-C14 A25-B4-C14<BR> <BR> <BR> <BR> <BR> A59-Bl-C14 A48-B2-C14 A37-B3-C14 A26-B4-C14<BR> <BR> <BR> <BR> <BR> A60-B1-C14 A49-B2-C14 A38-B3-C14 A27-B4-C14<BR> <BR> <BR> <BR> <BR> A61-Bl-C14 A50-B2-C14 A39-B3-C14 A28-B4-C14<BR> <BR> <BR> <BR> <BR> A62-Bl-C14 A51-B2-C14 A40-B3-C14 A29-B4-C14<BR> <BR> <BR> <BR> <BR> A63-B1-C14 A52-B2-C14 A41-B3-C14 A30-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A64-B1-C14 A53-B2-C14 A42-B3-C14 A31-B4-C14<BR> <BR> <BR> <BR> <BR> A65-B1-C14 A54-B2-C14 A43-B3-C14 A32-B4-C14<BR> <BR> <BR> <BR> <BR> A66-B1-C14 A55-B2-C14 A44-B3-C14 A33-B4-C14<BR> <BR> <BR> <BR> <BR> A67-Bl-C14 A56-B2-C14 A45-B3-C14 A34-B4-C14<BR> <BR> <BR> <BR> <BR> A68-B1-C14 A57-B2-C14 A46-B3-C14 A35-B4-C14<BR> <BR> <BR> <BR> <BR> A69-B1-C14 A58-B2-C14 A47-B3-C14 A36-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A70-Bl-C14 A59-B2-C14 A48-B3-C14 A37-B4-C14<BR> <BR> <BR> <BR> <BR> A71-B1-C14 A60-B2-C14 A49-B3-C14 A38-B4-C14<BR> <BR> <BR> <BR> <BR> A72-Bl-C14 A61-B2-C14 A50-B3-C14 A39-B4-C14<BR> <BR> <BR> <BR> <BR> A73-B1-C14 A62-B2-C14 A51-B3-C14 A40-B4-C14<BR> <BR> <BR> <BR> <BR> A74-Bl-C14 A63-B2-C14 A52-B3-C14 A41-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A75-B1-C14 A64-B2-C14 A53-B3-C14 A42-B4-C14<BR> <BR> <BR> <BR> <BR> A76-Bl-C14 A65-B2-C14 A54-B3-C14 A43-B4-C14<BR> <BR> <BR> <BR> <BR> A77-B1-C14 A66-B2-C14 A55-B3-C14 A44-B4-C14<BR> <BR> <BR> <BR> <BR> A1-B2-C14 A67-B2-C14 A56-B3-C14 A45-B4-C14<BR> <BR> <BR> <BR> <BR> A2-B2-C14 A68-B2-C14 A57-B3-C14 A46-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A3-B2-C14 A69-B2-C14 A58-B3-C14 A47-B4-C14<BR> <BR> <BR> <BR> <BR> A4-B2-C14 A70-B2-C14 A59-B3-C14 A48-B4-C14<BR> <BR> <BR> <BR> <BR> A5-B2-C14 A71-B2-C14 A60-B3-C14 A49-B4-C14<BR> <BR> <BR> <BR> <BR> A6-B2-C14 A72-B2-C14 A61-B3-C14 A50-B4-C14<BR> <BR> <BR> <BR> <BR> A7-B2-C14 A73-B2-C14 A62-B3-C14 A51-B4-C14<BR> <BR> <BR> <BR> <BR> A8-B2-C14 A74-B2-C14 A63-B3-C14 A52-B4-C14<BR> <BR> <BR> <BR> <BR> <BR> A9-B2-C14 A75-B2-C14 A64-B3-C14 A53-B4-C14<BR> <BR> <BR> <BR> <BR> A10-B2-C14 A76-B2-C14 A65-B3-C14 A54-B4-C14<BR> <BR> <BR> <BR> <BR> A11-B2-C14 A77-B2-C14 A66-B3-C14 A55-B4-C14<BR> <BR> <BR> <BR> <BR> A12-B2-C14 A1-B3-C14 A67-B3-C14 A56-B4-C14<BR> <BR> <BR> <BR> <BR> A13-B2-C14 A2-B3-C14 A68-B3-C14 A57-B4-C14 A58-B4-C14 A47-B1-C15 A36-B2-C15 A25-B3-C15 A59-B4-C14 A48-B1-C15 A37-B2-C15 A26-B3-C15 A60-B4-C14 A49-B1-C15 A38-B2-C15 A27-B3-C15 A61-B4-C14 A50-B1-C15 A39-B2-C15 A28-B3-C15 A62-B4-C14 A51-B1-C15 A40-B2-C15 A29-B3-C15 A63-B4-C14 A52-B1-C15 A41-B2-C15 A30-B3-C15 A64-B4-C14 A53-B1-C15 A42-B2-C15 A31-B3-C15 A65-B4-C14 A54-B1-C15 A43-B2-C15 A32-B3-C15 A66-B4-C14 A55-B1-C15 A44-B2-C15 A33-B3-C15 A67-B4-C14 A56-B1-C15 A45-B2-C15 A34-B3-C15 A68-B4-C14 A57-B1-C15 A46-B2-C15 A35-B3-C15 A69-B4-C14 A58-B1-C15 A47-B2-C15 A36-B3-C15 A70-B4-C14 A59-B1-C15 A48-B2-C15 A37-B3-C15 A71-B4-C14 A60-B1-C15 A49-B2-C15 A38-B3-C15 A72-B4-C14 A61-B1-C15 A50-B2-C15 A39-B3-C15 A73-B4-C14 A62-B1-C15 A51-B2-C15 A40-B3-C15 A74-B4-C14 A63-B1-C15 A52-B2-C15 A41-B3-C15 A75-B4-C14 A64-B1-C15 A53-B2-C15 A42-B3-C15 A76-B4-C14 A65-B1-C15 A54-B2-C15 A43-B3-C15 A77-B4-C14 A66-B1-C15 A55-B1-C15 A44-B3-C15 A1-B1-C15 A67-B1-C15 A56-B2-C15 A45-B3-C15 A2-Bl-C15 A68-B1-C15 A57-B2-C15 A46-B3-C15 A3-B1-C15 A69-B1-C15 A58-B1-C15 A47-B3-C15 A4-B1-C15 A70-B1-C15 A59-B2-C15 A48-B3-C15 A5-B1-C15 A71-B1-C15 A60-B2-C15 A49-B3-C15 A6-B1-C15 A72-B1-C15 A61-B2-C15 A50-B3-C15 A7-B1-C15 A73-B1-C15 A62-B2-C15 A51-B3-C15 A8-B1-C15 A74-B1-C15 A63-B2-C15 A52-B3-C15 A9-B1-C15 A75-B1-C15 A64-B2-C15 A53-B3-C15 A10-B1-C15 A76-B1-C15 A65-B2-C15 A54-B3-C15 A11-B1-C15 A77-B1-C15 A66-B2-C15 A55-B3-C15 A12-B1-C15 A1-B2-C15 A67-B2-C15 A56-B3-C15 A13-Bl-C15 A2-B2-C15 A68-B2-C15 A57-B3-C15 A14-B1-C15 A3-B2-C15 A69-B2-C15 A58-B3-C15 A15-B1-C15 A4-B2-C15 A70-B2-C15 A59-B3-C15 A16-B1-C15 A5-B2-C15 A71-B2-C15 A60-B3-C15 A17-B1-C15 A6-B2-C15 A72-B2-C15 A61-B3-C15 A18-B1-C15 A7-B2-C15 A73-B2-C15 A62-B3-C15 A19-B1-C15 A8-B2-C15 A74-B2-C15 A63-B3-C15 A20-B1-C15 A9-B2-C15 A75-B2-C15 A64-B3-C15 A21-B1-C15 A10-B2-C15 A76-B2-C15 A65-B3-C15 A22-Bl-C15 A11-B2-C15 A77-B2-C15 A66-B3-C15 A23-B1-C15 A12-B2-C15 A1-B3-C15 A67-B3-C15 A24-B1-C15 A13-B2-C15 A2-B3-C15 A68-B3-C15 A25-B1-C15 A14-B2-C15 A3-B3-C15 A69-B3-C15 A26-B1-C15 A15-B2-C15 A4-B3-C15 A70-B3-C15 A27-Bl-C15 A16-B2-C15 A5-B3-C15 A71-B3-C15 A28-B1-C15 A17-B2-C15 A6-B3-C15 A72-B3-C15 A29-B1-C15 A18-B2-C15 A7-B3-C15 A73-B3-C15 A30-B1-C15 A19-B2-C15 A8-B3-C15 A74-B3-C15 A31-B1-C15 A20-B2-C15 A9-B3-C15 A75-B3-C15 A32-B1-C15 A21-B2-C15 A10-B3-C15 A76-B3-C15 A33-B1-C15 A22-B2-C15 A11-B3-C15 A77-B3-C15 A34-Bl-C15 A23-B2-C15 A12-B3-C15 A1-B4-C15 A35-Bl-C15 A24-B2-C15 A13-B3-C15 A2-B4-C15 A36-B1-C15 A25-B2-C15 A14-B3-C15 A3-B4-C15 A37-B1-C15 A26-B2-C15 A15-B3-C15 A4-B4-C15 A38-B1-C15 A27-B2-C15 A16-B3-C15 A5-B4-C15 A39-B1-C15 A28-B2-C15 A17-B3-C15 A6-B4-C15 A40-B1-C15 A29-B2-C15 A18-B3-C15 A7-B4-C15 A41-Bl-C15 A30-B2-C15 A19-B3-C15 A8-B4-C15 A42-B1-C15 A31-B2-C15 A20-B3-C15 A9-B4-C15 A43-B1-C15 A32-B2-C15 A21-B3-C15 A10-B4-C15 A44-B1-C15 A33-B2-C15 A22-B3-C15 A11-B4-C15 A45-B1-C15 A34-B2-C15 A23-B3-C15 A12-B4-C15 A46-B1-C15 A35-B2-C15 A24-B3-C15 A13-B4-C15 A14-B4-C15 A3-B1-C16 A69-B1-C16 A58-B2-C16 A15-B4-C15 A4-B1-C16 A70-B1-C16 A59-B2-C16 A16-B4-C15 A5-B1-C16 A71-B1-C16 A60-B2-C16 A17-B4-C15 A6-B1-C16 A72-B1-C16 A61-B2-C16 A18-B4-C15 A7-B1-C16 A73-B1-C16 A62-B2-C16 A19-B4-C15 A8-B1-C16 A74-B1-C16 A63-B2-C16 A20-B4-C15 A9-B1-C16 A75-B1-C16 A64-B2-C16 A21-B4-C15 A10-B1-C16 A76-B1-C16 A65-B2-C16 A22-B4-C15 A11-B1-C16 A77-B1-C16 A66-B2-C16 A23-B4-C15 A12-B1-C16 A1-B2-C16 A67-B2-C16 A24-B4-C15 A13-B1-C16 A2-B2-C16 A68-B2-C16 A25-B4-C15 A14-B1-C16 A3-B2-C16 A69-B2-C16 A26-B4-C15 A15-B1-C16 A4-B2-C16 A70-B2-C16 A27-B4-C15 A16-B1-C16 A5-B2-C16 A71-B2-C16 A28-B4-C15 A17-B1-C16 A6-B2-C16 A72-B2-C16 A29-B4-C15 A18-B1-C16 A7-B2-C16 A73-B2-C16 A30-B4-C15 A19-B1-C16 A8-B2-C16 A74-B2-C16 A31-B4-C15 A20-B1-C16 A9-B2-C16 A75-B2-C16 A32-B4-C15 A21-B1-C16 A10-B2-C16 A76-B2-C16 A33-B4-C15 A22-B1-C16 A11-B2-C16 A77-B2-C16 A34-B4-C15 A23-B1-C16 A12-B2-C16 A1-B3-C16 A35-B4-C15 A24-B1-C16 A13-B2-C16 A2-B3-C16 A36-B4-C15 A25-B1-C16 A14-B2-C16 A3-B3-C16 A37-B4-C15 A26-B1-C16 A15-B2-C16 A4-B3-C16 A38-B4-C15 A27-B1-C16 A16-B2-C16 A5-B3-C16 A39-B4-C15 A28-B1-C16 A17-B2-C16 A6-B3-C16 A40-B4-C15 A29-B1-C16 A18-B2-C16 A7-B3-C16 A41-B4-C15 A30-B1-C16 A19-B1-C16 A8-B3-C16 A42-B4-C15 A31-B1-C16 A20-B2-C16 A9-B3-C16 A43-B4-C15 A32-B1-C16 A21-B2-C16 A10-B3-C16 A44-B4-C15 A33-B1-C16 A22-B2-C16 A11-B3-C16 A45-B4-C15 A34-B1-C16 A23-B2-C16 A12-B3-C16 A46-B4-C15 A35-B1-C16 A24-B2-C16 A13-B3-C16 A47-B4-C15 A36-B1-C16 A25-B2-C16 A14-B3-C16 A48-B4-C15 A37-B1-C16 A26-B2-C16 A15-B3-C16 A49-B4-C15 A38-B1-C16 A27-B2-C16 A16-B3-C16 A50-B4-C15 A39-B1-C16 A28-B2-C16 A17-B3-C16 A51-B4-C15 A40-B1-C16 A29-B2-C16 A18-B3-C16 A52-B4-C15 A41-B1-C16 A30-B2-C16 A19-B3-C16 A53-B4-C15 A42-B1-C16 A31-B2-C16 A20-B3-C16 A54-B4-C15 A43-B1-C16 A32-B2-C16 A21-B3-C16 A55-B4-C15 A44-B1-C16 A33-B2-C16 A22-B3-C16 A56-B4-C15 A45-B1-C16 A34-B2-C16 A23-B3-C16 A57-B4-C15 A46-B1-C16 A35-B2-C16 A24-B3-C16 A58-B4-C15 A47-B1-C16 A36-B2-C16 A25-B3-C16 A59-B4-C15 A48-B1-C16 A37-B2-C16 A26-B3-C16 A60-B4-C15 A49-B1-C16 A38-B2-C16 A27-B3-C16 A61-B4-C15 A50-B1-C16 A39-B2-C16 A28-B3-C16 A62-B4-C15 A51-B1-C16 A40-B2-C16 A29-B3-C16 A63-B4-C15 A52-B1-C16 A41-B2-C16 A30-B3-C16 A64-B4-C15 A53-B1-C16 A42-B2-C16 A31-B3-C16 A65-B4-C15 A54-B1-C16 A43-B2-C16 A32-B3-C16 A66-B4-C15 A55-B1-C16 A44-B2-C16 A33-B3-C16 A67-B4-C15 A56-B1-C16 A45-B2-C16 A34-B3-C16 A68-B4-C15 A57-B1-C16 A46-B2-C16 A35-B3-C16 A69-B4-C15 A58-B1-C16 A47-B2-C16 A36-B3-C16 A70-B4-C15 A59-B1-C16 A48-B2-C16 A37-B3-C16 A71-B4-C15 A60-B1-C16 A49-B2-C16 A38-B3-C16 A72-B4-C15 A61-B1-C16 A50-B2-C16 A39-B3-C16 A73-B4-C15 A62-B1-C16 A51-B2-C16 A40-B3-C16 A74-B4-C15 A63-B1-C16 A52-B2-C16 A41-B3-C16 A75-B4-C15 A64-B1-C16 A53-B2-C16 A42-B3-C16 A76-B4-C15 A65-B1-C16 A54-B2-C16 A43-B3-C16 A77-B4-C15 A66-B1-C16 A55-B2-C16 A44-B3-C16 A1-B1-C16 A67-B1-C16 A56-B2-C16 A45-B3-C16 A2-Bl-C16 A68-B1-C16 A57-B2-C16 A46-B3-C16 A47-B3-C16 A36-B4-C16 A25-B1-C17 A14-B2-C17 A48-B3-C16 A37-B4-C16 A26-B1-C17 A15-B2-C17 A49-B3-C16 A38-B4-C16 A27-B1-C17 A16-B2-C17 A50-B3-C16 A39-B4-C16 A28-B1-C17 A17-B2-C17 A51-B3-C16 A40-B4-C16 A29-B1-C17 A18-B2-C17 A52-B3-C16 A41-B4-C16 A30-B1-C17 A19-B2-C17 A53-B3-C16 A42-B4-C16 A31-B1-C17 A20-B2-C17 A54-B3-C16 A43-B4-C16 A32-B1-C17 A21-B2-C17 A55-B3-C16 A44-B4-C16 A33-B1-C17 A22-B2-C17 A56-B3-C16 A45-B4-C16 A34-B1-C17 A23-B2-C17 A57-B3-C16 A46-B4-C16 A35-B1-C17 A24-B2-C17 A58-B3-C16 A47-B4-C16 A36-B1-C17 A25-B2-C17 A59-B3-C16 A48-B4-C16 A37-B1-C17 A26-B2-C17 A60-B3-C16 A49-B4-C16 A38-B1-C17 A27-B2-C17 A61-B3-C16 A50-B4-C16 A39-B1-C17 A28-B2-C17 A62-B3-C16 A51-B4-C16 A40-B1-C17 A29-B2-C17 A63-B3-C16 A52-B4-C16 A41-B1-C17 A30-B2-C17 A64-B3-C16 A53-B4-C16 A42-B1-C17 A31-B2-C17 A65-B3-C16 A54-B4-C16 A43-B1-C17 A32-B2-C17 A66-B3-C16 A55-B4-C16 A44-B1-C17 A33-B2-C17 A67-B3-C16 A56-B4-C16 A45-B1-C17 A34-B2-C17 A68-B3-C16 A57-B4-C16 A46-B1-C17 A35-B2-C17 A69-B3-C16 A58-B4-C16 A47-B1-C17 A36-B2-C17 A70-B3-C16 A59-B4-C16 A48-B1-C17 A37-B2-C17 A71-B3-C16 A60-B4-C16 A49-B1-C17 A38-B2-C17 A72-B3-C16 A61-B4-C16 A50-B1-C17 A39-B2-C17 A73-B3-C16 A62-B4-C16 A51-B1-C17 A40-B2-C17 A74-B3-C16 A63-B4-C16 A52-B1-C17 A41-B2-C17 A75-B3-C16 A64-B4-C16 A53-B1-C17 A42-B2-C17 A76-B3-C16 A65-B4-C16 A54-B1-C17 A43-B2-C17 A77-B3-C16 A66-B4-C16 A55-B1-C17 A44-B2-C17 A1-B4-C16 A67-B4-C16 A56-B1-C17 A45-B2-C17 A2-B4-C16 A68-B4-C16 A57-B1-C17 A46-B2-C17 A3-B4-C16 A69-B4-C16 A58-B1-C17 A47-B2-C17 A4-B4-C16 A70-B4-C16 A59-B1-C17 A48-B2-C17 A5-B4-C16 A71-B4-C16 A60-B1-C17 A49-B2-C17 A6-B4-C16 A72-B4-C16 A61-B1-C17 A50-B2-C17 A7-B4-C16 A73-B4-C16 A62-B1-C17 A51-B2-C17 A8-B4-C16 A74-B4-C16 A63-B1-C17 A52-B2-C17 A9-B4-C16 A75-B4-C16 A64-B1-C17 A53-B2-C17 A10-B4-C16 A76-B4-C16 A65-B1-C17 A54-B2-C17 A11-B4-C16 A77-B4-C16 A66-B1-C17 A55-B2-C17 A12-B4-C16 A1-B1-C17 A67-B1-C17 A56-B2-C17 A13-B4-C16 A2-B1-C17 A68-B1-C17 A57-B2-C17 A14-B4-C16 A3-B1-C17 A69-B1-C17 A58-B2-C17 A15-B4-C16 A4-B1-C17 A70-B1-C17 A59-B2-C17 A16-B4-C16 A5-B1-C17 A71-B1-C17 A60-B2-C17 A17-B4-C16 A6-B1-C17 A72-B1-C17 A61-B2-C17 A18-B4-C16 A7-B1-C17 A73-B1-C17 A62-B2-C17 A19-B4-C16 A8-B1-C17 A74-B1-C17 A63-B2-C17 A20-B4-C16 A9-B1-C17 A75-B1-C17 A64-B2-C17 A21-B4-C16 A10-B1-C17 A76-B1-C17 A65-B2-C17 A22-B4-C16 A11-B1-C17 A77-B1-C17 A66-B2-C17 A23-B4-C16 A12-B1-C17 A1-B2-C17 A67-B2-C17 A24-B4-C16 A13-B1-C17 A2-B2-C17 A68-B2-C17 A25-B4-C16 A14-B1-C17 A3-B2-C17 A69-B2-C17 A26-B4-C16 A15-B1-C17 A4-B2-C17 A70-B2-C17 A27-B4-C16 A16-B1-C17 A5-B2-C17 A71-B2-C17 A28-B4-C16 A17-B1-C17 A6-B2-C17 A72-B2-C17 A29-B4-C16 A18-B1-C17 A7-B2-C17 A73-B2-C17 A30-B4-C16 A19-B1-C17 A8-B2-C17 A74-B2-C17 A31-B4-C16 A20-B1-C17 A9-B2-C17 A75-B2-C17 A32-B4-C16 A21-B1-C17 A10-B2-C17 A76-B2-C17 A33-B4-C16 A22-B1-C17 A11-B2-C17 A77-B2-C17 A34-B4-C16 A23-B1-C17 A12-B2-C17 A1-B3-C17 A35-B4-C16 A24-B1-C17 A13-B2-C17 A2-B3-C17 A3-B3-C17 A69-B3-C17 A58-B4-C17 A47-B1-C18 A4-B3-C17 A70-B3-C17 A59-B4-C17 A48-B1-C18 A5-B3-C17 A71-B3-C17 A60-B4-C17 A49-B1-C18 A6-B3-C17 A72-B3-C17 A61-B4-C17 A50-B1-C18 A7-B3-C17 A73-B3-C17 A62-B4-C17 A51-B1-C18 A8-B3-C17 A74-B3-C17 A63-B4-C17 A52-B1-C18 A9-B3-C17 A75-B3-C17 A64-B4-C17 A53-B1-C18 A10-B3-C17 A76-B3-C17 A65-B4-C17 A54-B1-C18 A11-B3-C17 A77-B3-C17 A66-B4-C17 A55-B1-C18 A12-B3-C17 A1-B4-C17 A67-B4-C17 A56-B1-C18 A13-B3-C17 A2-B4-C17 A68-B4-C17 A57-B1-C18 A14-B3-C17 A3-B4-C17 A69-B4-C17 A58-B1-C18 A15-B3-C17 A4-B4-C17 A70-B4-C17 A59-B1-C18 A16-B3-C17 A5-B4-C17 A71-B4-C17 A60-B1-C18 A17-B3-C17 A6-B4-C17 A72-B4-C17 A61-B1-C18 A18-B3-C17 A7-B4-C17 A73-B4-C17 A62-B1-C18 A19-B3-C17 A8-B4-C17 A74-B4-C17 A63-B1-C18 A20-B3-C17 A9-B4-C17 A75-B4-C17 A64-B1-C18 A21-B3-C17 A10-B4-C17 A76-B4-C17 A65-B1-C18 A22-B3-C17 A11-B4-C17 A77-B4-C17 A66-B1-C18 A23-B3-C17 A12-B4-C17 A1-B1-C18 A67-B1-C18 A24-B3-C17 A13-B4-C17 A2-B1-C18 A68-B1-C18 A25-B3-C17 A14-B4-C17 A3-B1-C18 A69-B1-C18 A26-B3-C17 A15-B4-C17 A4-B1-C18 A70-B1-C18 A27-B3-C17 A16-B4-C17 A5-B1-C18 A71-B1-C18 A28-B3-C17 A17-B4-C17 A6-B1-C18 A72-B1-C18 A29-B3-C17 A18-B4-C17 A7-B1-C18 A73-B1-C18 A30-B3-C17 A19-B4-C17 A8-B1-C18 A74-B1-C18 A31-B3-C17 A20-B4-C17 A9-B1-C18 A75-B1-C18 A32-B3-C17 A21-B4-C17 A10-B1-C18 A76-B1-C18 A33-B3-C17 A22-B4-C17 A11-B1-C18 A77-B1-C18 A34-B3-C17 A23-B4-C17 A12-B1-C18 A1-B2-C18 A35-B3-C17 A24-B4-C17 A13-B1-C18 A2-B2-C18 A36-B3-C17 A25-B4-C17 A14-B1-C18 A3-B2-C18 A37-B3-C17 A26-B4-C17 A15-B1-C18 A4-B2-C18 A38-B3-C17 A27-B4-C17 A16-B1-C18 A5-B2-C18 A39-B3-C17 A28-B4-C17 A17-B1-C18 A6-B2-C18 A40-B3-C17 A29-B4-C17 A18-B1-C18 A7-B2-C18 A41-B3-C17 A30-B4-C17 A19-B1-C18 A8-B2-C18 A42-B3-C17 A31-B4-C17 A20-B1-C18 A9-B2-C18 A43-B3-C17 A32-B4-C17 A21-B1-C18 A10-B2-C18 A44-B3-C17 A33-B4-C17 A22-B1-C18 A11-B2-C18 A45-B3-C17 A34-B4-C17 A23-B1-C18 A12-B2-C18 A46-B3-C17 A35-B4-C17 A24-B1-C18 A13-B2-C18 A47-B3-C17 A36-B4-C17 A25-B1-C18 A14-B2-C18 A48-B3-C17 A37-B4-C17 A26-B1-C18 A15-B2-C18 A49-B3-C17 A38-B4-C17 A27-B1-C18 A16-B2-C18 A50-B3-C17 A39-B4-C17 A28-B1-C18 A17-B2-C18 A51-B3-C17 A40-B4-C17 A29-B1-C18 A18-B2-C18 A52-B3-C17 A41-B4-C17 A30-B1-C18 A19-B2-C18 A53-B3-C17 A42-B4-C17 A31-B1-C18 A20-B2-C18 A54-B3-C17 A43-B4-C17 A32-B1-C18 A21-B2-C18 A55-B3-C17 A44-B4-C17 A33-B1-C18 A22-B2-C18 A56-B3-C17 A45-B4-C17 A34-B1-C18 A23-B2-C18 A57-B3-C17 A46-B4-C17 A35-B1-C18 A24-B2-C18 A58-B3-C17 A47-B4-C17 A36-B1-C18 A25-B2-C18 A59-B3-C17 A48-B4-C17 A37-B1-C18 A26-B2-C18 A60-B3-C17 A49-B4-C17 A38-B1-C18 A27-B2-C18 A61-B3-C17 A50-B4-C17 A39-B1-C18 A28-B2-C18 A62-B3-C17 A51-B4-C17 A40-B1-C18 A29-B2-C18 A63-B3-C17 A52-B4-C17 A41-B1-C18 A30-B2-C18 A64-B3-C17 A53-B4-C17 A42-B1-C18 A31-B2-C18 A65-B3-C17 A54-B4-C17 A43-B1-C18 A32-B2-C18 A66-B3-C17 A55-B4-C17 A44-B1-C18 A33-B2-C18 A67-B3-C17 A56-B4-C17 A45-B1-C18 A34-B2-C18 A68-B3-C17 A57-B4-C17 A46-B1-C18 A35-B2-C18 A36-B2-C18 A25-B3-C18 A14-B4-C18 A3-B1-C19 A37-B2-C18 A26-B3-C18 A15-B4-C18 A4-B1-C19 A38-B2-C18 A27-B3-C18 A16-B4-C18 A5-B1-C19 A39-B2-C18 A28-B3-C18 A17-B4-C18 A6-B1-C19 A40-B2-C18 A29-B3-C18 A18-B4-C18 A7-B1-C19 A41-B2-C18 A30-B3-C18 A19-B4-C18 A8-B1-C19 A42-B2-C18 A31-B3-C18 A20-B4-C18 A9-B1-C19 A43-B2-C18 A32-B3-C18 A21-B4-C18 A10-B1-C19 A44-B2-C18 A33-B3-C18 A22-B4-C18 A11-B1-C19 A45-B2-C18 A34-B3-C18 A23-B4-C18 A12-B1-C19 A46-B2-C18 A35-B3-C18 A24-B4-C18 A13-B1-C19 A47-B2-C18 A36-B3-C18 A25-B4-C18 A14-B1-C19 A48-B2-C18 A37-B3-C18 A26-B4-C18 A15-B1-C19 A49-B2-C18 A38-B3-C18 A27-B4-C18 A16-B1-C19 A50-B2-C18 A39-B3-C18 A28-B4-C18 A17-B1-C19 A51-B2-C18 A40-B3-C18 A29-B4-C18 A18-B1-C19 A52-B2-C18 A41-B3-C18 A30-B4-C18 A19-B1-C19 A53-B2-C18 A42-B3-C18 A31-B4-C18 A20-B1-C19 A54-B2-C18 A43-B3-C18 A32-B4-C18 A21-B1-C19 A55-B2-C18 A44-B3-C18 A33-B4-C18 A22-B1-C19 A56-B2-C18 A45-B3-C18 A34-B4-C18 A23-B1-C19 A57-B2-C18 A46-B3-C18 A35-B4-C18 A24-B1-C19 A58-B2-C18 A47-B3-C18 A36-B4-C18 A25-B1-C19 A59-B2-C18 A48-B3-C18 A37-B4-C18 A26-B1-C19 A60-B2-C18 A49-B3-C18 A38-B4-C18 A27-B1-C19 A61-B2-C18 A50-B3-C18 A39-B4-C18 A28-B1-C19 A62-B2-C18 A51-B3-C18 A40-B4-C18 A29-B1-C19 A63-B2-C18 A52-B3-C18 A41-B4-C18 A30-B1-C19 A64-B2-C18 A53-B3-C18 A42-B4-C18 A31-B1-C19 A65-B2-C18 A54-B3-C18 A43-B4-C18 A32-B1-C19 A66-B2-C18 A55-B3-C18 A44-B4-C18 A33-B1-C19 A67-B2-C18 A56-B3-C18 A45-B4-C18 A34-B1-C19 A68-B2-C18 A57-B3-C18 A46-B4-C18 A35-B1-C19 A69-B2-C18 A58-B3-C18 A47-B4-C18 A36-B1-C19 A70-B2-C18 A59-B3-C18 A48-B4-C18 A37-B1-C19 A71-B2-C18 A60-B3-C18 A49-B4-C18 A38-B1-C19 A72-B2-C18 A61-B3-C18 A50-B4-C18 A39-B1-C19 A73-B2-C18 A62-B3-C18 A51-B4-C18 A40-B1-C19 A74-B2-C18 A63-B3-C18 A52-B4-C18 A41-B1-C19 A75-B2-C18 A64-B3-C18 A53-B4-C18 A42-B1-C19 A76-B2-C18 A65-B3-C18 A54-B4-C18 A43-B1-C19 A77-B2-C18 A66-B3-C18 A55-B4-C18 A44-B1-C19 A1-B3-C18 A67-B3-C18 A56-B4-C18 A45-B1-C19 A2-B3-C18 A68-B3-C18 A57-B4-C18 A46-B1-C19 A3-B3-C18 A69-B3-C18 A58-B4-C18 A47-B1-C19 A4-B3-C18 A70-B3-C18 A59-B4-C18 A48-B1-C19 A5-B3-C18 A71-B3-C18 A60-B4-C18 A49-B1-C19 A6-B3-C18 A72-B3-C18 A61-B4-C18 A50-B1-C19 A7-B3-C18 A73-B3-C18 A62-B4-C18 A51-B1-C19 A8-B3-C18 A74-B3-C18 A63-B4-C18 A52-B1-C19 A9-B3-C18 A75-B3-C18 A64-B4-C18 A53-B1-C19 A10-B3-C18 A76-B3-C18 A65-B4-C18 A54-B1-C19 A11-B3-C18 A77-B3-C18 A66-B4-C18 A55-B1-C19 A12-B3-C18 A1-B4-C18 A67-B4-C18 A56-B1-C19 A13-B3-C18 A2-B4-C18 A68-B4-C18 A57-B1-C19 A14-B3-C18 A3-B4-C18 A69-B4-C18 A58-B1-C19 A15-B3-C18 A4-B4-C18 A70-B4-C18 A59-B1-C19 A16-B3-C18 A5-B4-C18 A71-B4-C18 A60-B1-C19 A17-B3-C18 A6-B4-C18 A72-B4-C18 A61-B1-C19 A18-B3-C18 A7-B4-C18 A73-B4-C18 A62-B1-C19 A19-B3-C18 A8-B4-C18 A74-B4-C18 A63-B1-C19 A20-B3-C18 A9-B4-C18 A75-B4-C18 A64-B1-C19 A21-B3-C18 A10-B4-C18 A76-B4-C18 A65-B1-C19 A22-B3-C18 A11-B4-C18 A77-B4-C18 A66-B1-C19 A23-B3-C18 A12-B4-C18 A1-B1-C19 A67-B1-C19 A24-B3-C18 A13-B4-C18 A2-B1-C19 A68-B1-C19 A69-B1-C19 A58-B2-C19 A47-B3-C19 A36-B4-C19 A70-B1-C19 A59-B2-C19 A48-B3-C19 A37-B4-C19 A71-B1-C19 A60-B2-C19 A49-B3-C19 A38-B4-C19 A72-B1-C19 A61-B2-C19 A50-B3-C19 A39-B4-C19 A73-B1-C19 A62-B2-C19 A51-B3-C19 A40-B4-C19 A74-B1-C19 A63-B2-C19 A52-B3-C19 A41-B4-C19 A75-B1-C19 A64-B2-C19 A53-B3-C19 A42-B4-C19 A76-B1-C19 A65-B2-C19 A54-B3-C19 A43-B4-C19 A77-B1-C19 A66-B2-C19 A55-B3-C19 A44-B4-C19 A1-B2-C19 A67-B2-C19 A56-B3-C19 A45-B4-C19 A2-B2-C19 A68-B2-C19 A57-B3-C19 A46-B4-C19 A3-B2-C19 A69-B2-C19 A58-B3-C19 A47-B4-C19 A4-B2-C19 A70-B2-C19 A59-B3-C19 A48-B4-C19 A5-B2-C19 A71-B2-C19 A60-B3-C19 A49-B4-C19 A6-B2-C19 A72-B2-C19 A61-B3-C19 A50-B4-C19 A7-B2-C19 A73-B2-C19 A62-B3-C19 A51-B4-C19 A8-B2-C19 A74-B2-C19 A63-B3-C19 A52-B4-C19 A9-B2-C19 A75-B2-C19 A64-B3-C19 A53-B4-C19 A10-B2-C19 A76-B2-C19 A65-B3-C19 A54-B4-C19 A11-B2-C19 A77-B2-C19 A66-B3-C19 A55-B4-C19 A12-B2-C19 A1-B3-C19 A67-B3-C19 A56-B4-C19 A13-B2-C19 A2-B3-C19 A68-B3-C19 A57-B4-C19 A14-B2-C19 A3-B3-C19 A69-B3-Cl9 A58-B4-C19 A15-B2-Cl9 A4-B3-C19 A70-B3-C19 A59-B4-C19 A16-B2-C19 A5-B3-C19 A71-B3-C19 A60-B4-C19 A17-B2-C19 A6-B3-C19 A72-B3-C19 A61-B4-C19 A18-B2-C19 A7-B3-C19 A73-B3-C19 A62-B4-C19 A19-B2-C19 A8-B3-C19 A74-B3-C19 A63-B4-C19 A20-B2-C19 A9-B3-C19 A75-B3-C19 A64-B4-C19 A21-B2-C19 A10-B3-C19 A76-B3-C19 A65-B4-C19 A22-B2-C19 A11-B3-C19 A77-B3-C19 A66-B4-C19 A23-B2-C19 A12-B3-C19 A1-B4-C19 A67-B4-C19 A24-B2-C19 A13-B3-C19 A2-B4-C19 A68-B4-C19 A25-B2-C19 A14-B3-C19 A3-B4-C19 A69-B4-C19 A26-B2-C19 A15-B3-C19 A4-B4-C19 A70-B4-C19 A27-B2-C19 A16-B3-C19 A5-B4-C19 A71-B4-C19 A28-B2-C19 A17-B3-C19 A6-B4-C19 A72-B4-C19 A29-B2-C19 A18-B3-C19 A7-B4-C19 A73-B4-C19 A30-B2-C19 A19-B3-C19 A8-B4-C19 A74-B4-C19 A31-B2-C19 A20-B3-C19 A9-B4-C19 A75-B4-C19 A32-B2-C19 A21-B3-C19 A10-B4-C19 A76-B4-C19 A33-B2-C19 A22-B3-C19 A11-B4-C19 A77-B4-C19 A34-B2-C19 A23-B3-C19 A12-B4-C19 A1-B1-C20 A35-B2-C19 A24-B3-C19 A13-B4-C19 A2-B1-C20 A36-B2-C19 A25-B3-C19 A14-B4-C19 A3-B1-C20 A37-B2-C19 A26-B3-C19 A15-B4-C19 A4-B1-C20 A38-B2-C19 A27-B3-C19 A16-B4-C19 A5-B1-C20 A39-B2-C19 A28-B3-C19 A17-B4-C19 A6-B1-C20 A40-B2-C19 A29-B3-C19 A18-B4-C19 A7-B1-C20 A41-B2-C19 A30-B3-C19 A19-B4-C19 A8-B1-C20 A42-B2-C19 A31-B3-C19 A20-B4-C19 A9-B1-C20 A43-B2-C19 A32-B3-C19 A21-B4-C19 A10-B1-C20 A44-B2-C19 A33-B3-C19 A22-B4-C19 A11-B1-C20 A45-B2-C19 A34-B3-C19 A23-B4-C19 A12-B1-C20 A46-B2-C19 A35-B3-C19 A24-B4-C19 A13-B1-C20 A47-B2-C19 A36-B3-C19 A25-B4-C19 A14-B1-C20 A48-B2-C19 A37-B3-C19 A26-B4-C19 A15-B1-C20 A49-B2-C19 A38-B3-C19 A27-B4-C19 A16-B1-C20 A50-B2-C19 A39-B3-C19 A28-B4-C19 A17-B1-C20 A51-B2-C19 A40-B3-C19 A29-B4-C19 A18-B1-C20 A52-B2-Cl9 A41-B3-C19 A30-B4-C19 A19-B1-C20 A53-B2-C19 A42-B3-C19 A31-B4-C19 A20-B1-C20 A54-B2-C19 A43-B3-C19 A32-B4-C19 A21-B1-C20 A55-B2-C19 A44-B3-C19 A33-B4-C19 A22-B1-C20 A56-B2-C19 A45-B3-C19 A34-B4-C19 A23-B1-C20 A57-B2-C19 A46-B3-C19 A35-B4-C19 A24-B1-C20 A25-B1-C20 A14-B2-C20 A3-B3-C20 A69-B3-C20 A26-B1-C20 A15-B2-C20 A4-B3-C20 A70-B3-C20 A27-B1-C20 A16-B2-C20 A5-B3-C20 A71-B3-C20 A28-B1-C20 A17-B2-C20 A6-B3-C20 A72-B3-C20 A29-B1-C20 A18-B2-C20 A7-B3-C20 A73-B3-C20 A30-B1-C20 A19-B2-C20 A8-B3-C20 A74-B3-C20 A31-B1-C20 A20-B2-C20 A9-B3-C20 A75-B3-C20 A32-B1-C20 A21-B2-C20 A10-B3-C20 A76-B3-C20 A33-B1-C20 A22-B2-C20 A11-B3-C20 A77-B3-C20 A34-B1-C20 A23-B2-C20 A12-B3-C20 A1-B4-C20 A35-B1-C20 A24-B2-C20 A13-B3-C20 A2-B4-C20 A36-B1-C20 A25-B2-C20 A14-B3-C20 A3-B4-C20 A37-B1-C20 A26-B2-C20 A15-B3-C20 A4-B4-C20 A38-B1-C20 A27-B2-C20 A16-B3-C20 A5-B4-C20 A39-B1-C20 A28-B2-C20 A17-B3-C20 A6-B4-C20 A40-B1-C20 A29-B2-C20 A18-B3-C20 A7-B4-C20 A41-B1-C20 A30-B2-C20 A19-B3-C20 A8-B4-C20 A42-B1-C20 A31-B2-C20 A20-B3-C20 A9-B4-C20 A43-B1-C20 A32-B2-C20 A21-B3-C20 A10-B4-C20 A44-B1-C20 A33-B2-C20 A22-B3-C20 A11-B4-C20 A45-B1-C20 A34-B2-C20 A23-B3-C20 A12-B4-C20 A46-B1-C20 A35-B2-C20 A24-B3-C20 A13-B4-C20 A47-B1-C20 A36-B2-C20 A25-B3-C20 A14-B4-C20 A48-B1-C20 A37-B2-C20 A26-B3-C20 A15-B4-C20 A49-B1-C20 A38-B2-C20 A27-B3-C20 A16-B4-C20 A50-B1-C20 A39-B2-C20 A28-B3-C20 A17-B4-C20 A51-B1-C20 A40-B2-C20 A29-B3-C20 A18-B4-C20 A52-B1-C20 A41-B2-C20 A30-B3-C20 A19-B4-C20 A53-B1-C20 A42-B2-C20 A31-B3-C20 A20-B4-C20 A54-B1-C20 A43-B2-C20 A32-B3-C20 A21-B4-C20 A55-B1-C20 A44-B2-C20 A33-B3-C20 A22-B4-C20 A56-B1-C20 A45-B2-C20 A34-B3-C20 A23-B4-C20 A57-B1-C20 A46-B2-C20 A35-B3-C20 A24-B4-C20 A58-B1-C20 A47-B2-C20 A36-B3-C20 A25-B4-C20 A59-B1-C20 A48-B2-C20 A37-B3-C20 A26-B4-C20 A60-B1-C20 A49-B2-C20 A38-B3-C20 A27-B4-C20 A61-B1-C20 A50-B2-C20 A39-B3-C20 A28-B4-C20 A62-B1-C20 A51-B2-C20 A40-B3-C20 A29-B4-C20 A63-B1-C20 A52-B2-C20 A41-B3-C20 A30-B4-C20 A64-B1-C20 A53-B2-C20 A42-B3-C20 A31-B4-C20 A65-B1-C20 A54-B2-C20 A43-B3-C20 A32-B4-C20 A66-B1-C20 A55-B2-C20 A44-B3-C20 A33-B4-C20 A67-B1-C20 A56-B2-C20 A45-B3-C20 A34-B4-C20 A68-B1-C20 A57-B2-C20 A46-B3-C20 A35-B4-C20 A69-B1-C20 A58-B2-C20 A47-B3-C20 A36-B4-C20 A70-B1-C20 A59-B2-C20 A48-B3-C20 A37-B4-C20 A71-B1-C20 A60-B2-C20 A49-B3-C20 A38-B4-C20 A72-B1-C20 A61-B2-C20 A50-B3-C20 A39-B4-C20 A73-B1-C20 A62-B2-C20 A51-B3-C20 A40-B4-C20 A74-B1-C20 A63-B2-C20 A52-B3-C20 A41-B4-C20 A75-B1-C20 A64-B2-C20 A53-B3-C20 A42-B4-C20 A76-B1-C20 A65-B2-C20 A54-B3-C20 A43-B4-C20 A77-B1-C20 A66-B2-C20 A55-B3-C20 A44-B4-C20 A1-B2-C20 A67-B2-C20 A56-B3-C20 A45-B4-C20 A2-B2-C20 A68-B2-C20 A57-B3-C20 A46-B4-C20 A3-B2-C20 A69-B2-C20 A58-B3-C20 A47-B4-C20 A4-B2-C20 A70-B2-C20 A59-B3-C20 A48-B4-C20 A5-B2-C20 A71-B2-C20 A60-B3-C20 A49-B4-C20 A6-B2-C20 A72-B2-C20 A61-B3-C20 A50-B4-C20 A7-B2-C20 A73-B2-C20 A62-B3-C20 A51-B4-C20 A8-B2-C20 A74-B2-C20 A63-B3-C20 A52-B4-C20 A9-B2-C20 A75-B2-C20 A64-B3-C20 A53-B4-C20 A10-B2-C20 A76-B2-C20 A65-B3-C20 A54-B4-C20 A11-B2-C20 A77-B2-C20 A66-B3-C20 A55-B4-C20 A12-B2-C20 A1-B3-C20 A67-B3-C20 A56-B4-C20 A13-B2-C20 A2-B3-C20 A68-B3-C20 A57-B4-C20 A58-B4-C20 A47-B1-C21 A36-B2-C21 A25-B3-C21 A59-B4-C20 A48-B1-C21 A37-B2-C21 A26-B3-C21 A60-B4-C20 A49-B1-C21 A38-B2-C21 A27-B3-C21 A61-B4-C20 A50-B1-C21 A39-B2-C21 A28-B3-C21 A62-B4-C20 A51-B1-C21 A40-B2-C21 A29-B3-C21 A63-B4-C20 A52-B1-C21 A41-B2-C21 A30-B3-C21 A64-B4-C20 A53-B1-C21 A42-B2-C21 A31-B3-C21 A65-B4-C20 A54-B1-C21 A43-B2-C21 A32-B3-C21 A66-B4-C20 A55-B1-C21 A44-B2-C21 A33-B3-C21 A67-B4-C20 A56-B1-C21 A45-B2-C21 A34-B3-C21 A68-B4-C20 A57-B1-C21 A46-B2-C21 A35-B3-C21 A69-B4-C20 A58-B1-C21 A47-B2-C21 A36-B3-C21 A70-B4-C20 A59-B1-C21 A48-B2-C21 A37-B3-C21 A71-B4-C20 A60-B1-C21 A49-B2-C21 A38-B3-C21 A72-B4-C20 A61-B1-C21 A50-B2-C21 A39-B3-C21 A73-B4-C20 A62-B1-C21 A51-B2-C21 A40-B3-C21 A74-B4-C20 A63-B1-C21 A52-B2-C21 A41-B3-C21 A75-B4-C20 A64-B1-C21 A53-B2-C21 A42-B3-C21 A76-B4-C20 A65-B1-C21 A54-B2-C21 A43-B3-C21 A77-B4-C20 A66-B1-C21 A55-B2-C21 A44-B3-C21 A1-B1-C21 A67-B1-C21 A56-B2-C21 A45-B3-C21 A2-B1-C21 A68-B1-C21 A57-B2-C21 A46-B3-C21 A3-B1-C21 A69-B1-C21 A58-B2-C21 A47-B3-C21 A4-B1-C21 A70-B1-C21 A59-B2-C21 A48-B3-C21 A5-B1-C21 A71-B1-C21 A60-B2-C21 A49-B3-C21 A6-B1-C21 A72-B1-C21 A61-B2-C21 A50-B3-C21 A7-B1-C21 A73-B1-C21 A62-B2-C21 A51-B3-C21 A8-B1-C21 A74-B1-C21 A63-B2-C21 A52-B3-C21 A9-B1-C21 A75-B1-C21 A64-B2-C21 A53-B3-C21 A10-B1-C21 A76-B1-C21 A65-B2-C21 A54-B3-C21 A11-B1-C21 A77-B1-C21 A66-B2-C21 A55-B3-C21 A12-B1-C21 A1-B2-C21 A67-B2-C21 A56-B3-C21 A13-B1-C21 A2-B2-C21 A68-B2-C21 A57-B3-C21 A14-B1-C21 A3-B2-C21 A69-B2-C21 A58-B3-C21 A15-B1-C21 A4-B2-C21 A70-B2-C21 A59-B3-C21 A16-B1-C21 A5-B2-C21 A71-B2-C21 A60-B3-C21 A17-B1-C21 A6-B2-C21 A72-B2-C21 A61-B3-C21 A18-B1-C21 A7-B2-C21 A73-B2-C21 A62-B3-C21 A19-B1-C21 A8-B2-C21 A74-B2-C21 A63-B3-C21 A20-B1-C21 A9-B2-C21 A75-B2-C21 A64-B3-C21 A21-B1-C21 A10-B2-C21 A76-B2-C21 A65-B3-C21 A22-B1-C21 All-B2-C21 A77-B2-C21 A66-B3-C21 A23-B1-C21 A12-B2-C21 A1-B3-C21 A67-B3-C21 A24-B1-C21 A13-B2-C21 A2-B3-C21 A68-B3-C21 A25-B1-C21 A14-B2-C21 A3-B3-C21 A69-B3-C21 A26-B1-C21 A15-B2-C21 A4-B3-C21 A70-B3-C21 A27-B1-C21 A16-B2-C21 A5-B3-C21 A71-B3-C21 A28-B1-C21 A17-B2-C21 A6-B3-C21 A72-B3-C21 A29-B1-C21 A18-B2-C21 A7-B3-C21 A73-B3-C21 A30-B1-C21 A19-B2-C21 A8-B3-C21 A74-B3-C21 A31-B1-C21 A20-B2-C21 A9-B3-C21 A75-B3-C21 A32-B1-C21 A21-B2-C21 A10-B3-C21 A76-B3-C21 A33-B1-C21 A22-B2-C21 A11-B3-C21 A77-B3-C21 A34-B1-C21 A23-B2-C21 A12-B3-C21 A1-B4-C21 A35-B1-C21 A24-B2-C21 A13-B3-C21 A2-B4-C21 A36-B1-C21 A25-B2-C21 A14-B3-C21 A3-B4-C21 A37-B1-C21 A26-B2-C21 A15-B3-C21 A4-B4-C21 A38-B1-C21 A27-B2-C21 A16-B3-C21 A5-B4-C21 A39-B1-C21 A28-B2-C21 A17-B3-C21 A6-B4-C21 A40-B1-C21 A29-B2-C2. 1 A18-B3-C21 A7-B4-C21 A41-B1-C21 A30-B2-C21 A19-B3-C21 A8-B4-C21 A42-B1-C21 A31-B2-C21 A20-B3-C21 A9-B4-C21 A43-B1-C21 A32-B2-C21 A21-B3-C21 A10-B4-C21 A44-B1-C21 A33-B2-C21 A22-B3-C21 A11-B4-C21 A45-B1-C21 A34-B2-C21 A23-B3-C21 A12-B4-C21 A46-B1-C21 A35-B2-C21 A24-B3-C21 A13-B4-C21 A14-B4-C21 A3-B1-C22 A69-B1-C22 A58-B2-C22 A15-B4-C21 A4-B1-C22 A70-B1-C22 A59-B2-C22 A16-B4-C21 A5-B1-C22 A71-B1-C22 A60-B2-C22 A17-B4-C21 A6-B1-C22 A72-B1-C22 A61-B2-C22 A18-B4-C21 A7-B1-C22 A73-B1-C22 A62-B2-C22 A19-B4-C21 A8-B1-C22 A74-B1-C22 A63-B2-C22 A20-B4-C21 A9-B1-C22 A75-B1-C22 A64-B2-C22 A21-B4-C21 A10-B1-C22 A76-B1-C22 A65-B2-C22 A22-B4-C21 A11-B1-C22 A77-B1-C22 A66-B2-C22 A23-B4-C21 A12-B1-C22 A1-B2-C22 A67-B2-C22 A24-B4-C21 A13-B1-C22 A2-B2-C22 A68-B2-C22 A25-B4-C21 A14-B1-C22 A3-B2-C22 A69-B2-C22 A26-B4-C21 A15-B1-C22 A4-B2-C22 A70-B2-C22 A27-B4-C21 A16-B1-C22 A5-B2-C22 A71-B2-C22 A28-B4-C21 A17-B1-C22 A6-B2-C22 A72-B2-C22 A29-B4-C21 A18-B1-C22 A7-B2-C22 A73-B2-C22 A30-B4-C21 A19-B1-C22 A8-B2-C22 A74-B2-C22 A31-B4-C21 A20-B1-C22 A9-B2-C22 A75-B2-C22 A32-B4-C21 A21-B1-C22 A10-B2-C22 A76-B2-C22 A33-B4-C21 A22-B1-C22 All-B2-C22 A77-B2-C22 A34-B4-C21 A23-B1-C22 A12-B2-C22 A1-B3-C22 A35-B4-C21 A24-B1-C22 A13-B2-C22 A2-B3-C22 A36-B4-C21 A25-B1-C22 A14-B2-C22 A3-B3-C22 A37-B4-C21 A26-B1-C22 A15-B2-C22 A4-B3-C22 A38-B4-C21 A27-B1-C22 A16-B2-C22 A5-B3-C22 A39-B4-C21 A28-B1-C22 A17-B2-C22 A6-B3-C22 A40-B4-C21 A29-B1-C22 A18-B2-C22 A7-B3-C22 A41-B4-C21 A30-B1-C22 A19-B2-C22 A8-B3-C22 A42-B4-C21 A31-B1-C22 A20-B2-C22 A9-B3-C22 A43-B4-C21 A32-B1-C22 A21-B2-C22 A10-B3-C22 A44-B4-C21 A33-B1-C22 A22-B2-C22 A11-B3-C22 A45-B4-C21 A34-B1-C22 A23-B2-C22 A12-B3-C22 A46-B4-C21 A35-B1-C22 A24-B2-C22 A13-B3-C22 A47-B4-C21 A36-B1-C22 A25-B2-C22 A14-B3-C22 A48-B4-C21 A37-B1-C22 A26-B2-C22 A15-B3-C22 A49-B4-C21 A38-B1-C22 A27-B2-C22 A16-B3-C22 A50-B4-C21 A39-B1-C22 A28-B2-C22 A17-B3-C22 A51-B4-C21 A40-B1-C22 A29-B2-C22 A18-B3-C22 A52-B4-C21 A41-B1-C22 A30-B2-C22 A19-B3-C22 A53-B4-C21 A42-B1-C22 A31-B2-C22 A20-B3-C22 A54-B4-C21 A43-B1-C22 A32-B2-C22 A21-B3-C22 A55-B4-C21 A44-B1-C22 A33-B2-C22 A22-B3-C22 A56-B4-C21 A45-B1-C22 A34-B2-C22 A23-B3-C22 A57-B4-C21 A46-B1-C22 A35-B2-C22 A24-B3-C22 A58-B4-C21 A47-B1-C22 A36-B2-C22 A25-B3-C22 A59-B4-C21 A48-B1-C22 A37-B2-C22 A26-B3-C22 A60-B4-C21 A49-B1-C22 A38-B2-C22 A27-B3-C22 A61-B4-C21 A50-B1-C22 A39-B2-C22 A28-B3-C22 A62-B4-C21 A51-B1-C22 A40-B2-C22 A29-B3-C22 A63-B4-C21 A52-B1-C22 A41-B2-C22 A30-B3-C22 A64-B4-C21 A53-B1-C22 A42-B2-C22 A31-B3-C22 A65-B4-C21 A54-B1-C22 A43-B2-C22 A32-B3-C22 A66-B4-C21 A55-B1-C22 A44-B2-C22 A33-B3-C22 A67-B4-C21 A56-B1-C22 A45-B2-C22 A34-B3-C22 A68-B4-C21 A57-B1-C22 A46-B2-C22 A35-B3-C22 A69-B4-C21 A58-B1-C22 A47-B2-C22 A36-B3-C22 A70-B4-C21 A59-B1-C22 A48-B2-C22 A37-B3-C22 A71-B4-C21 A60-B1-C22 A49-B2-C22 A38-B3-C22 A72-B4-C21 A61-B1-C22 A50-B2-C22 A39-B3-C22 A73-B4-C21 A62-B1-C22 A51-B2-C22 A40-B3-C22 A74-B4-C21 A63-B1-C22 A52-B2-C22 A41-B3-C22 A75-B4-C21 A64-B1-C22 A53-B2-C22 A42-B3-C22 A76-B4-C21 A65-B1-C22 A54-B2-C22 A43-B3-C22 A77-B4-C21 A66-B1-C22 A55-B2-C22 A44-B3-C22 A1-B1-C22 A67-B1-C22 A56-B2-C22 A45-B3-C22 A2-B1-C22 A68-B1-C22 A57-B2-C22 A46-B3-C22 A47-B3-C22 A36-B4-C22 A25-B1-C23 A14-B2-C23 A48-B3-C22 A37-B4-C22 A26-B1-C23 A15-B2-C23 A49-B3-C22 A38-B4-C22 A27-B1-C23 A16-B2-C23 A50-B3-C22 A39-B4-C22 A28-B1-C23 A17-B2-C23 A51-B3-C22 A40-B4-C22 A29-B1-C23 A18-B2-C23 A52-B3-C22 A41-B4-C22 A30-B1-C23 A19-B2-C23 A53-B3-C22 A42-B4-C22 A31-B1-C23 A20-B2-C23 A54-B3-C22 A43-B4-C22 A32-B1-C23 A21-B2-C23 A55-B3-C22 A44-B4-C22 A33-B1-C23 A22-B2-C23 A56-B3-C22 A45-B4-C22 A34-B1-C23 A23-B2-C23 A57-B3-C22 A46-B4-C22 A35-B1-C23 A24-B2-C23 A58-B3-C22 A47-B4-C22 A36-B1-C23 A25-B2-C23 A59-B3-C22 A48-B4-C22 A37-B1-C23 A26-B2-C23 A60-B3-C22 A49-B4-C22 A38-B1-C23 A27-B2-C23 A61-B3-C22 A50-B4-C22 A39-B1-C23 A28-B2-C23 A62-B3-C22 A51-B4-C22 A40-B1-C23 A29-B2-C23 A63-B3-C22 A52-B4-C22 A41-B1-C23 A30-B2-C23 A64-B3-C22 A53-B4-C22 A42-B1-C23 A31-B2-C23 A65-B3-C22 A54-B4-C22 A43-B1-C23 A32-B2-C23 A66-B3-C22 A55-B4-C22 A44-B1-C23 A33-B2-C23 A67-B3-C22 A56-B4-C22 A45-B1-C23 A34-B2-C23 A68-B3-C22 A57-B4-C22 A46-B1-C23 A35-B2-C23 A69-B3-C22 A58-B4-C22 A47-B1-C23 A36-B2-C23 A70-B3-C22 A59-B4-C22 A48-B1-C23 A37-B2-C23 A71-B3-C22 A60-B4-C22 A49-B1-C23 A38-B2-C23 A72-B3-C22 A61-B4-C22 A50-B1-C23 A39-B2-C23 A73-B3-C22 A62-B4-C22 A51-B1-C23 A40-B2-C23 A74-B3-C22 A63-B4-C22 A52-B1-C23 A41-B2-C23 A75-B3-C22 A64-B4-C22 A53-B1-C23 A42-B2-C23 A76-B3-C22 A65-B4-C22 A54-B1-C23 A43-B2-C23 A77-B3-C22 A66-B4-C22 A55-B1-C23 A44-B2-C23 A1-B4-C22 A67-B4-C22 A56-B1-C23 A45-B2-C23 A2-B4-C22 A68-B4-C22 A57-B1-C23 A46-B2-C23 A3-B4-C22 A69-B4-C22 A58-B1-C23 A47-B2-C23 A4-B4-C22 A70-B4-C22 A59-B1-C23 A48-B2-C23 A5-B4-C22 A71-B4-C22 A60-B1-C23 A49-B2-C23 A6-B4-C22 A72-B4-C22 A61-B1-C23 A50-B2-C23 A7-B4-C22 A73-B4-C22 A62-B1-C23 A51-B2-C23 A8-B4-C22 A74-B4-C22 A63-B1-C23 A52-B2-C23 A9-B4-C22 A75-B4-C22 A64-B1-C23 A53-B2-C23 A10-B4-C22 A76-B4-C22 A65-B1-C23 A54-B2-C23 All-B4-C22 A77-B4-C22 A66-B1-C23 A55-B2-C23 A12-B4-C22 A1-B1-C23 A67-B1-C23 A56-B2-C23 A13-B4-C22 A2-B1-C23 A68-B1-C23 A57-B2-C23 A14-B4-C22 A3-B1-C23 A69-B1-C23 A58-B2-C23 A15-B4-C22 A4-B1-C23 A70-B1-C23 A59-B2-C23 A16-B4-C22 A5-B1-C23 A71-B1-C23 A60-B2-C23 A17-B4-C22 A6-B1-C23 A72-B1-C23 A61-B2-C23 A18-B4-C22 A7-B1-C23 A73-B1-C23 A62-B2-C23 A19-B4-C22 A8-B1-C23 A74-B1-C23 A63-B2-C23 A20-B4-C22 A9-B1-C23 A75-B1-C23 A64-B2-C23 A21-B4-C22 A10-B1-C23 A76-B1-C23 A65-B2-C23 A22-B4-C22 A11-B1-C23 A77-B1-C23 A66-B2-C23 A23-B4-C22 A12-B1-C23 A1-B2-C23 A67-B2-C23 A24-B4-C22 A13-B1-C23 A2-B2-C23 A68-B2-C23 A25-B4-C22 A14-B1-C23 A3-B2-C23 A69-B2-C23 A26-B4-C22 A15-B1-C23 A4-B2-C23 A70-B2-C23 A27-B4-C22 A16-B1-C23 A5-B2-C23 A71-B2-C23 A28-B4-C22 A17-B1-C23 A6-B2-C23 A72-B2-C23 A29-B4-C22 A18-B1-C23 A7-B2-C23 A73-B2-C23 A30-B4-C22 A19-B1-C23 A8-B2-C23 A74-B2-C23 A31-B4-C22 A20-B1-C23 A9-B2-C23 A75-B2-C23 A32-B4-C22 A21-B1-C23 A10-B2-C23 A76-B2-C23 A33-B4-C22 A22-B1-C23 A11-B2-C23 A77-B2-C23 A34-B4-C22 A23-B1-C23 A12-B2-C23 A1-B3-C23 A35-B4-C22 A24-B1-C23 A13-B2-C23 A2-B3-C23 A3-B3-C23 A69-B3-C23 A58-B4-C23 A47-B1-C24 A4-B3-C23 A70-B3-C23 A59-B4-C23 A48-B1-C24 A5-B3-C23 A71-B3-C23 A60-B4-C23 A49-B1-C24 A6-B3-C23 A72-B3-C23 A61-B4-C23 A50-B1-C24 A7-B3-C23 A73-B3-C23 A62-B4-C23 A51-B1-C24 A8-B3-C23 A74-B3-C23 A63-B4-C23 A52-B1-C24 A9-B3-C23 A75-B3-C23 A64-B4-C23 A53-B1-C24 A10-B3-C23 A76-B3-C23 A65-B4-C23 A54-B1-C24 A11-B3-C23 A77-B3-C23 A66-B4-C23 A55-B1-C24 A12-B3-C23 A1-B4-C23 A67-B4-C23 A56-B1-C24 A13-B3-C23 A2-B4-C23 A68-B4-C23 A57-B1-C24 A14-B3-C23 A3-B4-C23 A69-B4-C23 A58-B1-C24 A15-B3-C23 A4-B4-C23 A70-B4-C23 A59-B1-C24 A16-B3-C23 A5-B4-C23 A71-B4-C23 A60-B1-C24 A17-B3-C23 A6-B4-C23 A72-B4-C23 A61-B1-C24 A18-B3-C23 A7-B4-C23 A73-B4-C23 A62-B1-C24 A19-B3-C23 A8-B4-C23 A74-B4-C23 A63-B1-C24 A20-B3-C23 A9-B4-C23 A75-B4-C23 A64-B1-C24 A21-B3-C23 A10-B4-C23 A76-B4-C23 A65-B1-C24 A22-B3-C23 All-B4-C23 A77-B4-C23 A66-B1-C24 A23-B3-C23 A12-B4-C23 A1-B1-C24 A67-B1-C24 A24-B3-C23 A13-B4-C23 A2-B1-C24 A68-B1-C24 A25-B3-C23 A14-B4-C23 A3-B1-C24 A69-B1-C24 A26-B3-C23 A15-B4-C23 A4-B1-C24 A70-B1-C24 A27-B3-C23 A16-B4-C23 A5-B1-C24 A71-B1-C24 A28-B3-C23 A17-B4-C23 A6-B1-C24 A72-B1-C24 A29-B3-C23 A18-B4-C23 A7-B1-C24 A73-B1-C24 A30-B3-C23 A19-B4-C23 A8-B1-C24 A74-B1-C24 A31-B3-C23 A20-B4-C23 A9-B1-C24 A75-B1-C24 A32-B3-C23 A21-B4-C23 A10-B1-C24 A76-B1-C24 A33-B3-C23 A22-B4-C23 A11-B1-C24 A77-B1-C24 A34-B3-C23 A23-B4-C23 A12-B1-C24 A1-B2-C24 A35-B3-C23 A24-B4-C23 A13-B1-C24 A2-B2-C24 A36-B3-C23 A25-B4-C23 A14-B1-C24 A3-B2-C24 A37-B3-C23 A26-B4-C23 A15-B1-C24 A4-B2-C24 A38-B3-C23 A27-B4-C23 A16-B1-C24 A5-B2-C24 A39-B3-C23 A28-B4-C23 A17-B1-C24 A6-B2-C24 A40-B3-C23 A29-B4-C23 A18-B1-C24 A7-B2-C24 A41-B3-C23 A30-B4-C23 A19-B1-C24 A8-B2-C24 A42-B3-C23 A31-B4-C23 A20-B1-C24 A9-B2-C24 A43-B3-C23 A32-B4-C23 A21-B1-C24 A10-B2-C24 A44-B3-C23 A33-B4-C23 A22-B1-C24 All-B2-C24 A45-B3-C23 A34-B4-C23 A23-B1-C24 A12-B2-C24 A46-B3-C23 A35-B4-C23 A24-B1-C24 A13-B2-C24 A47-B3-C23 A36-B4-C23 A25-B1-C24 A14-B2-C24 A48-B3-C23 A37-B4-C23 A26-B1-C24 A15-B2-C24 A49-B3-C23 A38-B4-C23 A27-B1-C24 A16-B2-C24 A50-B3-C23 A39-B4-C23 A28-B1-C24 A17-B2-C24 A51-B3-C23 A40-B4-C23 A29-B1-C24 A18-B2-C24 A52-B3-C23 A41-B4-C23 A30-B1-C24 A19-B2-C24 A53-B3-C23 A42-B4-C23 A31-B1-C24 A20-B2-C24 A54-B3-C23 A43-B4-C23 A32-B1-C24 A21-B2-C24 A55-B3-C23 A44-B4-C23 A33-B1-C24 A22-B2-C24 A56-B3-C23 A45-B4-C23 A34-B1-C24 A23-B2-C24 A57-B3-C23 A46-B4-C23 A35-B1-C24 A24-B2-C24 A58-B3-C23 A47-B4-C23 A36-B1-C24 A25-B2-C24 A59-B3-C23 A48-B4-C23 A37-B1-C24 A26-B2-C24 A60-B3-C23 A49-B4-C23 A38-B1-C24 A27-B2-C24 A61-B3-C23 A50-B4-C23 A39-B1-C24 A28-B2-C24 A62-B3-C23 A51-B4-C23 A40-B1-C24 A29-B2-C24 A63-B3-C23 A52-B4-C23 A41-B1-C24 A30-B2-C24 A64-B3-C23 A53-B4-C23 A42-B1-C24 A31-B2-C24 A65-B3-C23 A54-B4-C23 A43-B1-C24 A32-B2-C24 A66-B3-C23 A55-B4-C23 A44-B1-C24 A33-B2-C24 A67-B3-C23 A56-B4-C23 A45-B1-C24 A34-B2-C24 A68-B3-C23 A57-B4-C23 A46-B1-C24 A35-B2-C24 A36-B2-C24 A25-B3-C24 A14-B4-C24 A3-B1-C25 A37-B2-C24 A26-B3-C24 A15-B4-C24 A4-B1-C25 A38-B2-C24 A27-B3-C24 A16-B4-C24 A5-B1-C25 A39-B2-C24 A28-B3-C24 A17-B4-C24 A6-B1-C25 A40-B2-C24 A29-B3-C24 A18-B4-C24 A7-B1-C25 A41-B2-C24 A30-B3-C24 A19-B4-C24 A8-B1-C25 A42-B2-C24 A31-B3-C24 A20-B4-C24 A9-B1-C25 A43-B2-C24 A32-B3-C24 A21-B4-C24 A10-B1-C25 A44-B2-C24 A33-B3-C24 A22-B4-C24 A11-B1-C25 A45-B2-C24 A34-B3-C24 A23-B4-C24 A12-B1-C25 A46-B2-C24 A35-B3-C24 A24-B4-C24 A13-B1-C25 A47-B2-C24 A36-B3-C24 A25-B4-C24 A14-B1-C25 A48-B2-C24 A37-B3-C24 A26-B4-C24 A15-B1-C25 A49-B2-C24 A38-B3-C24 A27-B4-C24 A16-B1-C25 A50-B2-C24 A39-B3-C24 A28-B4-C24 A17-B1-C25 A51-B2-C24 A40-B3-C24 A29-B4-C24 A18-B1-C25 A52-B2-C24 A41-B3-C24 A30-B4-C24 A19-B1-C25 A53-B2-C24 A42-B3-C24 A31-B4-C24 A20-B1-C25 A54-B2-C24 A43-B3-C24 A32-B4-C24 A21-B1-C25 A55-B2-C24 A44-B3-C24 A33-B4-C24 A22-B1-C25 A56-B2-C24 A45-B3-C24 A34-B4-C24 A23-B1-C25 A57-B2-C24 A46-B3-C24 A35-B4-C24 A24-B1-C25 A58-B2-C24 A47-B3-C24 A36-B4-C24 A25-B1-C25 A59-B2-C24 A48-B3-C24 A37-B4-C24 A26-B1-C25 A60-B2-C24 A49-B3-C24 A38-B4-C24 A27-B1-C25 A61-B2-C24 A50-B3-C24 A39-B4-C24 A28-B1-C25 A62-B2-C24 A51-B3-C24 A40-B4-C24 A29-B1-C25 A63-B2-C24 A52-B3-C24 A41-B4-C24 A30-B1-C25 A64-B2-C24 A53-B3-C24 A42-B4-C24 A31-B1-C25 A65-B2-C24 A54-B3-C24 A43-B4-C24 A32-B1-C25 A66-B2-C24 A55-B3-C24 A44-B4-C24 A33-B1-C25 A67-B2-C24 A56-B3-C24 A45-B4-C24 A34-B1-C25 A68-B2-C24 A57-B3-C24 A46-B4-C24 A35-B1-C25 A69-B2-C24 A58-B3-C24 A47-B4-C24 A36-B1-C25 A70-B2-C24 A59-B3-C24 A48-B4-C24 A37-B1-C25 A71-B2-C24 A60-B3-C24 A49-B4-C24 A38-B1-C25 A72-B2-C24 A61-B3-C24 A50-B4-C24 A39-B1-C25 A73-B2-C24 A62-B3-C24 A51-B4-C24 A40-B1-C25 A74-B2-C24 A63-B3-C24 A52-B4-C24 A41-B1-C25 A75-B2-C24 A64-B3-C24 A53-B4-C24 A42-B1-C25 A76-B2-C24 A65-B3-C24 A54-B4-C24 A43-B1-C25 A77-B2-C24 A66-B3-C24 A55-B4-C24 A44-B1-C25 A1-B3-C24 A67-B3-C24 A56-B4-C24 A45-B1-C25 A2-B3-C24 A68-B3-C24 A57-B4-C24 A46-B1-C25 A3-B3-C24 A69-B3-C24 A58-B4-C24 A47-B1-C25 A4-B3-C24 A70-B3-C24 A59-B4-C24 A48-B1-C25 A5-B3-C24 A71-B3-C24 A60-B4-C24 A49-B1-C25 A6-B3-C24 A72-B3-C24 A61-B4-C24 A50-B1-C25 A7-B3-C24 A73-B3-C24 A62-B4-C24 A51-B1-C25 A8-B3-C24 A74-B3-C24 A63-B4-C24 A52-B1-C25 A9-B3-C24 A75-B3-C24 A64-B4-C24 A53-B1-C25 A10-B3-C24 A76-B3-C24 A65-B4-C24 A54-B1-C25 A11-B3-C24 A77-B3-C24 A66-B4-C24 A55-B1-C25 A12-B3-C24 A1-B4-C24 A67-B4-C24 A56-B1-C25 A13-B3-C24 A2-B4-C24 A68-B4-C24 A57-B1-C25 A14-B3-C24 A3-B4-C24 A69-B4-C24 A58-B1-C25 A15-B3-C24 A4-B4-C24 A70-B4-C24 A59-B1-C25 A16-B3-C24 A5-B4-C24 A71-B4-C24 A60-B1-C25 A17-B3-C24 A6-B4-C24 A72-B4-C24 A61-B1-C25 A18-B3-C24 A7-B4-C24 A73-B4-C24 A62-B1-C25 A19-B3-C24 A8-B4-C24 A74-B4-C24 A63-B1-C25 A20-B3-C24 A9-B4-C24 A75-B4-C24 A64-B1-C25 A21-B3-C24 A10-B4-C24 A76-B4-C24 A65-B1-C25 A22-B3-C24 A11-B4-C24 A77-B4-C24 A66-B1-C25 A23-B3-C24 A12-B4-C24 A1-B1-C25 A67-B1-C25 A24-B3-C24 A13-B4-C24 A2-B1-C25 A68-B1-C25 A69-B1-C25 A58-B2-C25 A47-B3-C25 A36-B4-C25 A70-B1-C25 A59-B2-C25 A48-B3-C25 A37-B4-C25 A71-B1-C25 A60-B2-C25 A49-B3-C25 A38-B4-C25 A72-B1-C25 A61-B2-C25 A50-B3-C25 A39-B4-C25 A73-B1-C25 A62-B2-C25 A51-B3-C25 A40-B4-C25 A74-B1-C25 A63-B2-C25 A52-B3-C25 A41-B4-C25 A75-B1-C25 A64-B2-C25 A53-B3-C25 A42-B4-C25 A76-B1-C25 A65-B2-C25 A54-B3-C25 A43-B4-C25 A77-B1-C25 A66-B2-C25 A55-B3-C25 A44-B4-C25 A1-B2-C25 A67-B2-C25 A56-B3-C25 A45-B4-C25 A2-B2-C25 A68-B2-C25 A57-B3-C25 A46-B4-C25 A3-B2-C25 A69-B2-C25 A58-B3-C25 A47-B4-C25 A4-B2-C25 A70-B2-C25 A59-B3-C25 A48-B4-C25 A5-B2-C25 A71-B2-C25 A60-B3-C25 A49-B4-C25 A6-B2-C25 A72-B2-C25 A61-B3-C25 A50-B4-C25 A7-B2-C25 A73-B2-C25 A62-B3-C25 A51-B4-C25 A8-B2-C25 A74-B2-C25 A63-B3-C25 A52-B4-C25 A9-B2-C25 A75-B2-C25 A64-B3-C25 A53-B4-C25 A10-B2-C25 A76-B2-C25 A65-B3-C25 A54-B4-C25 A11-B2-C25 A77-B2-C25 A66-B3-C25 A55-B4-C25 A12-B2-C25 A1-B3-C25 A67-B3-C25 A56-B4-C25 A13-B2-C25 A2-B3-C25 A68-B3-C25 A57-B4-C25 A14-B2-C25 A3-B3-C25 A69-B3-C25 A58-B4-C25 A15-B2-C25 A4-B3-C25 A70-B3-C25 A59-B4-C25 A16-B2-C25 A5-B3-C25 A71-B3-C25 A60-B4-C25 A17-B2-C25 A6-B3-C25 A72-B3-C25 A61-B4-C25 A18-B2-C25 A7-B3-C25 A73-B3-C25 A62-B4-C25 A19-B2-C25 A8-B3-C25 A74-B3-C25 A63-B4-C25 A20-B2-C25 A9-B3-C25 A75-B3-C25 A64-B4-C25 A21-B2-C25 A10-B3-C25 A76-B3-C25 A65-B4-C25 A22-B2-C25 A11-B3-C25 A77-B3-C25 A66-B4-C25 A23-B2-C25 A12-B3-C25 A1-B4-C25 A67-B4-C25 A24-B2-C25 A13-B3-C25 A2-B4-C25 A68-B4-C25 A25-B2-C25 A14-B3-C25 A3-B4-C25 A69-B4-C25 A26-B2-C25 A15-B3-C25 A4-B4-C25 A70-B4-C25 A27-B2-C25 A16-B3-C25 A5-B4-C25 A71-B4-C25 A28-B2-C25 A17-B3-C25 A6-B4-C25 A72-B4-C25 A29-B2-C25 A18-B3-C25 A7-B4-C25 A73-B4-C25 A30-B2-C25 A19-B3-C25 A8-B4-C25 A74-B4-C25 A31-B2-C25 A20-B3-C25 A9-B4-C25 A75-B4-C25 A32-B2-C25 A21-B3-C25 A10-B4-C25 A76-B4-C25 A33-B2-C25 A22-B3-C25 A11-B4-C25 A77-B4-C25 A34-B2-C25 A23-B3-C25 A12-B4-C25 A1-B1-C26 A35-B2-C25 A24-B3-C25 A13-B4-C25 A2-B1-C26 A36-B2-C25 A25-B3-C25 A14-B4-C25 A3-B1-C26 A37-B2-C25 A26-B3-C25 A15-B4-C25 A4-B1-C26 A38-B2-C25 A27-B3-C25 A16-B4-C25 A5-B1-C26 A39-B2-C25 A28-B3-C25 A17-B4-C25 A6-B1-C26 A40-B2-C25 A29-B3-C25 A18-B4-C25 A7-B1-C26 A41-B2-C25 A30-B3-C25 A19-B4-C25 A8-B1-C26 A42-B2-C25 A31-B3-C25 A20-B4-C25 A9-B1-C26 A43-B2-C25 A32-B3-C25 A21-B4-C25 A10-B1-C26 A44-B2-C25 A33-B3-C25 A22-B4-C25 A11-B1-C26 A45-B2-C25 A34-B3-C25 A23-B4-C25 A12-B1-C26 A46-B2-C25 A35-B3-C25 A24-B4-C25 A13-B1-C26 A47-B2-C25 A36-B3-C25 A25-B4-C25 A14-B1-C26 A48-B2-C25 A37-B3-C25 A26-B4-C25 A15-B1-C26 A49-B2-C25 A38-B3-C25 A27-B4-C25 A16-B1-C26 A50-B2-C25 A39-B3-C25 A28-B4-C25 A17-B1-C26 A51-B2-C25 A40-B3-C25 A29-B4-C25 A18-B1-C26 A52-B2-C25 A41-B3-C25 A30-B4-C25 A19-B1-C26 A53-B2-C25 A42-B3-C25 A31-B4-C25 A20-B1-C26 A54-B2-C25 A43-B3-C25 A32-B4-C25 A21-B1-C26 A55-B2-C25 A44-B3-C25 A33-B4-C25 A22-B1-C26 A56-B2-C25 A45-B3-C25 A34-B4-C25 A23-B1-C26 A57-B2-C25 A46-B3-C25 A35-B4-C25 A24-B1-C26 A25-B1-C26 A14-B2-C26 A3-B3-C26 A69-B3-C26 A26-B1-C26 A15-B2-C26 A4-B3-C26 A70-B3-C26 A27-B1-C26 A16-B2-C26 A5-B3-C26 A71-B3-C26 A28-B1-C26 A17-B2-C26 A6-B3-C26 A72-B3-C26 A29-B1-C26 A18-B2-C26 A7-B3-C26 A73-B3-C26 A30-B1-C26 A19-B2-C26 A8-B3-C26 A74-B3-C26 A31-B1-C26 A20-B2-C26 A9-B3-C26 A75-B3-C26 A32-B1-C26 A21-B2-C26 A10-B3-C26 A76-B3-C26 A33-B1-C26 A22-B2-C26 A11-B3-C26 A77-B3-C26 A34-B1-C26 A23-B2-C26 A12-B3-C26 A1-B4-C26 A35-B1-C26 A24-B2-C26 A13-B3-C26 A2-B4-C26 A36-B1-C26 A25-B2-C26 A14-B3-C26 A3-B4-C26 A37-B1-C26 A26-B2-C26 A15-B3-C26 A4-B4-C26 A38-B1-C26 A27-B2-C26 A16-B3-C26 A5-B4-C26 A39-B1-C26 A28-B2-C26 A17-B3-C26 A6-B4-C26 A40-B1-C26 A29-B2-C26 A18-B3-C26 A7-B4-C26 A41-B1-C26 A30-B2-C26 A19-B3-C26 A8-B4-C26 A42-B1-C26 A31-B2-C26 A20-B3-C26 A9-B4-C26 A43-B1-C26 A32-B2-C26 A21-B3-C26 A10-B4-C26 A44-B1-C26 A33-B2-C26 A22-B3-C26 A11-B4-C26 A45-B1-C26 A34-B2-C26 A23-B3-C26 A12-B4-C26 A46-B1-C26 A35-B2-C26 A24-B3-C26 A13-B4-C26 A47-B1-C26 A36-B2-C26 A25-B3-C26 A14-B4-C26 A48-B1-C26 A37-B2-C26 A26-B3-C26 A15-B4-C26 A49-B1-C26 A38-B2-C26 A27-B3-C26 A16-B4-C26 A50-B1-C26 A39-B2-C26 A28-B3-C26 A17-B4-C26 A51-B1-C26 A40-B2-C26 A29-B3-C26 A18-B4-C26 A52-B1-C26 A41-B2-C26 A30-B3-C26 A19-B4-C26 A53-B1-C26 A42-B2-C26 A31-B3-C26 A20-B4-C26 A54-B1-C26 A43-B2-C26 A32-B3-C26 A21-B4-C26 A55-B1-C26 A44-B2-C26 A33-B3-C26 A22-B4-C26 A56-B1-C26 A45-B2-C26 A34-B3-C26 A23-B4-C26 A57-B1-C26 A46-B2-C26 A35-B3-C26 A24-B4-C26 A58-B1-C26 A47-B2-C26 A36-B3-C26 A25-B4-C26 A59-B1-C26 A48-B2-C26 A37-B3-C26 A26-B4-C26 A60-B1-C26 A49-B2-C26 A38-B3-C26 A27-B4-C26 A61-B1-C26 A50-B2-C26 A39-B3-C26 A28-B4-C26 A62-B1-C26 A51-B2-C26 A40-B3-C26 A29-B4-C26 A63-B1-C26 A52-B2-C26 A41-B3-C26 A30-B4-C26 A64-B1-C26 A53-B2-C26 A42-B3-C26 A31-B4-C26 A65-B1-C26 A54-B2-C26 A43-B3-C26 A32-B4-C26 A66-B1-C26 A55-B2-C26 A44-B3-C26 A33-B4-C26 A67-B1-C26 A56-B2-C26 A45-B3-C26 A34-B4-C26 A68-B1-C26 A57-B2-C26 A46-B3-C26 A35-B4-C26 A69-B1-C26 A58-B2-C26 A47-B3-C26 A36-B4-C26 A70-B1-C26 A59-B2-C26 A48-B3-C26 A37-B4-C26 A71-B1-C26 A60-B2-C26 A49-B3-C26 A38-B4-C26 A72-B1-C26 A61-B2-C26 A50-B3-C26 A39-B4-C26 A73-B1-C26 A62-B2-C26 A51-B3-C26 A40-B4-C26 A74-B1-C26 A63-B2-C26 A52-B3-C26 A41-B4-C26 A75-B1-C26 A64-B2-C26 A53-B3-C26 A42-B4-C26 A76-B1-C26 A65-B2-C26 A54-B3-C26 A43-B4-C26 A77-B1-C26 A66-B2-C26 A55-B3-C26 A44-B4-C26 A1-B2-C26 A67-B2-C26 A56-B3-C26 A45-B4-C26 A2-B2-C26 A68-B2-C26 A57-B3-C26 A46-B4-C26 A3-B2-C26 A69-B2-C26 A58-B3-C26 A47-B4-C26 A4-B2-C26 A70-B2-C26 A59-B3-C26 A48-B4-C26 A5-B2-C26 A71-B2-C26 A60-B3-C26 A49-B4-C26 A6-B2-C26 A72-B2-C26 A61-B3-C26 A50-B4-C26 A7-B2-C26 A73-B2-C26 A62-B3-C26 A51-B4-C26 A8-B2-C26 A74-B2-C26 A63-B3-C26 A52-B4-C26 A9-B2-C26 A75-B2-C26 A64-B3-C26 A53-B4-C26 A10-B2-C26 A76-B2-C26 A65-B3-C26 A54-B4-C26 A11-B2-C26 A77-B2-C26 A66-B3-C26 A55-B4-C26 A12-B2-C26 A1-B3-C26 A67-B3-C26 A56-B4-C26 A13-B2-C26 A2-B3-C26 A68-B3-C26 A57-B4-C26 A58-B4-C26 A47-B1-C27 A36-B2-C27 A25-B3-C27 A59-B4-C26 A48-B1-C27 A37-B2-C27 A26-B3-C27 A60-B4-C26 A49-B1-C27 A38-B2-C27 A27-B3-C27 A61-B4-C26 A50-B1-C27 A39-B2-C27 A28-B3-C27 A62-B4-C26 A51-B1-C27 A40-B2-C27 A29-B3-C27 A63-B4-C26 A52-B1-C27 A41-B2-C27 A30-B3-C27 A64-B4-C26 A53-B1-C27 A42-B2-C27 A31-B3-C27 A65-B4-C26 A54-B1-C27 A43-B2-C27 A32-B3-C27 A66-B4-C26 A55-B1-C27 A44-B2-C27 A33-B3-C27 A67-B4-C26 A56-B1-C27 A45-B2-C27 A34-B3-C27 A68-B4-C26 A57-B1-C27 A46-B2-C27 A35-B3-C27 A69-B4-C26 A58-B1-C27 A47-B2-C27 A36-B3-C27 A70-B4-C26 A59-B1-C27 A48-B2-C27 A37-B3-C27 A71-B4-C26 A60-B1-C27 A49-B2-C27 A38-B3-C27 A72-B4-C26 A61-B1-C27 A50-B2-C27 A39-B3-C27 A73-B4-C26 A62-B1-C27 A51-B2-C27 A40-B3-C27 A74-B4-C26 A63-B1-C27 A52-B2-C27 A41-B3-C27 A75-B4-C26 A64-B1-C27 A53-B2-C27 A42-B3-C27 A76-B4-C26 A65-B1-C27 A54-B2-C27 A43-B3-C27 A77-B4-C26 A66-B1-C27 A55-B2-C27 A44-B3-C27 A1-B1-C27 A67-B1-C27 A56-B2-C27 A45-B3-C27 A2-B1-C27 A68-B1-C27 A57-B2-C27 A46-B3-C27 A3-B1-C27 A69-B1-C27 A58-B2-C27 A47-B3-C27 A4-B1-C27 A70-B1-C27 A59-B2-C27 A48-B3-C27 A5-B1-C27 A71-B1-C27 A60-B2-C27 A49-B3-C27 A6-B1-C27 A72-B1-C27 A61-B2-C27 A50-B3-C27 A7-B1-C27 A73-B1-C27 A62-B2-C27 A51-B3-C27 A8-B1-C27 A74-B1-C27 A63-B2-C27 A52-B3-C27 A9-B1-C27 A75-B1-C27 A64-B2-C27 A53-B3-C27 A10-B1-C27 A76-B1-C27 A65-B2-C27 A54-B3-C27 A11-B1-C27 A77-B1-C27 A66-B2-C27 A55-B3-C27 A12-B1-C27 A1-B2-C27 A67-B2-C27 A56-B3-C27 A13-B1-C27 A2-B2-C27 A68-B2-C27 A57-B3-C27 A14-B1-C27 A3-B2-C27 A69-B2-C27 A58-B3-C27 A15-B1-C27 A4-B2-C27 A70-B2-C27 A59-B3-C27 A16-B1-C27 A5-B2-C27 A71-B2-C27 A60-B3-C27 A17-B1-C27 A6-B2-C27 A72-B2-C27 A61-B3-C27 A18-B1-C27 A7-B2-C27 A73-B2-C27 A62-B3-C27 A19-B1-C27 A8-B2-C27 A74-B2-C27 A63-B3-C27 A20-B1-C27 A9-B2-C27 A75-B2-C27 A64-B3-C27 A21-B1-C27 A10-B2-C27 A76-B2-C27 A65-B3-C27 A22-B1-C27 A11-B2-C27 A77-B2-C27 A66-B3-C27 A23-B1-C27 A12-B2-C27 A1-B3-C27 A67-B3-C27 A24-B1-C27 A13-B2-C27 A2-B3-C27 A68-B3-C27 A25-B1-C27 A14-B2-C27 A3-B3-C27 A69-B3-C27 A26-B1-C27 A15-B2-C27 A4-B3-C27 A70-B3-C27 A27-B1-C27 A16-B2-C27 A5-B3-C27 A71-B3-C27 A28-B1-C27 A17-B2-C27 A6-B3-C27 A72-B3-C27 A29-B1-C27 A18-B2-C27 A7-B3-C27 A73-B3-C27 A30-B1-C27 A19-B2-C27 A8-B3-C27 A74-B3-C27 A31-B1-C27 A20-B2-C27 A9-B3-C27 A75-B3-C27 A32-B1-C27 A21-B2-C27 A10-B3-C27 A76-B3-C27 A33-B1-C27 A22-B2-C27 A11-B3-C27 A77-B3-C27 A34-B1-C27 A23-B2-C27 A12-B3-C27 A1-B4-C27 A35-B1-C27 A24-B2-C27 A13-B3-C27 A2-B4-C27 A36-B1-C27 A25-B2-C27 A14-B3-C27 A3-B4-C27 A37-B1-C27 A26-B2-C27 A15-B3-C27 A4-B4-C27 A38-B1-C27 A27-B2-C27 A16-B3-C27 A5-B4-C27 A39-B1-C27 A28-B2-C27 A17-B3-C27 A6-B4-C27 A40-B1-C27 A29-B2-C27 A18-B3-C27 A7-B4-C27 A41-B1-C27 A30-B2-C27 A19-B3-C27 A8-B4-C27 A42-B1-C27 A31-B2-C27 A20-B3-C27 A9-B4-C27 A43-B1-C27 A32-B2-C27 A21-B3-C27 A10-B4-C27 A44-B1-C27 A33-B2-C27 A22-B3-C27 A11-B4-C27 A45-B1-C27 A34-B2-C27 A23-B3-C27 A12-B4-C27 A46-B1-C27 A35-B2-C27 A24-B3-C27 A13-B4-C27 A14-B4-C27 A3-B1-C28 A69-B1-C28 A58-B2-C28 A15-B4-C27 A4-B1-C28 A70-B1-C28 A59-B2-C28 A16-B4-C27 A5-B1-C28 A71-B1-C28 A60-B2-C28 A17-B4-C27 A6-B1-C28 A72-B1-C28 A61-B2-C28 A18-B4-C27 A7-B1-C28 A73-B1-C28 A62-B2-C28 A19-B4-C27 A8-B1-C28 A74-B1-C28 A63-B2-C28 A20-B4-C27 A9-B1-C28 A75-B1-C28 A64-B2-C28 A21-B4-C27 A10-B1-C28 A76-B1-C28 A65-B2-C28 A22-B4-C27 A1l-B1-C28 A77-B1-C28 A66-B2-C28 A23-B4-C27 A12-B1-C28 A1-B2-C28 A67-B2-C28 A24-B4-C27 A13-B1-C28 A2-B2-C28 A68-B2-C28 A25-B4-C27 A14-B1-C28 A3-B2-C28 A69-B2-C28 A26-B4-C27 A15-B1-C28 A4-B2-C28 A70-B2-C28 A27-B4-C27 A16-B1-C28 A5-B2-C28 A71-B2-C28 A28-B4-C27 A17-B1-C28 A6-B2-C28 A72-B2-C28 A29-B4-C27 A18-B1-C28 A7-B2-C28 A73-B2-C28 A30-B4-C27 A19-B1-C28 A8-B2-C28 A74-B2-C28 A31-B4-C27 A20-B1-C28 A9-B2-C28 A75-B2-C28 A32-B4-C27 A21-B1-C28 A10-B2-C28 A76-B2-C28 A33-B4-C27 A22-B1-C28 A11-B2-C28 A77-B2-C28 A34-B4-C27 A23-B1-C28 A12-B2-C28 A1-B3-C28 A35-B4-C27 A24-B1-C28 A13-B2-C28 A2-B3-C28 A36-B4-C27 A25-B1-C28 A14-B2-C28 A3-B3-C28 A37-B4-C27 A26-B1-C28 A15-B2-C28 A4-B3-C28 A38-B4-C27 A27-B1-C28 A16-B2-C28 A5-B3-C28 A39-B4-C27 A28-B1-C28 A17-B2-C28 A6-B3-C28 A40-B4-C27 A29-B1-C28 A18-B2-C28 A7-B3-C28 A41-B4-C27 A30-B1-C28 A19-B2-C28 A8-B3-C28 A42-B4-C27 A31-B1-C28 A20-B2-C28 A9-B3-C28 A43-B4-C27 A32-B1-C28 A21-B2-C28 A10-B3-C28 A44-B4-C27 A33-B1-C28 A22-B2-C28 A11-B3-C28 A45-B4-C27 A34-B1-C28 A23-B2-C28 A12-B3-C28 A46-B4-C27 A35-B1-C28 A24-B2-C28 A13-B3-C28 A47-B4-C27 A36-B1-C28 A25-B2-C28 A14-B3-C28 A48-B4-C27 A37-B1-C28 A26-B2-C28 A15-B3-C28 A49-B4-C27 A38-B1-C28 A27-B2-C28 A16-B3-C28 A50-B4-C27 A39-B1-C28 A28-B2-C28 A17-B3-C28 A51-B4-C27 A40-B1-C28 A29-B2-C28 A18-B3-C28 A52-B4-C27 A41-B1-C28 A30-B2-C28 A19-B3-C28 A53-B4-C27 A42-B1-C28 A31-B2-C28 A20-B3-C28 A54-B4-C27 A43-B1-C28 A32-B2-C28 A21-B3-C28 A55-B4-C27 A44-B1-C28 A33-B2-C28 A22-B3-C28 A56-B4-C27 A45-B1-C28 A34-B2-C28 A23-B3-C28 A57-B4-C27 A46-B1-C28 A35-B2-C28 A24-B3-C28 A58-B4-C27 A47-B1-C28 A36-B2-C28 A25-B3-C28 A59-B4-C27 A48-B1-C28 A37-B2-C28 A26-B3-C28 A60-B4-C27 A49-B1-C28 A38-B2-C28 A27-B3-C28 A61-B4-C27 A50-B1-C28 A39-B2-C28 A28-B3-C28 A62-B4-C27 A51-B1-C28 A40-B2-C28 A29-B3-C28 A63-B4-C27 A52-B1-C28 A41-B2-C28 A30-B3-C28 A64-B4-C27 A53-B1-C28 A42-B2-C28 A31-B3-C28 A65-B4-C27 A54-B1-C28 A43-B2-C28 A32-B3-C28 A66-B4-C27 A55-B1-C28 A44-B2-C28 A33-B3-C28 A67-B4-C27 A56-B1-C28 A45-B2-C28 A34-B3-C28 A68-B4-C27 A57-B1-C28 A46-B2-C28 A35-B3-C28 A69-B4-C27 A58-B1-C28 A47-B2-C28 A36-B3-C28 A70-B4-C27 A59-B1-C28 A48-B2-C28 A37-B3-C28 A71-B4-C27 A60-B1-C28 A49-B2-C28 A38-B3-C28 A72-B4-C27 A61-B1-C28 A50-B2-C28 A39-B3-C28 A73-B4-C27 A62-B1-C28 A51-B2-C28 A40-B3-C28 A74-B4-C27 A63-B1-C28 A52-B2-C28 A41-B3-C28 A75-B4-C27 A64-B1-C28 A53-B2-C28 A42-B3-C28 A76-B4-C27 A65-B1-C28 A54-B2-C28 A43-B3-C28 A77-B4-C27 A66-B1-C28 A55-B2-C28 A44-B3-C28 A1-B1-C28 A67-B1-C28 A56-B2-C28 A45-B3-C28 A2-B1-C28 A68-B1-C28 A57-B2-C28 A46-B3-C28 A47-B3-C28 A36-B4-C28 A25-B1-C29 A14-B2-C29 A48-B3-C28 A37-B4-C28 A26-B1-C29 A15-B2-C29 A49-B3-C28 A38-B4-C28 A27-B1-C29 A16-B2-C29 A50-B3-C28 A39-B4-C28 A28-B1-C29 A17-B2-C29 A51-B3-C28 A40-B4-C28 A29-B1-C29 A18-B2-C29 A52-B3-C28 A41-B4-C28 A30-B1-C29 A19-B2-C29 A53-B3-C28 A42-B4-C28 A31-B1-C29 A20-B2-C29 A54-B3-C28 A43-B4-C28 A32-B1-C29 A21-B2-C29 A55-B3-C28 A44-B4-C28 A33-B1-C29 A22-B2-C29 A56-B3-C28 A45-B4-C28 A34-B1-C29 A23-B2-C29 A57-B3-C28 A46-B4-C28 A35-B1-C29 A24-B2-C29 A58-B3-C28 A47-B4-C28 A36-B1-C29 A25-B2-C29 A59-B3-C28 A48-B4-C28 A37-B1-C29 A26-B2-C29 A60-B3-C28 A49-B4-C28 A38-B1-C29 A27-B2-C29 A61-B3-C28 A50-B4-C28 A39-B1-C29 A28-B2-C29 A62-B3-C28 A51-B4-C28 A40-B1-C29 A29-B2-C29 A63-B3-C28 A52-B4-C28 A41-B1-C29 A30-B2-C29 A64-B3-C28 A53-B4-C28 A42-B1-C29 A31-B2-C29 A65-B3-C28 A54-B4-C28 A43-B1-C29 A32-B2-C29 A66-B3-C28 A55-B4-C28 A44-B1-C29 A33-B2-C29 A67-B3-C28 A56-B4-C28 A45-B1-C29 A34-B2-C29 A68-B3-C28 A57-B4-C28 A46-B1-C29 A35-B2-C29 A69-B3-C28 A58-B4-C28 A47-B1-C29 A36-B2-C29 A70-B3-C28 A59-B4-C28 A48-B1-C29 A37-B2-C29 A71-B3-C28 A60-B4-C28 A49-B1-C29 A38-B2-C29 A72-B3-C28 A61-B4-C28 A50-B1-C29 A39-B2-C29 A73-B3-C28 A62-B4-C28 A51-B1-C29 A40-B2-C29 A74-B3-C28 A63-B4-C28 A52-B1-C29 A41-B2-C29 A75-B3-C28 A64-B4-C28 A53-B1-C29 A42-B2-C29 A76-B3-C28 A65-B4-C28 A54-B1-C29 A43-B2-C29 A77-B3-C28 A66-B4-C28 A55-B1-C29 A44-B2-C29 A1-B4-C28 A67-B4-C28 A56-B1-C29 A45-B2-C29 A2-B4-C28 A68-B4-C28 A57-B1-C29 A46-B2-C29 A3-B4-C28 A69-B4-C28 A58-B1-C29 A47-B2-C29 A4-B4-C28 A70-B4-C28 A59-B1-C29 A48-B2-C29 A5-B4-C28 A71-B4-C28 A60-B1-C29 A49-B2-C29 A6-B4-C28 A72-B4-C28 A61-B1-C29 A50-B2-C29 A7-B4-C28 A73-B4-C28 A62-B1-C29 A51-B2-C29 A8-B4-C28 A74-B4-C28 A63-B1-C29 A52-B2-C29 A9-B4-C28 A75-B4-C28 A64-B1-C29 A53-B2-C29 A10-B4-C28 A76-B4-C28 A65-B1-C29 A54-B2-C29 A11-B4-C28 A77-B4-C28 A66-B1-C29 A55-B2-C29 A12-B4-C28 A1-B1-C29 A67-B1-C29 A56-B2-C29 A13-B4-C28 A2-B1-C29 A68-B1-C29 A57-B2-C29 A14-B4-C28 A3-B1-C29 A69-B1-C29 A58-B2-C29 A15-B4-C28 A4-B1-C29 A70-B1-C29 A59-B2-C29 A16-B4-C28 A5-B1-C29 A71-B1-C29 A60-B2-C29 A17-B4-C28 A6-B1-C29 A72-B1-C29 A61-B2-C29 A18-B4-C28 A7-B1-C29 A73-B1-C29 A62-B2-C29 A19-B4-C28 A8-B1-C29 A74-B1-C29 A63-B2-C29 A20-B4-C28 A9-B1-C29 A75-B1-C29 A64-B2-C29 A21-B4-C28 A10-B1-C29 A76-B1-C29 A65-B2-C29 A22-B4-C28 A11-B1-C29 A77-B1-C29 A66-B2-C29 A23-B4-C28 A12-B1-C29 A1-B2-C29 A67-B2-C29 A24-B4-C28 A13-B1-C29 A2-B2-C29 A68-B2-C29 A25-B4-C28 A14-B1-C29 A3-B2-C29 A69-B2-C29 A26-B4-C28 A15-B1-C29 A4-B2-C29 A70-B2-C29 A27-B4-C28 A16-B1-C29 A5-B2-C29 A71-B2-C29 A28-B4-C28 A17-B1-C29 A6-B2-C29 A72-B2-C29 A29-B4-C28 A18-B1-C29 A7-B2-C29 A73-B2-C29 A30-B4-C28 A19-B1-C29 A8-B2-C29 A74-B2-C29 A31-B4-C28 A20-B1-C29 A9-B2-C29 A75-B2-C29 A32-B4-C28 A21-B1-C29 A10-B2-C29 A76-B2-C29 A33-B4-C28 A22-B1-C29 A11-B2-C29 A77-B2-C29 A34-B4-C28 A23-B1-C29 A12-B2-C29 A1-B3-C29 A35-B4-C28 A24-B1-C29 A13-B2-C29 A2-B3-C29 A3-B3-C29 A69-B3-C29 A58-B4-C29 A47-B1-C30 A4-B3-C29 A70-B3-C29 A59-B4-C29 A48-B1-C30 A5-B3-C29 A71-B3-C29 A60-B4-C29 A49-B1-C30 A6-B3-C29 A72-B3-C29 A61-B4-C29 A50-B1-C30 A7-B3-C29 A73-B3-C29 A62-B4-C29 A51-B1-C30 A8-B3-C29 A74-B3-C29 A63-B4-C29 A52-B1-C30 A9-B3-C29 A75-B3-C29 A64-B4-C29 A53-B1-C30 A10-B3-C29 A76-B3-C29 A65-B4-C29 A54-B1-C30 A11-B3-C29 A77-B3-C29 A66-B4-C29. A55-B1-C30 A12-B3-C29 A1-B4-C29 A67-B4-C29 A56-B1-C30 A13-B3-C29 A2-B4-C29 A68-B4-C29 A57-B1-C30 A14-B3-C29 A3-B4-C29 A69-B4-C29 A58-B1-C30 A15-B3-C29 A4-B4-C29 A70-B4-C29 A59-B1-C30 A16-B3-C29 A5-B4-C29 A71-B4-C29 A60-B1-C30 A17-B3-C29 A6-B4-C29 A72-B4-C29 A61-B1-C30 A18-B3-C29 A7-B4-C29 A73-B4-C29 A62-B1-C30 A19-B3-C29 A8-B4-C29 A74-B4-C29 A63-B1-C30 A20-B3-C29 A9-B4-C29 A75-B4-C29 A64-B1-C30 A21-B3-C29 A10-B4-C29 A76-B4-C29 A65-B1-C30 A22-B3-C29 A11-B4-C29 A77-B4-C29 A66-B1-C30 A23-B3-C29 A12-B4-C29 A1-B1-C30 A67-B1-C30 A24-B3-C29 A13-B4-C29 A2-B1-C30 A68-B1-C30 A25-B3-C29 A14-B4-C29 A3-B1-C30 A69-B1-C30 A26-B3-C29 A15-B4-C29 A4-B1-C30 A70-B1-C30 A27-B3-C29 A16-B4-C29 A5-B1-C30 A71-B1-C30 A28-B3-C29 A17-B4-C29 A6-B1-C30 A72-B1-C30 A29-B3-C29 A18-B4-C29 A7-B1-C30 A73-B1-C30 A30-B3-C29 A19-B4-C29 A8-B1-C30 A74-B1-C30 A31-B3-C29 A20-B4-C29 A9-B1-C30 A75-B1-C30 A32-B3-C29 A21-B4-C29 A10-B1-C30 A76-B1-C30 A33-B3-C29 A22-B4-C29 A11-B1-C30 A77-B1-C30 A34-B3-C29 A23-B4-C29 A12-B1-C30 A1-B2-C30 A35-B3-C29 A24-B4-C29 A13-B1-C30 A2-B2-C30 A36-B3-C29 A25-B4-C29 A14-B1-C30 A3-B2-C30 A37-B3-C29 A26-B4-C29 A15-B1-C30 A4-B2-C30 A38-B3-C29 A27-B4-C29 A16-B1-C30 A5-B2-C30 A39-B3-C29 A28-B4-C29 A17-B1-C30 A6-B2-C30 A40-B3-C29 A29-B4-C29 A18-B1-C30 A7-B2-C30 A41-B3-C29 A30-B4-C29 A19-B1-C30 A8-B2-C30 A42-B3-C29 A31-B4-C29 A20-B1-C30 A9-B2-C30 A43-B3-C29 A32-B4-C29 A21-B1-C30 A10-B2-C30 A44-B3-C29 A33-B4-C29 A22-B1-C30 A11-B2-C30 A45-B3-C29 A34-B4-C29 A23-B1-C30 A12-B2-C30 A46-B3-C29 A35-B4-C29 A24-B1-C30 A13-B2-C30 A47-B3-C29 A36-B4-C29 A25-B1-C30 A14-B2-C30 A48-B3-C29 A37-B4-C29 A26-B1-C30 A15-B2-C30 A49-B3-C29 A38-B4-C29 A27-B1-C30 A16-B2-C30 A50-B3-C29 A39-B4-C29 A28-B1-C30 A17-B2-C30 A51-B3-C29 A40-B4-C29 A29-B1-C30 A18-B2-C30 A52-B3-C29 A41-B4-C29 A30-B1-C30 A19-B2-C30 A53-B3-C29 A42-B4-C29 A31-B1-C30 A20-B2-C30 A54-B3-C29 A43-B4-C29 A32-B1-C30 A21-B2-C30 A55-B3-C29 A44-B4-C29 A33-B1-C30 A22-B2-C30 A56-B3-C29 A45-B4-C29 A34-B1-C30 A23-B2-C30 A57-B3-C29 A46-B4-C29 A35-B1-C30 A24-B2-C30 A58-B3-C29 A47-B4-C29 A36-B1-C30 A25-B2-C30 A59-B3-C29 A48-B4-C29 A37-B1-C30 A26-B2-C30 A60-B3-C29 A49-B4-C29 A38-B1-C30 A27-B2-C30 A61-B3-C29 A50-B4-C29 A39-B1-C30 A28-B2-C30 A62-B3-C29 A51-B4-C29 A40-B1-C30 A29-B2-C30 A63-B3-C29 A52-B4-C29 A41-B1-C30 A30-B2-C30 A64-B3-C29 A53-B4-C29 A42-B1-C30 A31-B2-C30 A65-B3-C29 A54-B4-C29 A43-B1-C30 A32-B2-C30 A66-B3-C29 A55-B4-C29 A44-B1-C30 A33-B2-C30 A67-B3-C29 A56-B4-C29 A45-B1-C30 A34-B2-C30 A68-B3-C29 A57-B4-C29 A46-B1-C30 A35-B2-C30 A36-B2-C30 A25-B3-C30 A14-B4-C30 A3-B1-C31 A37-B2-C30 A26-B3-C30 A15-B4-C30 A4-B1-C31 A38-B2-C30 A27-B3-C30 A16-B4-C30 A5-B1-C31 A39-B2-C30 A28-B3-C30 A17-B4-C30 A6-B1-C31 A40-B2-C30 A29-B3-C30 A18-B4-C30 A7-B1-C31 A41-B2-C30 A30-B3-C30 A19-B4-C30 A8-B1-C31 A42-B2-C30 A31-B3-C30 A20-B4-C30 A9-B1-C31 A43-B2-C30 A32-B3-C30 A21-B4-C30 A10-B1-C31 A44-B2-C30 A33-B3-C30 A22-B4-C30 A11-B1-C31 A45-B2-C30 A34-B3-C30 A23-B4-C30 A12-B1-C31 A46-B2-C30 A35-B3-C30 A24-B4-C30 A13-B1-C31 A47-B2-C30 A36-B3-C30 A25-B4-C30 A14-B1-C31 A48-B2-C30 A37-B3-C30 A26-B4-C30 A15-B1-C31 A49-B2-C30 A38-B3-C30 A27-B4-C30 A16-B1-C31 A50-B2-C30 A39-B3-C30 A28-B4-C30 A17-B1-C31 A51-B2-C30 A40-B3-C30 A29-B4-C30 A18-B1-C31 A52-B2-C30 A41-B3-C30 A30-B4-C30 A19-B1-C31 A53-B2-C30 A42-B3-C30 A31-B4-C30 A20-B1-C31 A54-B2-C30 A43-B3-C30 A32-B4-C30 A21-B1-C31 A55-B2-C30 A44-B3-C30 A33-B4-C30 A22-B1-C31 A56-B2-C30 A45-B3-C30 A34-B4-C30 A23-B1-C31 A57-B2-C30 A46-B3-C30 A35-B4-C30 A24-B1-C31 A58-B2-C30 A47-B3-C30 A36-B4-C30 A25-B1-C31 A59-B2-C30 A48-B3-C30 A37-B4-C30 A26-B1-C31 A60-B2-C30 A49-B3-C30 A38-B4-C30 A27-B1-C31 A61-B2-C30 A50-B3-C30 A39-B4-C30 A28-B1-C31 A62-B2-C30 A51-B3-C30 A40-B4-C30 A29-B1-C31 A63-B2-C30 A52-B3-C30 A41-B4-C30 A30-B1-C31 A64-B2-C30 A53-B3-C30 A42-B4-C30 A31-B1-C31 A65-B2-C30 A54-B3-C30 A43-B4-C30 A32-B1-C31 A66-B2-C30 A55-B3-C30 A44-B4-C30 A33-B1-C31 A67-B2-C30 A56-B3-C30 A45-B4-C30 A34-B1-C31 A68-B2-C30 A57-B3-C30 A46-B4-C30 A35-B1-C31 A69-B2-C30 A58-B3-C30 A47-B4-C30 A36-B1-C31 A70-B2-C30 A59-B3-C30 A48-B4-C30 A37-B1-C31 A71-B2-C30 A60-B3-C30 A49-B4-C30 A38-B1-C31 A72-B2-C30 A61-B3-C30 A50-B4-C30 A39-B1-C31 A73-B2-C30 A62-B3-C30 A51-B4-C30 A40-B1-C31 A74-B2-C30 A63-B3-C30 A52-B4-C30 A41-B1-C31 A75-B2-C30 A64-B3-C30 A53-B4-C30 A42-B1-C31 A76-B2-C30 A65-B3-C30 A54-B4-C30 A43-B1-C31 A77-B2-C30 A66-B3-C30 A55-B4-C30 A44-B1-C31 A1-B3-C30 A67-B3-C30 A56-B4-C30 A45-B1-C31 A2-B3-C30 A68-B3-C30 A57-B4-C30 A46-B1-C31 A3-B3-C30 A69-B3-C30 A58-B4-C30 A47-B1-C31 A4-B3-C30 A70-B3-C30 A59-B4-C30 A48-B1-C31 A5-B3-C30 A71-B3-C30 A60-B4-C30 A49-B1-C31 A6-B3-C30 A72-B3-C30 A61-B4-C30 A50-B1-C31 A7-B3-C30 A73-B3-C30 A62-B4-C30 A51-B1-C31 A8-B3-C30 A74-B3-C30 A63-B4-C30 A52-B1-C31 A9-B3-C30 A75-B3-C30 A64-B4-C30 A53-B1-C31 A10-B3-C30 A76-B3-C30 A65-B4-C30 A54-B1-C31 A11-B3-C30 A77-B3-C30 A66-B4-C30 A55-B1-C31 A12-B3-C30 A1-B4-C30 A67-B4-C30 A56-B1-C31 A13-B3-C30 A2-B4-C30 A68-B4-C30 A57-B1-C31 A14-B3-C30 A3-B4-C30 A69-B4-C30 A58-B1-C31 A15-B3-C30 A4-B4-C30 A70-B4-C30 A59-B1-C31 A16-B3-C30 A5-B4-C30 A71-B4-C30 A60-B1-C31 A17-B3-C30 A6-B4-C30 A72-B4-C30 A61-B1-C31 A18-B3-C30 A7-B4-C30 A73-B4-C30 A62-B1-C31 A19-B3-C30 A8-B4-C30 A74-B4-C30 A63-B1-C31 A20-B3-C30 A9-B4-C30 A75-B4-C30 A64-B1-C31 A21-B3-C30 A10-B4-C30 A76-B4-C30 A65-B1-C31 A22-B3-C30 A11-B4-C30 A77-B4-C30 A66-B1-C31 A23-B3-C30 A12-B4-C30 A1-B1-C31 A67-B1-C31 A24-B3-C30 A13-B4-C30 A2-B1-C31 A68-B1-C31 A69-B1-C31 A52-B2-C31 A35-B3-C31 A18-B4-C31 A70-B1-C31 A53-B2-C31 A36-B3-C31 A19-B4-C31 A71-B1-C31 A54-B2-C31 A37-B3-C31 A20-B4-C31 A72-B1-C31 A55-B2-C31 A38-B3-C31 A21-B4-C31 A73-B1-C31 A56-B2-C31 A39-B3-C31 A22-B4-C31 A74-B1-C31 A57-B2-C31 A40-B3-C31 A23-B4-C31 A75-B1-C31 A58-B2-C31 A41-B3-C31 A24-B4-C31 A76-B1-C31 A59-B2-C31 A42-B3-C31 A25-B4-C31 A77-B1-C31 A60-B2-C31 A43-B3-C31 A26-B4-C31 A1-B2-C31 A61-B2-C31 A44-B3-C31 A27-B4-C31 A2-B2-C31 A62-B2-C31 A45-B3-C31 A28-B4-C31 A3-B2-C31 A63-B2-C31 A46-B3-C31 A29-B4-C31 A4-B2-C31 A64-B2-C31 A47-B3-C31 A30-B4-C31 A5-B2-C31 A65-B2-C31 A48-B3-C31 A31-B4-C31 A6-B2-C31 A66-B2-C31 A49-B3-C31 A32-B4-C31 A7-B2-C31 A67-B2-C31 A50-B3-C31 A33-B4-C31 A8-B2-C31 A68-B2-C31 A51-B3-C31 A34-B4-C31 A9-B2-C31 A69-B2-C31 A52-B3-C31 A35-B4-C31 A10-B2-C31 A70-B2-C31 A53-B3-C31 A36-B4-C31 All-B2-C31 A71-B2-C31 A54-B3-C31 A37-B4-C31 A12-B2-C31 A72-B2-C31 A55-B3-C31 A38-B4-C31 A13-B2-C31 A73-B2-C31 A56-B3-C31 A39-B4-C31 A14-B2-C31 A74-B2-C31 A57-B3-C31 A40-B4-C31 A15-B2-C31 A75-B2-C31 A58-B3-C31 A41-B4-C31 A16-B2-C31 A76-B2-C31 A59-B3-C31 A42-B4-C31 A17-B2-C31 A77-B2-C31 A60-B3-C31 A43-B4-C31 A18-B2-C31 A1-B3-C31 A61-B3-C31 A44-B4-C31 A19-B2-C31 A2-B3-C31 A62-B3-C31 A45-B4-C31 A20-B2-C31 A3-B3-C31 A63-B3-C31 A46-B4-C31 A21-B2-C31 A4-B3-C31 A64-B3-C31 A47-B4-C31 A22-B2-C31 A5-B3-C31 A65-B3-C31 A48-B4-C31 A23-B2-C31 A6-B3-C31 A66-B3-C31 A49-B4-C31 A24-B2-C31 A7-B3-C31 A67-B3-C31 A50-B4-C31 A25-B2-C31 A8-B3-C31 A68-B3-C31 A51-B4-C31 A26-B2-C31 A9-B3-C31 A69-B3-C31 A52-B4-C31 A27-B2-C31 A10-B3-C31 A70-B3-C31 A53-B4-C31 A28-B2-C31 A11-B3-C31 A71-B3-C31 A54-B4-C31 A29-B2-C31 A12-B3-C31 A72-B3-C31 A55-B4-C31 A30-B2-C31 A13-B3-C31 A73-B3-C31 A56-B4-C31 A31-B2-C31 A14-B3-C31 A74-B3-C31 A57-B4-C31 A32-B2-C31 A15-B3-C31 A75-B3-C31 A58-B4-C31 A33-B2-C31 A16-B3-C31 A76-B3-C31 A59-B4-C31 A34-B2-C31 A17-B3-C31 A77-B3-C31 A60-B4-C31 A35-B2-C31 A18-B3-C31 A1-B4-C31 A61-B4-C31 A36-B2-C31 A19-B3-C31 A2-B4-C31 A62-B4-C31 A37-B2-C31 A20-B3-C31 A3-B4-C31 A63-B4-C31 A38-B2-C31 A21-B3-C31 A4-B4-C31 A64-B4-C31 A39-B2-C31 A22-B3-C31 A5-B4-C31 A65-B4-C31 A40-B2-C31 A23-B3-C31 A6-B4-C31 A66-B4-C31 A41-B2-C31 A24-B3-C31 A7-B4-C31 A67-B4-C31 A42-B2-C31 A25-B3-C31 A8-B4-C31 A68-B4-C31 A43-B2-C31 A26-B3-C31 A9-B4-C31 A69-B4-C31 A44-B2-C31 A27-B3-C31 A10-B4-C31 A70-B4-C31 A45-B2-C31 A28-B3-C31 A11-B4-C31 A71-B4-C31 A46-B2-C31 A29-B3-C31 A12-B4-C31 A72-B4-C31 A47-B2-C31 A30-B3-C31 A13-B4-C31 A73-B4-C31 A48-B2-C31 A31-B3-C31 A14-B4-C31 A74-B4-C31 A49-B2-C31 A32-B3-C31 A15-B4-C31 A75-B4-C31 A50-B2-C31 A33-B3-C31 A16-B4-C31 A76-B4-C31 A51-B2-C31 A34-B3-C31 A17-B4-C31 A77-B4-C31 Thus, for example, in table 4 the compound denoted as A60-B1-C7 is the product of the combination of group A60 in Table 1 and B 1 in Table 2 and C7 in Table 3, namely 1H-indole-5- carboxylic acid (1- {1- [ (4-methoxy-phenylsulfamoyl)-methyl]-3-phenyl-propylcarbamoyl }-3- methyl-butyl) -amide:

Further preferred are compounds selected from the group consisting of : benzyl (1S-{1S-[(4-methoxyphenylsulfamoyl)-methyl]-3-phenyl-propylc arbamoyl}-3- methyl-butyl) -carbamate (Compound 1); benzyl (1S-{1S-[(4-methoxyphenylsulfamoyl)-methyl]-3-phenyl-propylc arbamoyl}-2- methyl-butyl) -carbamate (Compound 2); tert-butyl (lS- {lS- [ (4-methoxyphenylsulfamoyl)-methyl]-3-phenyl-propylcarbamoyl} -3- methyl-butyl)-carbamate (Compound 3); benzyl (1 S- {1 S- [(3-acetyl-phenylsulfamoyl)-methyl]-3-phenyl-propylcarbamoyl }-3- methyl-butyl) -carbamate (Compound 4); N-{lS-[lS-(4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcar bamoyl]-2-methylbutyl}- 4-methylpiperazine-1-carboxamide (Compound 5); benzyl {1S- [2- (4-methoxyphenylsulfamoyl)-ethylcarbamoyl]-2-methyl-butyl}- carbamate (Compound 6); (2-cyclohexyl-1 S- {3-phenyl-1 S- [(2-phenylaminoethylsulfamoyl)-methyl]- propylcarbamoyl} ethyl) -carbamic acid ter-butyl ester (Compound 7); 4-dimethylamino-N-(lS-{lS-[(4-methoxyphenylsulfamoyl) methyl] -3-phenyl- propylcarbamoyl}-3-methylbutyl)-benzamide (Compound 8); quinoline-6-carboxylic acid (1S- {lS- [ (4-methoxyphenylsulfamoyl) methyl] -3-phenyl- propylcarbamoyl}-3-methyl-butyl)-amide (Compound 9); morpholine-4-carboxylic acid (2-cyclohexyl-lS- (3-phenyl-lS- [ (2-phenylamino- ethylsulfamoyl) methyl]-propylcarbamoyl}-ethyl)-amide (Compound 10); 4-(2-dimethylaminothiazol-4-yl)-N-{lS-[2-(4-methoxyphenylsul famoyl)-ethylcarbamoyl]- 3-methyl-butyl} benzamide (Compound 11);

2S-acetylamino-3-cyclohexyl-N- {1-[(4-methoxyphenylsulfamoyl)-methyl]-3-phenyl- propyl} propionamide (Compound 12); 2R-acetylamino-3-cyclohexyl-N- {1- [ (4-methoxyphenylsulfamoyl) methyl] -3-phenyl- propyl} propionamide (Compound 13); 2RS-acetylamino-3-cyclohexyl-N- {1- [ (4-hydroxyphenylsulfamoyl) methyl] -3-phenyl- propyl}-propionamide (Compound 14); benzyl [6-(4-methoxyphenylsulfamoyl)-5S-(4-methyl-2S-{4-[2-(pyridin -3-ylamino)tiazol- 4-yl]-benzoylamino} pentanoylamino) hexyl] carbamate (Compound 15); N- (1S- { 1S- [ (4-methoxyphenylsulfamoyl) methyl]-3-phenylpropylcarbamoyl}-3-methyl- butyl)-4- [2- (pyridin-3-ylamino) thiazol-4-yl]-benzamide (Compound 16); N-(1S-{lS-[(4-methoxyphenylsulfamoyl) methyl]-3-phenyl-propylcarbamoyl}-3-methyl- butyl) -nicotinamide (Compound 19); N- (1S- { 1S- [ (4-methoxyphenylsulfamoyl)-methyl]-3-phenylpropylcarbamoyl}- 3-methyl- butyl)-isonicotinamide (Compound 20); N- {1- [1- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3- methylbutyl}- 1H-indole-5-carboxamide (Compound 21); tert-butyl [3-(1S-{lS-[(4-methoxyphenylsulfamoyl)-methyl]-3-phenylpropy lcarbamoyl}-3- methyl-butylcarbamoyl) phenyl]-carbamate (Compound 22); 3-amino-N-(lS-{lS-[(4-methoxyphenylSulfamoyl)-methyl]-3-phen ylpropylcarbamoyl}-3- methyl-butyl) -benzamide (Compound 23); N- (lS- {5-amino-lS- [ (4-methoxyphenylsulfamoyl) methyl] pentylcarbamoyl}-3-methyl- butyl)-4-[2-(pyridin-3-ylamino)-thiazol-4-yl]-benzamide (Compound 24); benzyl [lS-(lS-{ [3-(1-hydroxyethyl) phenylsulfamoyl] methyl}-3-phenylpropyl- carbamoyl) -3-methylbutyl] -carbamate (Compound 26); morpholine 4-carboxylic acid (1 S- {5-amino-1 S- [(4-methoxyphenylsulfamoyl) methyl]- pentylcarbamoyl}-2-phenylmethanesulfonylethyl) amide; (5S- [2S- (morpholin-4-ylcarbonyl) amino]-3-phenylmethanesulfonylpropionylamino}-6- phenylsulfamoylhexyl) carbamic acid benzyl ester; morpholine 4-carboxylic acid (1S-{lS-[(4-methoxyphenylsulfamoyl) methyl] -3- phenylpropylcarbamoyl}-2-phenylmethanesulfonylethyl) amide; N- S- {1 S-[(4-methoxy-phenylsulfamoyl)-methyl]-3-phenyl-propylcarbam oyl}- cyclohexyl)-4- [2- (4-methylpiperazin-1-yl) thiazol-4-yl] benzamide; and N-(1S- {1 S-[(4-methoxy-phenylsulfamoyl)-methyl]-3-phenyl-propylcarbam oyl}-

cyclohexyl)-4- (4-propylpiperazin-1-yl)-benzamide.

The names of these compounds were generated using Autonom Version 2.1 or 4.0.

GENERAL SYNTHESIS Compounds of this invention can be made by the methods depicted in the reaction schemes shown below.

The starting materials and reagents used in preparing these compounds are either available from commercial suppliers such as Aldrich Chemical Co. , (Milwaukee, Wis. ), or Bachem (Torrance, Calif. ), or are prepared by methods known to those skilled in the art following procedures set forth in references such as Fieser and Fieser's Reagents for Organic Synthesis, Volumes 1-17 (John Wiley and Sons, 1991); Rodd's Chemistry of Carbon Compounds, Volumes 1-5 and Supplementals (Elsevier Science Publishers, 1989); Organic Reactions, Volumes 1-40 (John Wiley and Sons, 1991), March's Advanced Organic Chemistry, (John Wiley and Sons, 4i Edition) and Larock's Comprehensive Organic Transformations (VCH Publishers Inc., 1989). These schemes are merely illustrative of some methods by which the compounds of this invention can be synthesized, and various modifications to these schemes can be made and will be suggested to one skilled in the art having referred to this disclosure.

The starting materials and the intermediates of the reaction may be isolated and purified if desired using conventional techniques, including but not limited to filtration, distillation, crystallization, chromatography and the like. Such materials may be characterized using conventional means, including physical constants and spectral data.

Unless specified to the contrary, the reactions described herein take place at atmospheric pressure over a temperature range from about-78° C. to about 150 ° C., more preferably from about 0 ° C. to about 125 ° C. and most preferably at about room (or ambient) temperature, e. g. , about 20 ° C.

Compounds of Formula I can be prepared by the procedure illustrated and described in Schemes 1 and 2 below: Compounds of Formula I in which Rl, R, R3, R4, Rs and R6 are as defined in the Summary of the Invention can be prepared by proceeding as in the following Scheme 1 below.

Scheme 1

Compounds of Formula I can be prepared by condensing a compound of formula 4 with a compound of formula 5. The compound of formula 4 may be in a free base or an acid addition salt form, preferably an acid addition salt form (e. g. p-toluenesulfonic acid salt, or the like). Typically, the condensation reaction is carried out under nitrogen in the presence of a suitable condensing agent (e. g. isobutyl chloroformate, PyBOP, HATU, or the like), a non- nucleophilic base (e. g. 4-methylmorpholine, triethylamine, or the like) and a suitable solvent (e. g., THF, DMF, or the like), at-20 to 0 °C, preferably at about-10 °C, and requires 45 minutes to 12 hours to complete. A detailed description of the condensation reaction is found in the Examples, infra.

Compounds of formula 4 in which R3 is as defined in the Summary of the Invention for Formula I can be prepared as illustrated and described below.

Treatment of an N-protected alpha amino acid compound of formula 1 with a condensing agent (e. g. , isobutyl chloroformate, or the like) in the presence of a suitable base (e. g., 4-methylmorpholine, or the like) in a suitable solvent (e. g., THF, etc. ) at a temperature of about-10 to 10 °C, preferably 0 °C, for about 5 to 20 hours, followed by reaction of the resulting anhydride intermediate with a suitable reducing agent (e. g. , sodium borohydride, and the like) provides a 2-N-protected aminoethanol intermediate of formula la. Compounds of formula 1 are commercially available or they can be prepared by methods well known in the

art.

Treatment of la with an alkylsulfonyl halide (e. g., methanesulfonylchloride, or the like) in the presence of a suitable base (e. g., triethylamine, etc. ) and in a suitable solvent (e. g. , DCM, and the like) and at a temperature of about-10 to 10°C, preferably 0 °C, for about 5 to 20 hours provides the corresponding alkylsulfonyloxy derivative. Treatment of the alkylsulfonyloxy derivative with an acylating agent (e. g. , cesium thiolacetate, or the like) in a suitable solvent (e. g. , DMF, and the like) and at a temperature of about 10 to 30 °C, preferably 20°C, for about 5 to 20 hours provides a thioester which upon reaction with chlorine gas in a suitable solvent (e. g. , DCM, and the like) at a temperature of about 10 to 30°C, preferably 20°C, for about 15 minutes to about 2 hours provides a compound of formula 2.

Compounds of formula 3 can be prepared by reacting a compound of formula 2 with an amine of the formula NHRlR2 and then removing the protecting group (PG) to yield a compound of formula 4. Typically, the reaction with the amine is carried out in the presence of a suitable solvent (e. g. , DCM, or the like) and at a temperature of about-10 to 10°C, preferably 0°C, for about 5 to 20 hours. Deprotection can be effected by any means that removes the protecting group and gives the desired product in reasonable yield. For example, when the protecting group is t-butoxycarbonyl, deprotecting can be effected with a suitable anhydrous acid (e. g. , anhydrous hydrogen chloride, anhydrous p-toluenesulfonic acid, or the like) at ambient temperature for about 12 to 24 hours.

Compounds of formula 5 are either commercially available or they can be prepared by methods well known in the art. For examples, t-BOC alanine, t-BOC-leucine, t-BOC- isoleucine are commercially available. Compounds of formula 5 where R6 is other groups within the scope of the invention sacan be readily prepared commercially available alpha amino acids by methods well known in the art. Some such methods are disclosed in US Patent 6,136, 844 the disclosure of which is incorporated by reference in its entirety.

Compounds of Formula I in which Rl, R2, R3, R4, R'and R6 are as defined in the Summary of the Invention can also be prepared from compounds of formula 6 as illustrated and described in Scheme 2 below.

Scheme 2 3 1. deprotect. N O R13 S/ R4R5 2. R60H R R 6 2. R60H R4 R5 H 6 I

Compounds of Formula I can also be prepared by deprotecting a compound of formula 6 and then treating the resulting free amine with an acid of formula R60H or its acid derivative such as acid chloride. The compound of formula 6 may be in a free base or an acid addition salt form, preferably an acid addition salt form (e. g. p-toluenesulfonic acid salt, or the like).

Deprotection can be effected by any means that removes the protecting group and gives the desired product in reasonable yield. A detailed description of the techniques applicable to the creation of protective groups and their removal can be found in T. W. Greene and P. G. M.

Wuts, Protective Groups in Organic Synthesis, John Wiley & Sons, Inc. (3rd Edition) 1999.

For example, when the protecting group is BOC, deprotection can be effected by treating with anhydrous hydrogen chloride in a suitable solvent (e. g. , dichloromethane, diethyl ether, dioxane, or the like), at 10 to 30°C, preferably at about 20°C, and requires about 5 to 10 hours to complete. A detailed description of the deprotection reaction is found in Example 5, infra.

The reaction conditions employed for the coupling of the free amine of compound 6 with R60H depend on the nature of R6OH. For example, if an acid is used, then the reaction is carried out in the presence of a coupling agent such as PyBOP as described in Scheme 1 above.

If an acid chloride is used then the reaction is carried out in the presence of a base such as triethylamine, pyridine, and the like and in a suitable organic solvent such as tetrahydrofuran, methylene chloride, and the like.

The reaction can be carried out at temperatures from about 10 to about 30°C, preferably at about 20°C, and requires 3 to 20 hours to complete. A detailed description of the step 2 reaction is found in the Examples, infra.

Additional Processes for Preparing Compounds of Formula I : Compounds of Formula I in which R6 is hydrogen can be prepared by deacylating a compound of Formula I in which R6 is-X3X4Rl3. For example, deacylation of a compound of Formula I in which R5 is t-butyloxycarbonyl or benzyloxycarbonyl can be effected by treating with anhydrous hydrogen chloride or hydrogen bromide in a suitable solvent (e. g. , DCM, dioxane, glacial acetic acid, or the like) at 10 to 30°C, preferable at about 20°C, for 5 to 20 hours. A detailed description of the reaction is found in the Examples, infra.

Compounds of Formula I can be further treated with a reducing agent (e. g., NaBH4, LiALH4, or the like), in the presence of a suitable solvent (e. g. , tetrahydrofuran (THF), dimethylformamide (DMF) or the like), at 10 to 30°C, preferably at about 20°C, and requires 15 minutes to 2 hours to complete. A detailed description of the reduction reaction is found in the Examples, infra.

A compound of Formula I can be prepared as a pharmaceutically acceptable acid addition salt by reacting the free base form of the compound with a pharmaceutically acceptable inorganic or organic acid. Alternatively, a pharmaceutically acceptable base addition salt of a compound of Formula I can be prepared by reacting the free acid form of the compound with a pharmaceutically acceptable inorganic or organic base. Inorganic and organic acids and bases suitable for the preparation of the pharmaceutically acceptable salts of compounds of Formula I are set forth in the definitions section of this application.

Alternatively, the salt forms of the compounds of Formula I can be prepared using salts of the starting materials or intermediates.

The free acid or free base forms of the compounds of Formula I can be prepared from the corresponding base addition salt or acid addition salt form. For example, a compound of Formula I in an acid addition salt form may be converted to the corresponding free base by treating with a suitable base (e. g. , ammonium hydroxide solution, sodium hydroxide, or the like). A compound of Formula I in a base addition salt form can be converted to the corresponding free acid by treating with a suitable acid (e. g. , hydrochloric acid, or the like).

The N-oxides of compounds of Formula I can be prepared by methods known to those of ordinary skill in the art. For example, N-oxides can be prepared by treating an unoxidized form of the compound of Formula I with an oxidizing agent (e. g., trifluoroperacetic acid, permaleic acid, perbenzoic acid, peracetic acid, meta-chloroperoxybenzoic acid, or the like) in a suitable inert organic solvent (e. g. , a halogenated hydrocarbon such as methylene chloride) at approximately 0°C. Alternatively, the N-oxides of the compounds of Formula I can be prepared from the N-oxide of an appropriate starting material.

Compounds of Formula I in unoxidized form can be prepared from N-oxides of compounds of Formula I by treating with a reducing agent (e. g. sulfur, sulfur dioxide, triphenyl phosphine, lithium borohydride, sodium borohydride, phosphorus trichloride, tribromide, or the like) in a suitable organic solvent (e. g. , acetonitrile, ethanol, aqueous dioxane, or the like) at 0 to 80°C.

Prodrug derivatives of the compounds of Formula I can be made by means known to

those of ordinary skill in the art (e. g. , for further details see Saulnier et al. (1994), Bioorganic and Medicinal Chemistry Letters. No. 16, Vol. 4, pp. 1985-1990). For example, appropriate drugs can be prepared by reacting a non-derivatized compound of Formula I with a suitable carbamylating agent (e. g., 1, l-acyloxyalkylcarbonochloridate, para-nitrophenyl carbonate, or the like).

Protected derivatives of the compounds of Formula I can be made by means known to those of ordinary skill in the art. A detailed description of the techniques applicable to the creation of protective groups and their removal can be found in T. W. Greene and P. G. M. Wuts, Protective Groups in Organic Synthesis, John Wiley & Sons, Inc. (3rd Edition) 1999.

Compounds of Formula I can be prepared as their individual stereoisomers by reacting a racemic mixture of the compound with an optically active resolving agent to form a pair of diastereoisomeric compounds, separating the diastereomers and recovering the optically pure enantiomer. While resolution of enantiomers can be carried out using covalent diastereomeric derivatives of compounds of Formula I, dissociable complexes are preferred (e. g. , crystalline diastereoisomeric salts). Diastereomers have distinct physical properties (e. g. , melting points, boiling points, solubilities, reactivity, and the like) and can be readily separated by taking advantage of these dissimilarities. The diastereomers can be separated by chromatography or, preferably, by separation/resolution techniques based upon differences in solubility. The optically pure enantiomer is then recovered, along with the resolving agent, by any practical means that would not result in racemization. A more detailed description of the techniques applicable to the resolution of stereoisomers of compounds from their racemic mixture can be found in Jean Jacques Andre Collet, Samuel H. Wilen, Enantiomers, Racemates and Resolutions, John Wiley & Sons, Inc. (1981).

In Summary, the compounds of Formula I are made by a process which comprises: (A) reacting a compound of formula 4: R3 0 0 H2NX sNR1R2 4 with a compound of formula 5 : 0 H N R4 Rs Ra Rs in which Rl, R2, R3, R4, R5 and R6 are as defined in the Summary of the Invention ; or (B) reacting a compound of formula 7:

with an acid compound of formula R6OH or an acid derivative thereof, wherein Rl, R2, R3, R Rs and R6 are defined in the Summary of the Invention; and (C) optionally converting a compound of Formula I into a pharmaceutically acceptable salt; (D) optionally converting a salt form of a compound of Formula I to non-salt form; (E) optionally converting an unoxidized form of a compound of Formula I into a pharmaceutically acceptable N-oxide; (F) optionally converting an N-oxide form of a compound of Formula I its unoxidized form; (G) optionally resolving an individual isomer of a compound of Formula I from a mixture of isomers; (H) optionally converting a non-derivatized compound of Formula I into a pharmaceutically prodrug derivative; (I) optionally converting a prodrug derivative of a compound of Formula I to its non- derivatized form; and (J) optionally modifying any of the Rl, R2, R3, R4, Rs and R6 groups.

Pharmacology and Utility The compounds of the invention are cysteine protease inhibitors. In particular the compounds of the invention inhibit the activity of cathepsins B, L, K and/or S and, as such, are useful for treating diseases in which cathepsin B, L, K and/or S activity contributes to the pathology and/or symptomatology of the disease. For example, the compounds of the invention are useful in treating tumor invasion and metastasis, in particular as anti-angiogenic agents, rheumatoid arthritis, osteo arthritis, pneumocystis carinii, acute pancreatitis, inflammatory airway disease and bone and joint disorders. Furthermore, the compounds of the invention are useful in treating bone resorption disorders, e. g. , osteoporosis. The compounds

of the invention also are useful in treating autoimmune disorders, including, but not limited to juvenile onset diabetes, multiple sclerosis, pemphigus vulgaris, Graves disease, myasthenia gravis, systemic lupus erythemotasus, rheumatoid arthritis and Hashimoto's thyroiditis. The compounds of the invention also are useful in treating allergic disorders, including, but not limited to asthma; and allogeneic immune reponses, including, but not limited to, organ transplants or tissue grafts.

The cysteine protease inhibitory activities of the compounds of the invention can be determined by methods known to those of ordinary skill in the art. Suitable izl vitro assays for measuring protease activity and the inhibition thereof by test compounds are known.

Typically, the assay measures protease-induced hydrolysis of a peptide-based substrate. Details of assays for measuring protease inhibitory activity are set forth in Examples 9,10, 11 and 12, infra.

Administration and Pharmaceutical Compositions In general, compounds of Formula I will be administered in therapeutically effective amounts via any of the usual and acceptable modes known in the art, either singly or in combination with another therapeutic agent. A therapeutically effective amount may vary widely depending on the severity of the disease, the age and relative health of the subject, the potency of the compound used and other factors. For example, therapeutically effective amounts of a compound of Formula I may range from 0.1 micrograms per kilogram body weight (llg/kg) per day to 10 milligram per kilogram body weight (mg/kg) per day, typically 1 Lg/k-g/day to 1 mg/kg/day. Therefore, a therapeutically effective amount for a 80 kg human patient may range from 10 ug/day to 100 mg/day, typically 0.1 mg/day to 10 mg/day. In general, one of ordinary skill in the art, acting in reliance upon personal knowledge and the disclosure of this Application, will be able to ascertain a therapeutically effective amount of a compound of Formula I for treating a given disease.

The compounds of Formula I can be administered as pharmaceutical compositions by one of the following routes: oral, systemic (e. g. , transdermal, intranasal or by suppository) or parenteral (e. g. , intramuscular, intravenous or subcutaneous). Compositions can take the form of tablets, pills, capsules, semisolids, powders, sustained release formulations, solutions, suspensions, elixirs, aerosols, or any other appropriate composition and are comprised of, in general, a compound of Formula I in combination with at least one pharmaceutically acceptable excipient. Acceptable excipients are non-toxic, aid administration, and do not adversely affect

the therapeutic benefit of the active ingredient. Such excipient may be any solid, liquid, semisolid or, in the case of an aerosol composition, gaseous excipient that is generally available to one of skill in the art.

Solid pharmaceutical excipients include starch, cellulose, talc, glucose, lactose, sucrose, gelatin, malt, rice, flour, chalk, silica gel, magnesium stearate, sodium stearate, glycerol monostearate, sodium chloride, dried skim milk, and the like. Liquid and semisolid excipients may be selected from water, ethanol, glycerol, propylene glycol and various oils, including those of petroleum, animal, vegetable or synthetic origin (e. g. , peanut oil, soybean oil, mineral oil, sesame oil, or the like). Preferred liquid carriers, particularly for injectable solutions, include water, saline, aqueous dextrose and glycols.

The amount of a compound of Formula I in the composition may vary widely depending upon the type of formulation, size of a unit dosage, kind of excipients and other factors known to those of skill in the art of pharmaceutical sciences. In general, a composition of a compound of Formula I for treating a given disease will comprise from 0. 01 % w to 10% w, preferably 0. 3% w to 1% w, of active ingredient with the remainder being the excipient or excipients. Preferably the pharmaceutical compositions is administered in a single unit dosage form for continuous treatment or in a single unit dosage form ad libitunl when relief of symptoms is specifically required. Representative pharmaceutical formulations containing a compound of Formula I are described in Example 13.

The compounds of Formula I can be administered alone or in combination with other compounds of Formula I or in combination with one or more other active ingredient (s). For example, the compounds of Formula I can be administered in combination with a therapeutically active amount of a bisphosphonic acid or acid ester derivative or any pharmaceutically acceptable salt thereof. Suitable bisphosphonic acids and acid ester derivatives include compounds corresponding to the following formula: wherein X is a bond or (Cl 7) alkylene, each R27 independently is hydrogen or (Ci.

3o) alkyl, R28 and R29 are selected independently from a group consisting of hydrogen, halo,

optionally substituted (C1-30) alkyl, (C3-30) cycloalkyl, hetero (C530) cycloalkyl, optionally substituted (C6 l0) aryl, hetero (C6-10) aryl, NR OR, OR, SR, wherein each R30 independently is hydrogen, (C1-10) alkyl, (C3-10)cycloalkyl, optionally substituted (C6-10)aryl, provided that both R28 and R29 are not selected from hydrogen or hydroxy when X is a bond; or R28 and R29 taken together form (C2-9) alkylene; wherein (C3-lo) cycloalkyl includes adamantyl and the like, hetero (Cs. io) cycloalkyl includes pyrrolidinyl and the like, (C6. to) aryl includes phenyl and naphthyl, and hetero (C6 l0) aryl includes quinolyl, isoquinolyl, pyridyl, furyl, imidazolyl, imidazopyridyl and the like.

Instances wherein R28 and/or R29 are substituted (C1-30) alkyl may include, but are not limited to, (C1-30) alkyl substituted by hetero (C5-10)cycloalkyl, (C6-10) aryl, hetero (C6-lo) aryl, NR3lR3l, OR and SR, wherein each R3l is independently hydrogen or (Cl-io) alkyl; wherein hetero (C5-10) cycloalkyl includes pyrrolidinyl and the like, (C6-lo) aryl includes phenyl and naphthyl, and hetero (C6-io) aryl includes quinolyl, isoquinolyl, pyridyl, furyl, imidazolyl, imidazopyridyl and the like. Suitable optionally substituted aryl groups include, but are not limited to, halo-substituted phenyl.

A non-limiting class of bisphosphonic acids and acid ester derivatives thereof suitable for administration in combination with compounds of Formula I include those in which R28 is selected from the group consisting of hydrogen, hydroxy or halo, and R29 is selected from the group consisting of optionally substituted (C1-30) alkyl, halo and SR30, wherein R30 is (C1-, io) alkyl or phenyl.

A non-limiting subclass of bisphosphonic acids and acid ester derivatives thereof suitable for administration in combination with compounds of Formula I include those in which R28 is selected from the group consisting of hydrogen, hydroxy and chloro and R29 is selected from the group consisting of optionally substituted (C1-30) alkyl, chloro and chlorophenylthio.

A non-limiting example of a bisphosphonic acid suitable for administration in combination with compounds of Formula I include that in which X is a bond, each R27 is hydrogen, R28 is hydroxy and R29 is 3-aminopropyl, namely 4-amino-1-hydroxybutylidene- 1,1-bisphosphonic acid (aka alendronic acid), or the monosodium trihydrate salt thereof, namely 4-amino-1-hydroxybutylidene-1, 1-bisphosphonate monosodium trihydrate (aka alendronate monosodium trihydrate), described in U. S. Patents 4,922, 007, to Kieczykowski et al. , issued May 1,1990 ; 5,019, 651, to Kieczykowski et al. , issued May 28,1991 ; 5,510, 517, to Dauer et al. , issued April 23,1996 ; 5,648, 491, to Dauer et al. , issued July 15,1997, all of

which patents are incorporated by reference herein in their entirety.

Further non-limiting examples of bisphosphonic acids suitable for administration in combination with compounds of Formula I include the following: cycloheptylaminomethylene-1, 1-bisphosphonic acid (aka cimadronic acid), described in U. S. Patent 4,970, 335, to Isomura et al. , issued November 13,1990 ; 1, 1-dichloromethylene-1, 1-diphosphonic acid (aka clodronic acid) and the disodium salt thereof, namely clodronate disodium, described in Belgium Patent 672,205 (1966) and J.

Org. Cherra 32, 4111 (1967); 1-hydroxy-3-pyrrolidin-1-ylpropylidene-l, l-bisphosphonic acid (aka EB-1053); 1-hydroxyethylidene-1, 1-diphosphonic acid (aka etidronic acid) ; 1-hydroxy-3- (N-methyl-N-pentylamino) propylidene-1, 1-bisphosphonic acid (aka ibandronic acid), described in U. S. Patent No. 4,927, 814, issued May 22,1990 ; 6-amino-1-hydroxyhexylidene-1, 1-bisphosphonic acid (aka neridronic acid) ; 3-(dimethylamino)-1-hydroxypropylidene-1, 1-bisphosphonic acid (aka olpadronic acid) ; 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid (aka pamidronic acid); 2-pyrid-2-ylethylidene-1, 1-bisphosphonic acid (aka piridronic acid), described in U. S.

Patent No. 4,761, 406; 1-hydroxy-2-pyrid-3-ylethylidene-1, 1-bisphosphonic acid (aka risedronic acid); 4-chlorophenylthiomethylenebisphosphonic acid (aka tiludronic acid), described in U. S.

Patent 4,876, 248, to Breliere et al. , October 24,1989 ; and 1-hydroxy-2- (IH-imidazol-1-yl) ethylidene-I, I-bisphosphonic acid (aka zoledronic acid); all of which patents and other documents referred to above are incorporated by reference herein in their entirety.

A non-limiting subclass of bisphosphonic acids suitable for administration in combination with compounds of Formula I include those selected from the group consisting of alendronic acid, cimadronic acid, clodronic acid, tiludronic acid, etidronic acid, ibandronic acid, risedronic acid, piridronic acid, pamidronic acid, zolendronic acid, pharmaceutically acceptable salts thereof, and mixtures thereof. A further example of a bisphosphonic acid suitable for administration in combination with compounds of Formula I is alendronic acid or a pharmaceutically acceptable salt thereof, and mixtures thereof. A further non-limiting example is alendronate monosodium trihydrate.

Compounds of Formula I can be administered in combination with a therapeutically

active amount of an estrogen receptor agonist. Non-limiting examples of estrogen receptor agonists suitable for administration in combination with the compounds of Formula I include naturally occurring estrogens such as estradiol, estrone and estroil, or synthetic estrogen receptor agonists such as [6-hydroxy-2- (4-hydroxyphenyl) benzo [b] thien-3-yl] [4- (2-piperidin- 1-ylethoxy) phenyl] methanone (aka raloxifene) and {2- [4- (1, 2-diphenylbut-1-enyl)- phenoxy] ethyl} dimethylarnine (aka tamoxifen). A non-limiting subclass of estrogen receptor agonists suitable for administration in combination with the compounds of Formula I include estrogen receptor partial agonists (i. e. , estrogen receptor agonists with mixed agonist/antagonist properties), sometimes referred to as estrogen receptor modulators. Estrogen receptor partial agonists can exert tissue-selective estrogen agonist effects. Tamoxifen, for example, selectively exerts an estrogen agonist effect on the bone, in humans. Additional suitable estrogen receptor partial agonists are described in Tissue-Selective Actions Of Estrogen Analogs, Bone Vol. 17, No. 4, October 1995, 181S-190S. Certain 3- [4- (2-phenylindol-1-ylmethyl) phenyl] acrylamides, described in U. S. Patent 5,985, 910 to Miller et al., November 16,1999 ; benzothiphene compounds, described in U. S. Patent 5,985, 897 to Meuhl et al., November 16,1999 ; naphthyl compounds, described in U. S. Patent 5,952, 350 to Cullinan et al., September 14,1999 ; substituted benzothiophene compounds, described in U. S. Patent 5,962, 475 to Schmid et al., October 4,1999, are suitable estrogen receptor partial agonists for administration with the compounds of Formula I ; all of which patents and other documents referred to above are incorporated by reference herein in their entirety.

More particularly a pharmaceutical composition of this invention may comprise a therapeutically effect amount of a compound of Formula I in combination with one or more active ingredient (s) selected from the group consisting of (i) a therapeutically effect amount of a bisphosphonic acid or acid ester thereof or a pharmaceutically acceptable salt thereof and (ii) a therapeutically effect amount of an estrogen receptor agonist or a pharmaceutically acceptable salt thereof; and one or more pharmaceutically acceptable excipient (s).

Non-limiting examples of such bisphosphonic acids include 1, 1-dichloromethylene-1, 1- diphosphonic acid, 1-hydroxy-3-pyrrolidin-1-ylpropylidene-1, 1-bisphosphonic acid, 1-hydroxyethylidene-1, 1-diphosphonic acid, 1-hydroxy-3- (N-methyl-N-pentylamino)- propylidene-1,1-bisphosphonic acid, 6-amino-1-hydroxyhexylidene-1, 1-bisphosphonic acid, 3- (dimethylamino)-1-hydroxypropylidene-1, 1-bisphosphonic acid, 3-amino-1-hydroxy- propylidene-1, 1-bisphosphonic acid, 2-pyrid-2-ylethylidene-1,1-bisphosphonic acid, 1-

hydroxy-2-pyrid-3-ylethylidene-1, 1-bisphosphonic acid, 4-chlorophenylthiomethylene- bisphosphonic acid and l-hydroxy-2-(lH-imidazol-l-yl) ethylidene-l, 1-bisphosphonic acid or acid ester thereof or a pharmaceutically acceptable salt thereof ; particularly l, l-dichloromethylene-l, 1-diphosphonic acid or a pharmaceutically acceptable salt thereof and preferably 1, 1-dichloromethylene-1, 1-diphosphonate monosodium trihydrate.

EXAMPLES The following preparations of intermediates (References) and compounds of Formula I (Examples) are given to enable those skilled in the art to more clearly understand and to practice the present invention. They should not be considered as limiting the scope of the invention, but merely as being illustrative and representative thereof.

REFERENCE 1 Synthesis of tert-butyl lS-(4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamate, i. e. , a compound of formula 3 in which PG is tert-butoxycarbonyl, R1 is 4-methoxyphenyl and R3 is 2-phenylethyl A mixture of 1S-chlorosulfonylmethyl-3-phenylpropylcarbamate (0.96 g, 2.76 mmol) and 4-methoxyaniline (0.34 g, 2.76 mmol) in DCM (15 mL) was cooled to 0°C and triethylamine (0.846 mL, 6.07 mmol) was added. The mixture was stirred at room temperature for approximately 12 hours and then diluted with DCM (30 mL). The dilution was washed with IN hydrochloric acid (30 mL), saturated aqueous sodium bicarbonate (30 mL), dried over magnesium sulfate, filtered and concentrated to dryness to provide tert-butyl 1S- (4- methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamate (0.60 g, 50% yield). Rf 0.4, 30% ethyl acetate/hexane. 1H NMR (CDCI3) : 1.42 (9H, s); 1.75-1. 85 (2H, m); 2.52-2. 75 (2H, m); 3.08 (2H, m) ; 3.75 (3H, s); 4.05 (1H, m); 5.02 (1H, d, J=9 Hz); 6.75 (2H, d, J= 8 Hz) 7.07-7. 28 (8H, m*).

Proceeding as in Reference 1 and using appropriate starting materials provided the

following compounds of Formula 3: tent-butyl lS- (4-hydroxyphenylsulfamoylmethyl)-3-phenylpropylcarbamate ; Rf 0.45 (10% methanol/DCM) ; test-butyl IS- (3-acetylphenylsulfamoylmethyl)-3-phenylpropylcarbamate ; Rf 0. 25 (30% ethyl acetate/hexane); benzyl 5S-tert-butoxycarbonylamino-6- (4-methoxyphenylsulfamoyl) hexylcarbamate ; MS: (M+1) 536; and benzyl 2- (4-methoxyphenylsulfamoyl) ethylcarbamate ; 1H NMR (chloroform-d) : 3.20 (2H, t, J=6 Hz); 3.67 (2H, q, J=6 Hz); 3. 78 (3H, s); 5.. 08 (2H, s); 5.39 (1H, t, J=6 Hz); 6.76 (1H, s); 6.82 (2H, d, J=9 Hz); 7.17 (2H, d, J=9 Hz); 7.32 (5H, s).

REFERENCE 2 Synthesis of 2S-amino-N- (4-methoxyphenyl)-4-phenylbutane-l-sulfonamide hydrochloride, i. e. , a compound of formula 4 in which Rl is 4-methoxyphenyl and R3is phenethyl A solution comprised of crude tert-butyl 1- (4-methoxyphenylsulfamoylmethyl)-3- phenylpropylcarbamate (1.92 g, 4.42 mmol), prepared as in Reference 1, in DCM (10 mL) was treated with a 4M solution of hydrogen chloride in dioxane (11 mL). The mixture was stirred for 16 hours at room temperature and diluted with diethyl ether. A resulting precipitate was collected by filtration, washed several times with diethyl ether and hexane and pumped dry to provide 2S-amino-N-4-methoxyphenyl-4-phenylbutane-1-sulfonamide hydrochloride with quantitative mass recovery. 1H NMR (DMSO): 2.05 (2H, m); 2.6-2. 7 (2H, m); 3.4 (3H, m*); 3.72 (3H, s); 6.9 (2H, d, J=7 Hz); 7.25 (5H, m); 7.3 (2H, d, J=7 Hz); 8.5 (br. s); 10.0 (1H, s).

Proceeding as in Reference 2 provided the following compounds of Formula 4: 2S-amino-N- (4-hydroxyphenyl)-4-phenylbutane-1-sulfonamide hydrochloride ; 1H NMR (DMSO) : 2.09 (2H, m); 2.72 (2H, m*); 3.68 (1H, m); 3.91-3. 94 (2H, 2xdd); 7. 22 (7H, m*); 7.67 (2H, d, J=7 Hz); 8.64 (2H, d, J=7 Hz); 8.7 (m*); and benzyl 5S-amino-6- (4-methoxyphenylsulfamoyl) hexylcarbamate hydrochloride.

REFERENCE 3 Synthesis of N- (3-acetylphenyl)-2S-amino-4-phenylbutane-1-sulfonamide p-toluenesulfonate, ie. , a compound of formula 4 in which R'is 3-acetylphenyl and R3 is 2-phenylethyl:

A solution comprised of crude tert-butyl 1S- (3-acetylphenylsulfamoylmethyl)-3- phenylpropylcarbamate, prepared as in Reference 1, in DCM (3 mL) was treated with azeotropically dried anhydrous p-toluenesulfonic acid (1.3 g, 6.83 mmol) in ether (3 mL). The mixture was stirred at room temperature for approximately 12 hours, diluted with diethyl ether (100 mL), washed with diethyl ether (2x30 mL) and pumped dry to provide N- (3- acetylphenyl)-2S-amino-4-phenylbutane-1-sulfonamide p-toluenesulfonate (1.59 g, 59% yield). zu NMR (DMSO-d6). 1.99 (2H, m*); 2.28 (3H, s); 2.56 (3H, sl) ; 2. 61 (2H, m*), 3. 42-3.54 (3H, m*) ; 7.09-7. 77 (13H, m*); 8.01 (2H, br. s); 10.4 (1H, s). MS (M+1, free amine): 347.

REFERENCE 4 Synthesis of 2-amino-N- (4-methoxyphenyl) ethanesulfonamide, i. e. , a compound of formula 4 in which Rl is 4-methoxyphenyl and R3 is hydrogen

A solution comprised of benzyl 2- (4-methoxyphenylsulfamoyl) ethylcarbamate (2.78 g, 7.63 mmol), prepared as in Reference 1, in ethanol (20 mL) and cyclohexene (20 mL) was treated with 20% palladium hydroxide (0.95 g). The mixture was heated at reflux for 2 hours, cooled, and concentrated to dryness. The solid was triturated with ether, filtered and dried to provide 2-amino-N (4-methoxyphenyl) ethanesulfonamide (1.08 grams, 61% yield). 1H NMR (DMSO-d6) : 2.86 (2H, t, J=6.4 Hz); 3.04 (2H, t, J=6.4 Hz); 3.72 (3H, s); 4.16 (2H, br. s); 6.87 (2H, d, J=9 Hz); 7.05 (2H, d, J=9 Hz).

REFERENCE 5 Synthesis of tert-butyl lS-chlorosulfonylmethyl-3-phenylpropylcarbamate, i. e. , a compound of formula 2 in which R3 is phenethyl and PG is tert-butoxycarbonyl

A solution comprised of 2S-tert-butoxycarbonylamino-4-phenylbutyric acid (20.27 g, 72.56 mmol) in THF (100 mL) was cooled to 0 °C and then 4-methylmorpholine (7.98 mL, 72.56 mmol) and isobutyl chloroformate (9.41 mL, 72.56 mmol) were added. The mixture was allowed to stand for 10 minutes and then filtered. The filter was washed through with THF (100 mL) and the combined filtrates were added, with rapid stirring, to a solution of sodium borohydride (5.45 g, 145.1 mmol) in water (200 mL) at 0°C. The mixture was stirred for 30 minutes and then diluted with saturated aqueous sodium bicarbonate (400 rnL) and ethyl acetate (200 mL). The mixture was stirred vigorously for 20 minutes, separated, and the organic phase was washed with brine (100 mL). The solution was dried over magnesium sulfate, filtered, and evaporated to dryness to provide ter-butyl 1S-hydroxymethyl-3- phenylpropylcarbamate.

The tert-butyl 1S-hydroxymethyl-3-phenylpropylcarbamate was dissolved in DCM (200 mL). The solution was cooled to 0°C and then triethylamine (27.31 mL, 195.9 mmol) was added. The mixture was stirred vigorously while methanesulfonyl chloride (13.48 mL, 174.1 mmol) was added over 5 minutes. The mixture was stirred for an additional 30 minutes and then diluted with water (200 mL). The dilution was stirred for an additional 30 minutes and then the organic phase was separated, dried over magnesium sulfate, filtered, and evaporated to dryness to provide tert-butyl 1S-methanesulfonyloxymethyl-3-phenylpropylcarbamate.

A solution of cesium thiolacetate was prepared by treating a solution of thiolacetic acid (10.36 mL, 145.1 mmol) in methanol (100 mL) with cesium carbonate (23.64 g, 72.56 mmol), concentrating the mixture and dissolving the residue in DMF (50 mL). The tert-butyl 1S- methanesulfonyloxymethyl-3-phenylpropylcarbamate was dissolved in DMF (50 mL) and added to the cesium thiolacetate solution. The mixture was stirred at room temperature for

approximately 12 hours and diluted with water (500 mL) and then ethyl acetate (300 mL). The mixture was stirred vigorously for 20 minutes and the organic phase was separated, washed with 1N hydrochloric acid (200 mL), saturated aqueous sodium bicarbonate (200 mL) and brine (200 mL), dried over a mixture of magnesium sulfate and decolorizing charcoal, filtered, and concentrated to dryness to provide tert-butyl 1S-acetylsulfanylmethyl-3- phenylpropyl) carbamate.

The tert-butyl 1S-acetylsulfanylmethyl-3-phenylpropyl) carbamate (14.73 g, 45.54 mmol) was dissolved in a 1: 1 mixture of DCM: water (500 mL). The biphasic mixture was stirred rapidly and cooled to 0°C. Chlorine gas was bubbled into the solution for approximately 30 minutes (to the saturation point). The organic layer was separated, dried over magnesium sulfate, filtered, concentrated and the residue was recrystallized from DCM/hexane to provide tert-butyl 1S-chlorosulfonylmethyl-3-phenylpropylcarbamate (9.80 g, 62% yield).

Proceeding as in Reference 5 and using appropriate starting materials provided the following compounds of Formula 2: (2-chlorosulfonylethyl) -carbamic acid ter-butyl ester; (5-tert-butoxycarbonylamino-6-chlorosulfonylhexyl)-carbamic acid benzyl ester; and (5-amino-1-chlorosulfonylmethylpentyl)-carbamic acid tert-butyl ester.

REFERENCE 6 Synthesis of 2S-amino-N-[lS-(4-methoxyphenylsulfamoylmethyl)-3-phenylprop yl]-4-methyl- pentanamide hydrochloride, i. e., a compound of formula 6 in which R'is 4-methoxyphenyl, R3 is 2-phenethyl and R4 is 2-methylpropyl and R5 is hydrogen

A solution of tert-butyl 1S- [lS- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropyl- carbamoyl]-3-methylbutylcarbamate (1.1 g, 2 mmol) in dichloromethane (5 mL) was treated with a 1M solution of hydrogen chloride in diethyl ether (20 mL), with stirring, at room temperature for 5 hours and then concentrated to provide 2S-amino-N- [1S- (4- methoxyphenylsulfamoylmethyl)-3-phenylpropyl]-4-methylpentan amidehydrochloride (810 mg, 84% yield).

EXAMPLE 1 Synthesis of benzyl 1S- [1S- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3- methylbutylcarbamate (Compound 1) A solution comprised of 2S-benzyloxycarbonylamino-4-methylpentanoic acid (0.25 g, 0.944 mmol) in THF (10 mL) was cooled to-10 °C and then 4-methylmoipholine (0.104 mL, 0.944 mmol) and isobutyl chloroformate (0.122 mL, 0.944 mmol) were added. The reaction mixture was allowed 5 minutes and then 2S-amino-N- (4-methoxyphenyl)-4-phenylbutane-l- sulfonamide hydrochloride (0.35 g, 0.944 mmol), prepared as in Reference 2, and 4- methylmorpholine (0.104 mL, 0.944 mmol) were added sequentially. The reaction mixture was stirred for 45 minutes and then ethyl acetate (50 mL) was added. The reaction mixture was washed with IN hydrochloric acid, saturated sodium bicarbonate and brine (10 mL each), dried

over MgS04, filtered and concentrated. Product was purified from the residue on a silica gel column, mobile phase 30-50% ethyl acetate/hexane and crystallized from DCM/diethyl ether/hexane to provide benzyl 1S-[1S-(4-methoxyphenylsulfamoylmethyl)-3- phenylpropylcarbamoyl]-3-methylbutylcarbamate (0.172 g, 31% yield)l. 1H NMR (CDCl3) : 0.91 (6H, 2xd*); 1.4-1. 81 (4H, m*); 1.93 (1H, m); 2.55 (2H, m); 3.1-3. 26 (2H, 2xdd); 3.74 (3H, s); 4.18 (1H, m); 4.22 (1H, m); 5.07 (2H, dd); 5.48 (1H, d, J=7 Hz); 6.76 (2H, d, J=9 Hz); 6.89 (1H, d); 7.04-7. 28 (12H, m); 7.87 (1H, s). MS (M+1) 582.

Proceeding as in Example 1 provided the following compounds of Formula I: benzyl 1S-[1S-(4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbam oyl]-2- methyl-butyl-carbamate (Compound 2) ; 1H NMR (CDCl3) : 0. 85 (3H, t, J=6.5 Hz); 0.91 (3H, d, J=6.5 Hz) ; 1.12 (1H, m); 1.52 (1H, m); 1.8-2. 05 (4H, m*); 2.55 (2H, m*); 3.18 (2H, m); 3.73 (3H, s); 4.03 (1H, m); 4.31 (1H, m); 5.09 (2H, dd); 5.31 (1H, br d); 6.76 (3H, d + m); 7.05- 7.31 (12H, m); 7.62 (1H, s). MS (M+1) : 582 ; tert-butyl IS- [lS- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3- methyl-butylcarbamate (Compound 3) ; lH NMR (CDC13) : 0.85 (6H, 2xd*); 0.93 (1H, m k) ; 1.44 (9H, s); 1.37-1. 62 (3H, m*). 2.07 (2H, m); 2.64 (2H, m); 3.62 (1H, dd, J=13.6, 3.7 Hz); 3.79 (3H, s); 3.91 (1H, dd*) ; 3.96 (1H, m*) ; 4.31 (1H, m); 4.81 (1H, m); 6.5 (1H, d, J=7.4 Hz); 7. 1-7. 26 (7H) ; benzyl 1 S- [1 S-(3-acetylphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3 - methylbutyl-carbamate (Compound 4); Rf (TLC, 20% ethyl acetate/CH2CIz) : 0. 65 ;'H NMR (CDCl3) ; 0.93 (6H, 2xd, J=6 Hz) ; 1.52 (1H, m); 1.67 (2H, m); 1.83 (1H, m); 1.98 (1H, m); 2.54-2. 59 (5H, s, m*); 3.14-3. 37 (2H, 2xdd); 4.11 (1H, m); 4.25 (1H, m); 5.07-5. 11 (3H, s, d*); 6.59 (1H, d, J=8.4 Hz); 7.04-7. 38 (13 H); 7.69 (1H, d); 7.82 (1H, s) ; 8.14 (1H, s). MS (M+1) : 594; N- {1S-[lS-(4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarba moyl]-2- methylbutyl}-4-methylpiperazine-1-carboxamide (Compound 5) ;'H NMR (CDCl3) : 0.9 (3H, t, J=6 Hz); 1.00 (3H, d, J=6 Hz); 1.19 (1H, m); 1.56 (1H, m); 1.85 (1H, m); 2.01 (2H, m); 2. 30 (3H, s); 2.42 (4H, m); 2.56 (2H, m); 3.15-3. 32 (2H, 2xdd); 3.43 (4H, m); 3.77 (3H, s); 4.07 (1H, t, J=6 Hz); 4.23 (1H, m); 4.89 (1H, br d); 6.78 (2H, d); 7.00 (1H, d); 7.05-7. 25 (7H, m); 8.28 (1H, br s). MS (M+) 574; and benzyl 1 S- [2- (4-methoxyphenylsulfamoyl) ethylcarbamoyl]-2-methylbutylcarbamate (Compound 6); Rf (TLC: 50% ethyl acetate/CH2Cl2) : 0.65 ; 1H NMR (CDC13) : 0.84-0. 92 (6H, . d, t*); 1.09 (1H, m); 1.46 (1H, m); 1.89 (1H, m); 3.22 (2H, m); 3.68 (2H, m*); 3.74 (3H, s);

4.01 (1H, t, J=6 Hz) ; 5.02 (2H, dd); 5.35 (dgl, d, J=8 Hz); 6.85 (2H, d, J=7. 5 Hz) ; 7.24 (2H, 7.5 Hz) ; 7.30 (6H, s, d*).

(2-cyclohexyl-1 S- {3-phenyl-1 S-[(2-phenylaminoethylsulfamoyl)-methyl]- propylcarbamoyl} ethyl) -carbamic acid tert-butyl ester (Compound 7); EXAMPLE 2 Synthesis of 4-dimethylamino-N- {1S-[1S-(4-methoxyphenylsulfamoylmethyl)-3- phenylpropylcarbamoyl]-3-methylbutyl} benzamide (Compound 8) A solution comprised of 2S-amino-N-(4-methoxyphenyl)-4-phenylbutane-1- sulfonamide hydrochloride (0.371 g, 1 mmol), prepared as in Reference 2, 2S- (4- dimethylaminobenzoylamino) -4-methylpentanoic acid (0. 278 g, 1 mmol) and PyBOP (0.52 g, 1 mmol) in DMF (10 mL) was treated with triethylamine (0.418 mL, 3 mmol). The mixture was stirred at room temperature for approximately 12 hours and then diluted with ethyl acetate (30 mL), washed with IN hydrochloric acid (10 mL) and saturated aqueous sodium bicarbonate (10 mL), dried (MgSO4), filtered and concentrated to dryness. The product was crystallized twice from DCM/diethyl ether/hexane to provide 4-dimethylamino-N-{1S-[1S-(4-methoxyphenyl- sulfamoylmethyl)-3-phenylpropylcarbamoyl]-3-methylbutyl} benzamide (50 mg, 8. 4% yield) as a diastereomeric/rotameric mixture.'H NMR (CDC13) : 0.85-1. 1 (6H, 2x d, t); 1.25 (1H, m); 1.5-2. 2 (SH, 5x m*); 2.56 (2H, m); 3.02 (6H, s); 3.04-3. 19 (2H, m*); 3.72 (3H, 2x s) 4.2-4. 44 (1H, m*); 4.45, 4.67 (1H total, 2 x dd); 6.7 (4H, 2x d*); 7.06-7. 24 (8H, m*) ; 7.69 (2H, d, J= 8.7 Hz); 7.92, 8.0 (1H total, 2x s).

Proceeding as in Example 2 provide the following compounds of Formula I : quinoline-6-carboxylic acid (1- {1- [ (4-methoxyphenylsulfamoyl)-methyl]-3-phenyl- propylcarbamoyl}-3-methylbutyl)-amide (Compound 9); morpholine-4-carboxylic acid (2-cyclohexyl-1 S- {3-phenyl-1 S-[(2-phenylamino- ethylsulfamoyl) methyl]-propylcarbamoyl}-ethyl)-amide (Compound 10); 4-(2-dimethylaminothiazol-4-yl)-N- {1 S-[2-(4-methoxyphenylsulfamoyl)-

ethylcarbamoyl]-3-methyl-butyl} benzamide (Compound 11); (S)-2-acetylamino-3-cyclohexyl-N- {1- [ (4-methoxyphenylsulfamoyl)-methyl]-3-phenyl- propyl}-propionamide (Compound 12); (R)-2-acetylamino-3-cyclohexyl-N- {1- [ (4-methoxyphenylsulfamoyl) methyl]-3-phenyl- propyl}-propionamide (Compound 13); 2 (RS)-aeetylamino-3-cyclohexyl-N-{1- [(4-hydroxyphenylsulfamoyl) methyl]-3-phenyl- propyl}-propionamide (Compound 14).

EXAMPLE 3 Synthesis of benzyl 6- (4-methoxyphenylsulfamoyl)-SS- {4-methyl-2S- [4- (2-pyridin-3- ylaminothiazol-4-yl)-benzoylamino] pentanoylamino} hexylcarbamate (Compound 15) A solution comprised of benzyl 5S-amino-6- (4-methoxyphenylsulfamoyl)- hexylcarbamate hydrochloride (0.254 g, 0.539 mmol), prepared as in Reference 2, 4-methyl-2S- [4- (2-pyridin-3-ylaminothiazol-4-yl) benzoylamino] pentanoic acid hydrochloride (0. 232 g, 0.539 mmol) and PyBOP (0.281 g, 0.539 mmol) in DMF (5 mL) was treated with triethylamine (0.226 mL, 1.62 mmol). The reaction mixture was stirred at room temperature for 90 minutes and then diluted with ethyl acetate (30 mL), washed with saturated aqueous sodium bicarbonate (20 mL), brine (5 mL), dried (MgS04), °filtered and concentrated to dryness. The residue was triturated with 5: 1 ether/dichloromethane. Solids were collected by filtration and product was purified on a short path of silica gel using 50% ethyl acetate/DCM followed by 5% methanol/DCM to provide benzyl 6- (4-methoxyphenylsulfamoyl)-SS- {4-methyl-2S- [4- (2- pyridin-3-ylaminothiazol-4-yl) benzoylamino]-pentanoylamino} hexylcarbamate. Rf (TLC: 10% methanol/DCM): 0. 45.'H NMR (DMSO-d6) : 0.88 (6H, 2xd); 0.9-1. 75 (9H, m*); 2.93 (2H, m); 3.09 (2H, m); 3.69 (3H, s); 4.19 (1H, m); 4.39 (1H, m); 4.99 (2H, s). 6.88 (2H, m); 7.13- 7.7. 45 (9H, m); 7.57 (1H, s); 7.98 (SH, m*); 8.19 (1H, d, J= 5 Hz); 8.29 (1H, d, J=7 Hz); 8.43 (1H, d, J=6 Hz); 8.86 (1H, d, J=2.4 Hz); 9.45 (1H, s); 10.6 (1H, s). MS (M+1) : 828.

Proceeding as in Example 3 the following compounds of Formula I were prepared: N- {1S-[1S-(4-methoxyphenylfulfamoylmethyl)-3-phenylpropylcarba moyl]-3-methyl- butyl}-4- (2-pyridin-3-ylaminothiazol-4-yl) benzamide (Compound 16) ; 1H NMR (DMSO-d6) 0.87 (6H, 2xd); 1.23 (1H, m*) ; 1.5-1. 86 (3H, mt) ; 1.99 (1H, m); 2.59 (2H, m); 3.15 (2H, m); 3.70 (3H, s); 4.24 (1H, m); 4.47 (1H, m); 6.87 (2H, d, J=9 Hz); 7.14-7. 25 (7H, m); 7.43 (1H, dd); 7.58 (1H, s); 7.99 (4H, 2xd); 8.14 (1H, d); 8.19 (1H, d); 8.3 (1H, d); 8.53 (1H, d); 8.86 (1H, d); 9.48 (1H, s); 10.55 (1H, s). MS (M+1) : 727.

EXAMPLE 4 Synthesis of N- {1S- [1S- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3- methylbutyl} nicotinamide (Compound 19) A mixture comprised of 2S-amino-N- [lS- (4-methoxyphenylsulfamoylmethyl)-3- phenylpropyl]-4-methylpentanamide hydrochloride (110 mg, 0.227 mmol), prepared as in Reference 6, and nicotinyl chloride hydrochloride (44 mg, 0.227 mmol) in TIF (2 mL) and DCM (2 mL) was treated with triethylamine (0.095 mL, 0.682 mmol). The mixture was stirred at room temperature for 3 hours and then diluted with ethyl acetate (25 mI,). The dilution was washed with saturated sodium bicarbonate (5 mL), dried (MgSO4), filtered and concentrated to dryness. The residue was dissolved in DCM/diethyl ether/hexane and product was crystallized to provide N- {1 S- [1 S- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3- methylbutyl} nicotinamide (63 mg, 50% yield). Rf (TLC, 50% ethyl acetate/DCM): 0. 25. 1H NMR (CDC13): 0.92-0. 97 (6H, 2xd); 1.7-1. 81 (4H, m*); 1.95 (1H, m); 2.54 (2H, m); 3.16 (2H, dd); 3.78 (3H, s); 4.30 (1H, m); 4.59 (1H, m); 6.74 (2H, d, J=9 Hz); 6.89 (1H, d, J=8 Hz); 7.02- 7.24 (8H, m); 7.37 (1H, dd); 7.96 (1H, br s); 8.12 (1H, d, J=8 Hz); 8.71 (1H, br s); 9.06 (1H, br s). MS (M+1) : 553.

Proceeding as in Example 4 provided: N- {1S- [1S- (4-methoxyphenylsulfamoyl-methyl)-3-phenylpropylcarbamoyl]-3 - methylbutyl}-isonicotinamide (Compound 20); Rf (TLC, 20% ethyl acetate/DCM); 0.1 ;'H

NMR (CDCl3) : 0.96 (6H, 2xd); 1.65-1. 89 (4H, m*); 1.98 (1H, m); 2.57 (2H, m); 3.16 (2H, 2xdd); 3.75 (3H, s); 4.30 (1H, m); 4.59 (1H, m); 6.75 (3H, d, m*); 6.85 (1H, d, J=8 Hz); 7.05- 7.24 (7H, m); 7.59 (3H, m); 8.71 (2H, d); MS (M+1) : 553.

EXAMPLE 5 Synthesis of N- {1- [1- (4-methoxyphenylsulfamoylmethyl)-3-phenylpropylcarbamoyl]-3- methylbutyl}-lH-indole-5-carboxamide (Compound 21) A mixture comprised of and 2S-amino-N-[lS-(4-methoxyphenylsulfamoyl-methyl)-3- phenylpropyl]-4-methylpentanamide hydrochloride (0.100 g, 0.206 mmol), prepared as in Reference 6, and 5-indolecarboxylic acid (33.3 mg, 0.206 mmol) in DCM (2 mL) was treated with triethylamine (0.029 mL, 0.206 mmol) and DCC (0.206 mL of a 1. 0 M DCM solution).

The reaction mixture was stirred at room temperature overnight and then eluted directly through a silica gel column (0-50% ethyl acetate/CH2Cl2 gradient). Product was crystallized from DCM/diethyl ether/hexane to provide N- {1- [1- (4-methoxyphenylsulfamoylmethyl)-3- phenylpropylcarbamoyl]-3-methylbutyl}-1H-indole-5-carboxamid e (58 mg, 48% yield). Rf (TLC, 20% ethyl acetate/CH2C12) : 0.2 ; NMR (CDCl3) : 0.97-1. 02 (6H, 2xd, J=6 Hz); 1.64-1. 98 (5H, m*); 2.54 (2H, m); 3.02-3. 19 (2H, 2xdd); 3.74 (3H, s); 4.27 (1H, m); 4.62 (1H, m); 6.48 (1H, d, J = 7 Hz); 6.61 (1H, s, t); 6.75 (2H, d, J=9 Hz); 6. 94-7. 27 (9H, m*); 7.41 (1H, d); 7.61 (1H, dd); 7.87 (1H, s) ; 8.10 (1H, s); 8.47 (1H, br s); MS (M+1) : 591.

Proceeding as in Example 5 provided: tert-Butyl 3- {1 S- [1S- (4-methoxyphenyl-sulfamoylmethyl)-3-phenylpropylcarbamoyl]- 3-methyl-butylcarbamoylphenyl} carbamate (Compound 22); Rf (TLC, 20% ethyl acetate/CH2C12) : 0.35 ; 1H NMR (CDCl3) : 0.93-0. 99 (6H, 2xd, J=6 Hz); 1.50 (9H, s); 1.42-1. 85 (4H, m*); 1.98 (1H, m); 2.58 (2H, m); 3.13 (2H, m) ; 3.75 (3H, s); 4.30 (1H. m); 4.60 (1H, m); 6.53 (1H, d, J=7 Hz); 6.73 (2H, d, J=9 Hz); 7.0-7. 4 (11H, m*); 7.62 (1H, d, J= 7,5 Hz); 7.72 (1H, s); 7.78 (1H, s); MS (M+1) : 667.

EXAMPLE 6 Synthesis of 3-amino-N- {1S- [lS- (4-methoxyphenylsulfamoylmethyl)-3- phenylpropylcarbamoyl]-3-methylbutyl} benzamide (Compound 23) A solution comprised of tert-butyl 3-{1S-[1S-(4-methoxyphenylsulfamoyl-methyl)-3- phenylpropylcarbamoyl]-3-methylbutylcarbamoyl} phenylcarbamate (20 mg, 30 pool), prepared as in Example 6, in methylene chloride (2 mL) was treated with a 4M solution of hydrochloric acid in dioxane (1 mL) at room temperature for 16 hours and then diluted with diethyl ether (100 mL) to form a precipitate. The precipitate was collected by filtration, washed with ether and dried in vacuo to provide 3-amino-N-{1S-[1S-(4-methoxyphenyl- sulfamoylmethyl)-3-phenylpropylcarbamoyl]-3-methylbutyl} benzamide (14.3 mg, 79% yield).

MS (M+l, free base): 567.

EXAMPLE 7 Synthesis of N-{1S-[5-amino-1S-(4-methoxyphenylsulfamoylmethyl) pentylcarbamoyl] -3- methyl-butyl}-4- (2-pyridin-3-ylaminothiazol-4-yl) benzamide hydrobromide (Compound 24) A solution of benzyl 6- (4-methoxyphenylsulfamoyl)-5S- {4-methyl-2S- [4- (2-pyridin-3- ylamino-thiazol-4-yl) benzoylamino] pentanoylamino} hexylcarbamate (0.1 g, 0.121 mmol),

prepared as in Example 3, in DCM (3 mL) was treated with 30% (0.1 g, 0.3 mL) solution of hydrogen bromide in glacial acetic acid for 3 hours. The solution was diluted with methanol/ether to form a precipitate which was isolated to provide N-f 1S- [5-amino-IS- (4- methoxyphenylsulfamoylmethyl) pentylcarbamoyl]-3-methylbutyl}-4- (2-pyridin-3- ylaminothiazol-4-yl) benzamide hydrobromide (90 mg, 0.1 mmol). 1H NMR (DMSO-d6) : 9.88 (6H, 2xd); 1.2-1. 71 (9H, m); 2.72 (2H, m); 3.12 (2H, m); 3.71 (3H, s); 4.22 (1H, m); 4.43 (1H. m); 6.89 (2H, d, J=9 Hz); 7.14 (2H, d, J=9 Hz);. 75 (3H, s, m*); 8.00-8. 06 (7H, m); 8.53-8. 66 (3H, d, d, m*); 9.47 (1H, s); 9.56 (1H, d, J=2 Hz); 11.55 (1H, s). MS (M+1, free base): 694.

EXAMPLE 8 Synthesis of benzyl 1S- {1S- [3- (l-hydroxyethyl) phenylsulfamoylmethyl]-3- phenylpropylcarbamoyl}-3-methylbutyl-carbamate (Compound 26) A solution comprised of benzyl 1S- [lS- (3-acetylphenylsulfamoylmethyl)-3- phenylpropyl-carbamoyl]-3-methylbutylcarbamate (85 mg, 0.143 mmol), prepared as in Example 1, in THF (5 mL) was treated with sodium borohydride (10 mg, 0.266 mmol). Water (0.5 mL) was added and the mixture was stirred for 30 minutes. Saturated aqueous sodium bicarbonate (5 mL) and ethyl acetate (25 mL) were added and the mixture was stirred for 15 minutes. The organic phase was separated, dried (MgS04), filtered and concentrated to dryness to provide benzyl 1S-11S- [3- (I-hydroxyethyl)-phenylsulfamoylmethyll-3-phenylpropyl- carbamoyl}-3-methylbutylcarbamate (70 mg, 82% yield). Rf (TLC, 20% ethyl acetate/CH2C12) : 0.2-0. 3 (2 spots, corresponding to diastereomers at the hydroxyethyl group). MS (M+1) : 596.

EXAMPLE 9 Cathepsin B Assay Solutions of test compounds in varying concentrations were prepared in 10 pu-ouf

dimethyl sulfoxide (DMSO) and then diluted into assay buffer (40 µL, comprising: N, N-bis (2- hydroxyethyl)-2-aminoethanesulfonic acid (BES), 50 mM (pH 6); polyoxyethylenesorbitan monolaurate, 0.05% ; and dithiothreitol (DTT), 2.5 mM). Human cathepsin B (0.025 pMoles in 25, ut of assay buffer) was added to the dilutions. The assay solutions were mixed for 5-10 seconds on a shaker plate, covered and incubated for 30 minutes at room temperature. Z-FR- AMC (20 nMoles in 25 pL of assay buffer) was added to the assay solutions and hydrolysis was followed spectrophotometrically at (S 460 nm) for 5 minutes. Apparent inhibition constants (ksi) were calculated from the enzyme progress curves using standard mathematical models.

Compounds of the invention were tested by the above-described assay and observed to exhibit cathepsin B inhibitory activity.

EXAMPLE 10 Cathepsin K Assay Solutions of test compounds in varying concentrations were prepared in 10 1L of dimethyl sulfoxide (DMSO) and then diluted into assay buffer (40 uL, comprising: MES, 50 mM (pH 5.5) ; EDTA, 2.5 mM; and DTT, 2.5 mM). Human cathepsin K (0. 0906 pMoles in 25 pat of assay buffer) was added to the dilutions. The assay solutions were mixed for 5-10 seconds on a shaker plate, covered and incubated for 30 minutes at room temperature. Z-Phe- Arg-AMC (4 nMoles in 25 pL of assay buffer) was added to the assay solutions and hydrolysis was followed spectrophotometrically at (R 460 nm) for 5 minutes. Apparent inhibition constants (Ki) were calculated from the enzyme progress curves using standard mathematical models.

Compounds of the invention were tested by the above-described assay and observed to exhibit cathepsin K inhibitory activity.

EXAMPLE 11 Cathepsin L Assay Solutions of test compounds in varying concentrations were prepared in 10 p. L of dimethyl sulfoxide (DMSO) and then diluted into assay buffer (40 FL, comprising: MES, 50 mM (pH 5.5) ; EDTA, 2.5 mM; and DTT, 2.5 mM). Human cathepsin L (0.05 pMoles in 25 µL of assay buffer) was added to the dilutions. The assay solutions were mixed for 5-10 seconds

on a shaker plate, covered and incubated for 30 minutes at room temperature. Z-Phe-Arg- AMC (1 nMoles in 25 p. L of assay buffer) was added to the assay solutions and hydrolysis was followed spectrophotometrically at (R 460 nm) for 5 minutes. Apparent inhibition constants (Ki) were calculated from the enzyme progress curves using standard mathematical models.

Compounds of the invention were tested by the above-described assay and observed to exhibit cathepsin L inhibitory activity.

EXAMPLE 12 Cathepsin S Assay Solutions of test compounds in varying concentrations were prepared in 10 p. L of dimethyl sulfoxide (DMSO) and then diluted into assay buffer (40 pL, comprising: MES, 50 mM (pH 6.5) ; EDTA, 2.5 mM; and NaCI, 100 mM). Human cathepsin S (0. 158 pMoles in 25 pL of assay buffer) was added to the dilutions. The assay solutions were mixed for 5-10 seconds on a shaker plate, covered and incubated for 30 minutes at room temperature. Z-Val- Val-Arg-AMC (9 nMoles in 25 IIL of assay buffer) was added to the assay solutions and hydrolysis was followed spectrophotometrically at (R 460 nm) for 5 minutes. Apparent inhibition constants (K ;) were calculated from the enzyme progress curves using standard mathematical models.

Compounds of the invention were tested by the above-described assay and observed to exhibit cathepsin S inhibitory activity.

EXAMPLE 13 Representative Pharmaceutical Formulations Containing a Compound of Formula I : ORAL FORMULATION Compound of Formula I 10-100 mg Citric Acid Monohydrate 105 mg Sodium Hydroxide 18 mg Flavoring Water q. s. to 100 mL INTRAVENOUS FORMULATION Compound of Formula I 0.1-10 mg

Dextrose Monohydrate q. s. to make isotonic Citric Acid Monohydrate 1.05 mg Sodium Hydroxide 0.18 mg Water for Injection q. s. to 1.0 mL TABLET FORMULATION Compound of Formula I 1 % Microcrystalline Cellulose 73% Stearic Acid 25% Colloidal Silica 1% The foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity and understanding. It will be obvious to one of skill in the art that changes and modifications may be practiced within the scope of the appended claims. Therefore, it is to be understood that the above description is intended to be illustrative and not restrictive. The scope of the invention should, therefore, be determined not with reference to the above description, but should instead be determined with reference to the following appended claims, along with the full scope of equivalents to which such claims are entitled.